var title_f1_49_1808="Single port laparosc set-up";
var content_f1_49_1808=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F85541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F85541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laparoendoscopic single-site surgery: Multichannel ports and instruments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Laparoendoscopic single-site (single port) surgery ports and instruments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission: Cleveland Clinic Center for Medical Art &amp; Photography &copy; 2012. All Rights Reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1808=[""].join("\n");
var outline_f1_49_1808=null;
var title_f1_49_1809="Eustachian tube PI";
var content_f1_49_1809=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F50422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F50422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eustachian tube",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 593px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The eustachian tube is a tube that connects the middle ear (the part of the ear behind the eardrum) to the back of the nose and throat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1809=[""].join("\n");
var outline_f1_49_1809=null;
var title_f1_49_1810="Ileal pouch anal anastomosis";
var content_f1_49_1810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ileal pouch-anal anastamosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anatomy of the J, W, and S ileal pouches used for anastomosis to the anal canal (ileal pouch-anal anastomosis).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     By permission of Mayo Foundation for Medical Education and Research. All rights reserved. This figure has been modified for this publication.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1810=[""].join("\n");
var outline_f1_49_1810=null;
var title_f1_49_1811="Corpus luteum Doppler";
var content_f1_49_1811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hemorrhagic corpus luteum (Doppler color ultrasound)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color Doppler image shows a \"ring of fire\" around a hemorrhagic corpus luteum (CL).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tejas S Mehta, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1811=[""].join("\n");
var outline_f1_49_1811=null;
var title_f1_49_1812="Fatty alcohol cycle";
var content_f1_49_1812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F82067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F82067&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Fatty alcohol cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1812=[""].join("\n");
var outline_f1_49_1812=null;
var title_f1_49_1813="Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Patient drug information";
var content_f1_49_1813=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/46/43749?source=see_link\">",
"     see \"Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/32/27141?source=see_link\">",
"     see \"Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F4090481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cyanokit&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F12785471\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cyanokit&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691430",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop and treat low vitamin B",
"       <sub>",
"        12",
"       </sub>",
"       .",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691802",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cyanide poisoning.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702271",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to hydroxocobalamin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3670069",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cyanide poisoning:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure. Blood pressure most often goes back to normal when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2791739",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of urine to red. May last 5 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697944",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of skin to red. May last 2 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696434",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pimple-like rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3670069",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cyanide poisoning:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3670069",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cyanide poisoning:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10818 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1813=[""].join("\n");
var outline_f1_49_1813=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4090481\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12785471\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017844\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017843\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017848\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017849\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017851\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017846\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017847\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017852\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017853\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/46/43749?source=related_link\">",
"      Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/32/27141?source=related_link\">",
"      Hydroxocobalamin (vitamin B12 supplement and cyanide antidote ): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_49_1814="Antibody mediated rejection in RT biopsy 2";
var content_f1_49_1814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F70194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F70194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light microscopy showing antibody mediated rejection in renal transplant biopsy, polymorphonuclear leukocytes and endotheliitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 284px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEcAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC1eeGbay0u502xvLq3unIlimRizHrkN3A6dKptoeqNHp8TalKZLcfvGckeZls5H4cVf8QeIJk8SwqiRwCc7d5jLFccdq6QaTevpVzANTRWltZI4XKAbSRlcN25r1U7NWPuJQjGN2v67HAaroXiaO2e5tNVaVZHIjHmHLfN0OeFIHp1rU0mz8qMM00kkrKQwLZHPUZ7+1by6t4j0XwBDc3Ol2eq65EVjd9ilypJAk4Hz4GMkc81X8U6lYvoMUusWZW7lCtNFakxhGx0yMZok5SIw8kpNOO3mZMNpa2c8QjD9TgZJweufrzWqYbTTkae6t5Ar8BrcElj9R2rFttdtoPD4u7G0ka3GURUGXDdPmJyce9Zr3+savFb3FqyWcySASxZ++uPvEdR/Wos2m5M6m4q0YI3L7W9F0zbfuTDJOfLA2EyHsfT2rYN9HYxxXk1uZYwQSOcP35/z3rmZYdYm1dmmjgfSWBxEybjnsRkcGtPwtrvibXtRuY20h0gjTy1laI4IHAB7dB1oujOV1o9EzdudQ1i9mt3sxp8mlXp3um4rPAO+MdD7VlHRI5LGXTbbWZYbwSmRY9+ZCp68elaN/pPi21uIb2xtLaWxIHmiFg7oAeTjqayp5dI1PVLLVrkCPUrWQo80bGNsAHAdfrQpXMYwVv3dnrqb0UVxEvlRzPIqoFw5yW7HNcz4l8R3miS28VvF5ryZ+VWyVPQcd667VNQit9Cur2O2kkeGLzENv8AMWx6etcBNpuj+LRaa1Z+YbhUAljVyphkByBge/IoWiuzTn5nyJalawk8Zm0mllMu5pQI3WN3zkdPlBx24NWbnTfGvhlIr9bS7nimUNI0oO0E8j6fU1atde8WaZo7Wd5Hdb4GZYY1O1WVutRWfiHxbqtvJoxt5razcfv23Fi+Ogye30qeZ73RnyVNFbT53t67fgdb4R1ltWsydTRbecsUaIKCJFHXIPetXRbmaaLU1MEtjLFMECyn78fZ1xxiuL8FaFb+FzILzUQZ7iQmKJzllGOuB613M2rwRw7SEk25BZW4dffuKT9AdNy0itepJfJbqQF1FZZTIA4QjhT1IH9K5sWmrX+ry2uno8kAjLCNFIcnP3gTWTpKaDL4me80+OeKaKTzWeNsw7vc966DW9UhvLm3uorh1eMsf3RBEnsSDxj2oemxdOnNe7uczot612buC4Dl/MMREq7Srg/XrWlaaDOIbpNRESjbtj2ZBC9TzVLWddsNNtmuvsZBZtgUHOMjktmvSvCFjo1/4UttRiupr64MXmGMy7Ccnpg9B70nLTm6MWIqxw1uZanl+gWtlY6RPepdmS2jDOXIw2M457n/AOvW74W8S2utv51xLLZ2CN5Qfbk5AyM+1N8T+G4tBstW0zT7iG5WfdP/AKseZEDyI5COGwT19Otcf4Vsnk0xNEuJ4oHuiyrh8BQ3HLf1q/dtdCg/bQUtlYt+ItX1jTPEjz6fd3N9pH31jC/MQeq49vWuh0vxPaX9zpsN+0lrPcRlzEy5KL7iqtlo83he2fS5UlL27gwvKMv8w+YZPUZ6UlzaWp0vUJr64ijksyEBYY3xEEOQe2P60uZS0sUoJR5r7/P5mR8RLzUYGtBZySpYXRCmeBsyIwJ4BHUEfyrQ1GSSyt7VY7HUL+bbtd0YZ4A+Y/WpNPexTwzYR6cv+iiPMIIP3fXnn1rK8P62msyXHkQTxeQ4Vix4OSf146UN9LbGsKaVnzas6bRNOt9d0W+hvTPp8rQlAlxjdgnGePw/CrHhdIdLt7XTJre485B5ZmX5omI/iCjkZ/nUccKqEaQyGZzgKOQBng+talifLWG6glyqksV3fMGHXFTYmUEr3d306Emu2cipOSjRyHgYP3fwrG+G3hldR8QayEjMVvHErqxYnMjZ+UZ6DirsHl22oKxjM0IbzJElJLOezNzkj6Vm33ivUtCk1G60vSYbq4vC3yqdqQ8YUqvcjJpa7GdVVPZNU/itv/wPQt6HNf2Wqz2z2sTzws8J3ncMj+L9K2pxeraG4uYkEbkbWj5B9eKz/BIbULiBXSKC8dVdt7b/AJicnOep5r0270UfYo1uriGGOMEsVTGWOcmhy5dDnxWJhQqJSWr9TxS/MerXtxo1peGC/kKmN48gOSfujHStHw9p+oeGppNP1acXF3Ew+QZYbT059OtXbrwdcDVRcW1oZbgAiOZAw4Pf61M1rqWlX1xdyW7tcSj5jIMn3xmquuh1c0Zy0aem3Uku4GluxOsSyRD5jE33W9D7EetVdFI02T/RIDEp+XYBlm45LHuc1UutTvJIppMHchJWKNdq5HYnrWxdXNhqeg2V2kMtneOAJIix3ZBxkfX17UWCS5bQlHf7vmdLonjSza6NrNOvnIuWiMgJHbPtXX6LqMWq2puIYmSPcVXfjJ96+ebPSrGzv7nU48R6rKXj3gn5gf4sdCa0bTW9Q06Bo455HgVMMgYgufXjpWc4RltuefXyaNRNx0f6H0LtHoKNo9BXzhF8Wb7ToEe8uJYIfMMaxuNx4HP4fWu8tfiZO8Sl4oCcDlsjNZyoSR5ksnrp2g0z0rUrqKwsJ7qZWaOJSxCLkmvmu21y11PXLiK3MsQMrMEJPAz0z3PNemS/EuUAr9lhO445c8D8K4jGjy6hNd2tlFbzztnKDI9cZJrSlFRupHq5Xga2G5nUjv8AMs3HhsShzayyy20hBXzlKknqR6cVn3FtfW2uW97caxcy21mNsNhEABH6kk9s88Uut+JItGtHl1B5BE58qMAnIJ9h7Vg6lrU8QtptKhjvfNbfJGp+YIRwQOo/Gtldao9Lki/dqa2+86RNXt2kj2GRScmPI+/zzg+tFc7DPZwahYSyN5W6UhImGTu7rnsKKvlTW9vv/RESunZ2/ATRdZGq3Go2g097eCykO12Yncc479Dxn6V13hKWS5WWLWkdI9pCeURnrwecj3rE8UaC2haiupyag88AcqsFvlifdh0HFbr7f7K862KhHhJZkQkqpXrj8elD1+Y1Lmp2vd/ca3iXWNP046LZsj29vIGit3f52kxjJOO+TWLqn2e9RgDDcwn5XG0ctnoR2rE+H7wWvg2ZYvOvUs7mSLz5lJUk8/J6D6d65GTWL59LurjR1821aX7OcxlFj3Hgk9c01HojGi/ZxXNr+J2tmkFtIkNqURRz5SEZC57Vi6ourp4lj/s9I10sgeYxUbj659+mKz9MvD4Y8QXFrrmmC3jtwI4ppizGUnB6jqDnIPpV7Vtbjs9TuLDbNlgWe4U8R/7I9R7mp5bXsdCrRqJNf1/wCbSftsE1xJeziSILtJ3nO719q6bQ/iDD4XtLq31QmGOc/upl+bd68DnpXILqMV+l5FYPIt/9nXYrDq6H+ZWm6XcN4qt40bR2vEU7JlgVTJbSjg+YjEHaeoYe4NDi3rMyrypOn7OWz+49Jj+I+k2EVlJCk1xKQXj2DEWD3Hf3rzrxvrWj3WrrZM48++bDtGMAMemcd6deeHL631YTG5kihtzj7MBt24/hx2rp7HwBpCR219cTW41C5Tz4U5fGRxz0Ums+aO1tRKnGj70X8Xzut9LGL8N9TK2s2mWN5JPChPyycEN2I/lW/rdnNNo08Nlp9ppeotKoaVAwjmH97YD1FcDps8On+JhZWdgY3mwXcNyDzjA9K9c1m+ew0WynIxLet5McjDJ4HzMB6gfrTd1IJ20tve2l1qN0wyWuhRWmpzm+dE+aVxgfme1c9qXiK4fVEtNBsIYLeNR511L/ABH0Qd/rUE08t0m3c/lpwqk/e+vvWQk15LqSw2MarbRNiWaTue6r6+5qFLqjpWFjH4vuRtXA+23IupwiNtxlV5FUNa0/7VafZo7tlV2+cg4LL6Cq+iW102oXl3dtMoMhWCFn+UKBwxA65NPt7SDRY4/t91JcXdxL8rzH+NuwHRc0+XXTc2jKytayLlpZRWUEcESL5SoMKp7+9Njt4/3aLGIYcn5UXAX/ADmnXF20RiVI4jI7bSryBSB0PHcj0pLe8W6SRrSeKby3KvsH3SOufepcHY0U47X1Kl69ss/2e5ZJLeYhYreQA8juKtWl2mqWg32n2ZEzB5SjaoA7YHaiyS7vtVt4ZZLWK3Lk7vus3YduOaWO+P8AbGreH9SdLO4aJ0sLtZNylx0ZiBxz/OrUexzVK0IO7RDd2/8Aov2aO7ubU44lt2wcfj1HtVjUbC3vNNjjt5ha6kItrXKxjZK2PvEdie/1rNW5vtL0oWuqgazq6v8AMlsQnlR88lsYY1o+VI5WJSy7lBVJBhhkZHtUtyj5lQjCrrZxZFa32vXkNvFryxzy2KFYLhWyzp6MR1xjjvzVNtM+zJDbyyi9i1W7aI28jbyqHl+PT61qbJPswKMUZTyPQ1c0uITwecQrXCfMfLwMe+D0/CqUrkSoqlFRW3+ZavNJX7RFa2YLsF2pGq4KYwAv/wCqo/D/AIP1e81y4jkjlgRjlmeMoi/4morm7uLPUo54yXRyFYE87vY/rXs3g2S0l0KN7CaSWJnYnzGyVbPI9hnnHvWc5cqujhzDFVMJTTWtzi9T8CXdtGHtZVmCoXZwcMGHTA79682TVE0zWhapIWmc8ow4Yddpr6YOOhFeV+LvANzJqUupWEdvJ/EFRcOPYCohUv8AEceX5r7VuniGvJnN2+pXF3Ks0y7nicqrH7vTp/SpLuNXuFVvn8xPN2gchQcfz4rjvFkut2FrFHpR8zbIWkiC5Pvwcd63IL6a80qOO4tka7hKso8wrtBxvXI6g9MVtpY9qzUrRR0BewgtfN0oXAurMiQv03epGPQ8Y9K6XQ/F1tq1yBqSNtSItvzgMQemPfNec23iOwvLy6CB7WcAKdiHDgjnI7Y5qunlS2sqWk6srLsWVOSjdfoCKWjOerg4VY2ne/R9T6HdIp5rYRuUki/ehR/dPGDSXtjHdLHtbZJF91sZ/A14/wCCvE17plo1trc9xqEiAIJ0GHVc8ZB64/rXpS+LbBxbqu9nnTcvGAG/unPT61g4NP3dT5uvgMRQkrJsp3/g9dRlknu5UgmbqYE4YD1HrXk3jINpF7Db3V0DCo2RuucEZ/zmvbNB8QQ6tcSRxmNWTjaJATkdRj6965D4jW1veOyBIpjbODgrkqSM4z+tXByvaR6GXYmvGt7Gr2+4850uZ5Ne+y3thd/Zlj3LcwKDz754x7Va1jSHe2mFujyWuSrSDgjP8jT7zzWsfLAc/PuyrED04HrW34OvLRYZ7aW6umui4MsfAjx/U9K1dnoe3UlOknPfyPJtP0yLRNdsLKexGoaVNLvmE7fOCOOD2+vevT7/AOGkOs3MeqeFtSkQMoLW8knzRj09DXMT6FqC6ndPqg82FZDLEy8YOeBjtxR4K1TU/D3j1tQlvnGhSRkSxk5CkD+79RRLXrqc1eFSMPaYf7t1/XpqTXPw+8V2E0s+mxpcwr99HkDg89sc59qxp7+4jguZYdOeK7t/leGTMag/y9a9f0HXbK5nv9V0SSO7RwRPEr5BOcr7g9ar/FgWlxo8TahEkYuoQGjOA27696Wt7Mzo4yq6ipyWj67a27anmGla3B4utMajpkRKHa8SnIyB94Vm3WladoeqT6280scJAjSMrxk+g78dqj+Hs8VrdXoWzmtxGww8jcnGRg8da9Vmn0DxRaw6V4gjhhEmBbzRDDA9vrWkt9DdzdOmpON7de3yPOZbOPWrjTby3eJ4oZBKqngOf8jpRXRfEbwhd+EtLtbfQ5XK7wY2wMkZ5HPGeaKcNVpKyM6leFRRnGPNdbooT6ndR+JfsPlzvGw8xJOuV564/WuvhNna6Gt+dT89nYxtBHwVH49R7VleJbC6e4a3uUeyjkVo0Zcj5Tz97v161y3/AAjupWmkS6XYPOsm/ck23eeuTgjsaV0dUk5xTv59NfL/AIJsXiT3TRvoFy1oI5md4CQsdwndenynoc11lxBbf8Inp6nTIRJ5nmptdQrv/Ejjqa4z+ztQ0/SY5LnzFvFUbdyGMS54bFaPhfU9G1y7h0zWJz5NvIcPBIUaJjwd3qDxn3qHK62M61NK009tfPRdNVcw9J8OWVnJc3up3PmSu+4RyDKxnOeQfT9Km1vTY9bt420q9jeIygXDrj5h1IBHXntXpXxC8HCaG6u7dUfTZkAliU4dM8blP5GvL/h7d6Pp2oXGiPcyxXDysCJ1AXcDtBBHA6frWkZc651uY0MTTqQTht28+xbgs4rRFezt12wjBCr0BPc/U96zdaXS7iD+zdabyDqP7tJ4RscMpB4b8Rwetdgvh3xjpPjg6nb28LeGreItKqYdrqNl+ZSPx7elcz4t02W28RRgRJPoBYTQSyD5k4zg98jP4iknZ3TKjiIYi8IrT+r7beX5CabfiSebwrMZLiYxNbpqGcMyhfkBXqCBxnPajw9e6toGgPpE1/JcxtKVCsu4xZ67SeRWroOl6fqOrx6j5xRsbBPAR17Ej8K2JdPt4NQnubyRXffnIHLD1HvRJ30RcYQTtLVrYyvDmn2cmomW9b93bx/aJZFYZCA42eoJOB+NTa1q02t34llRYoYlKwQr92JR2HufWp9bay+zXE1mgjuZ3WOVl48xVGRnHB61hWMUsF3JctKrwOVKRt/DjqPxrKS1sdFCF37aS16eX/D7Fu2UEjYc7xgg8getOaGWKSPdC8iODyDjYAOp+tT6aCHmkZAw6EIPzxWTNpkms+MZbmLVYxaWMfkvBGQHEhyNvPruHPtVwgnqyq9Zwsl1IdZn1AmSLT5LaO3aICIqf3rTf3OR0PFNvr17a0ca3ZMs8cAupAI8mNOAFbnrn2461FYQa34f+y2otLeSzjOSJGMkw55bJ54ORV7Uf7OhvINa1lrS31GMuouLYPtkTbx5gORkA9hzWlk9NzllOafMv+AZuvq17AXt4La8iREmlErlSuQCuMDO41d8JX7afKj+VZGylLeZDs3gtnnLDknOeOtSTRXVlp1/qLSLNYarGFt57GIzJA+3CFiBuHGOoqno2malp2mWGnP5LRKTJPIQRI8jZbv77ce2alx00Y41VUlqrrbToXtUlsLO8CC7hgEjZgMjbQwPTr0z0xRq+m6WY47jRp59HuJGdJ4ZIxJG7MMELnpkD1qK702K+/dX+24aCYTKEBULz0/LrWj4f0mK0k1C6N4bhpHd3juXysR9Bng+2BmhWW25dROTXNsv61KmniazeNrgrPNG6uzY2q+DzkfTGat6Xpd/rGoapqmpagheRxvmmbZFEgOFREHoO4pLyO9ktPPZF8oYCsSABznn1OKn0iKZEa/mMDWUIH7ppcGVwclSvpjnNZ67F1FF++viWie+/QgkuITeT2a3UUzRts3KQNw9G9Cah8z7NK8obyymWbJwABzzT9WsfD1vfXGpaHaLBc3wE04llBjVm6hM/d685rHlSbVNDNvqMTWN3lobmKKYM6DPHIz1HP0pyjpzIKNZySjNWbvoQa+ZfFSTT6beFbO5jTysDbtlRiOg9c/oK9u+EF4g0D7FM8Zu42+Yjq/HWvIrK0i0q2SOEbbS3jJbJ7cnP14q5p+vjSRa67aTGG3mUOGbgL7Ee/TFKV6iscuMwaq0XTvZ7/cfRsaMjyZdmVjkA/w+1UHm1NNWhTyInsCp3yqcMD24p3h/V7XXdJt9QsZFeGVc8HO09xU+pX0WnWjXFwwEYIHJx1rls07Hx8VJTcHG72sec654EupJ9QliT7ZPckyK5bYqknp78ZrhrvTBZX9zYWZ3S24Lyb2y+3v+FfQC3CXETtGzBAPvof5V418Q9TgWW8ntpkt7qRNjTbVUlQfX1rem3J2Z9FluNr1W4TWxzF1pFvqhKGaayupG3i4XpkjBBxztPr2rNsrc+HreS31YzxQq+FnnYFmZj0G3qMd6s6VexaP4JuNR192a7ll22oRslkH94Dp9ar37Q6vocUywyeS/zrKTloWxgYHcZ6kVry99j1lK7bjubDazDBOlhHHEHdfMR2GWx7Hp9K7TSNMS/wBGW7nlCZ+Rcc7yRyAPYZrx7Q3uNd0O9tGUJeWoMMVzH0f6H1yP1rW0867Z/wBmaO0NzqEmPNaSMlwhxyBjqAOppyjbqZTbqRXK7X6no3h62kj1hptNLhoX2425yT/Ou3k0/VbqFVeOBldt0jSDaTjoSK4jwrq+1hmTbc7zI6gYKgcY/PFenWOrQXEYEsiRyjOVLenf2rGo2tUjyMzqVYTUlG9vvOV1jwbLLbzSxywRuIyRHGuFLDvz0rxjVHv7TVWNqkctqRlVU7fmA7n619F3HiDTUZkafcvls5IXKnHUZ9fasfw9pOgXyX7wMl59pY743AYRey8e/WpU5JXaHhMxq0acniItrS2h41oHinWJoPN1mJclsCN1yWA449B25rR8awaWlql9ahkguHSFoyOAz5G04ro/iB4OtNDsft9nNgFwrRN79APpXK+HJEmuY4byMz2pOGHXjnOPf39q0UlPc9ejOFWmq1B6fn8jndJ8KS6bplyNKFzEkx3mVZBn5eg4/hFH2XXNY09l1B2uBZrlJ+WEQ65Y9K0LTR7bRPFcOtTa9Hc3untue0DEqYeAqlsYLEEZUDjNa2o+IdV1q3S30vTf7PsJZfOa2SIBWKnqWPIB4o9o7dSoJuS5IKy67aem/p0OXia11DQLizlvNtzKqhJB6/8A16yriyg0rR7f+1b2bFrIWWRM55Iwo/Hmu1j8P6nqcUcsllZCD5vlhTaEU9gVAzn3zUll4A1AaLFp2pwjUMsZXklUnBzkKvsBVQlJblVp012vru9jf8SeL7fUPh/CGEdxciNBGoP71u2fyorkL3wRK/iG31CdpIngCjyyNicdOP6UValCP2b+t/0aMaVH2atB2V76W6nrHi3R7my8i/mc3caMUdVjLF93ILA8A9sj2rntPuF0u4j1KXeiSkD7OOPlB5Wtzx941VY5dM0wjczeW9wCCB2IGOnPevNtCudSu1v4bm1XGD5aNyeD1X3NRC7XvHNgKdWeH/fK1/y/Q9V8UeI/DVzbI8y/bpVjYIsYIK7sZ+nT9K8p0TS/C0d5dalNcJZCYsTM7Hy155HHQ5q1/ZcXmie6kZZmiK43fd57iqOtWmm6Xol4uqrbz2TqreXGQWLEjGMdDnmnCFvdWxvSwtPDU3GEnfpfX7v+AdTq7TW+k7Y78z22xWjaOcsj/QehHTFchrmhzanpUktgqQ3jFZVk4DNjjBYc4+vpzUv9ty6x4Y0+KzjWO2gh2W0ZAXkcDOOtN8O3N5DbxtfOsVzjDeWMrjnH5jrTjJxZ0Qov2dnu9dP6+ZteGvHF/ouj2mi65dK1yqbR5bgSKuegB+9x0rpfETxa5ozPIIWto4wIbqMgecccq4/hYdq4fWPDFl4jDapawsbiGMSTxrIQzIvdR/EB3HUVzFvrUMutXGi3DyfZpwEwuVJbquD60cqvdHKqFNT5o2Ur/wBff9z/ABE8H39zpfiCezihP2BZXy7c5z6HvXca7dWl1d6fpaXirqEmHjiVipkHUDPuPWuO1vQ7n+2rM3YjilsZluEKNkOhGDnHrWhqEvka3pt3DpK3L7AGuWcqyAEg7e2cHrVNpXb7G6jJ/Drr+BqzahYXep6lpFv5ourPEkoK4VckZ57/ANazdKvVv4EljxsLFcehBIx+lbXgePQrnUrmewgje7zunaT5skvnr7YrM1K0ttL1C8ZVWCKSdpWBbChmPb0rOpbdLsbYacr8knexq2btFLIFBK8N9KwY9OjsP7UvYZJxeOhlurr+IcnlU6cdfwrZtnki8q4dHKuT8+ODUOoLdXUUo06SOO6B2kuMgg96cX06GlSCl71tTmdCFmrXc9pf3VzdNt82WQ/ON2cHnoOtdNN5LXtpaRGKUtHvlVnKFBjnBwQSPQ1i6rpkl+fskusW8U8ESyXcUcGGcA8YboOexpk2sQtcacuno89tMxW8aVTGbcAgZPue1W4t67nLzxS5Vp6f107+ptxSyNcC2h3wvASQwY7SOmcDipImaK3kTY87c7VaTAB6j9e9Pv57bTLiZ4ZGS2ECn94ej+lJIYG3+dNEYpIjvdDgBWHUk9M+tQkdF1bzMKd5tLja6BitXlZJb6WdyY0XuE7E9sVpxTWV7Gk8JDI4BQpxuXHWmxaHYxeHRpt2y3mnw8MZZQc4Oeo6HkVI6JvItl2oAABj7q44P6UTd+gqKd9HoOlmdokto3d40PQDgj1NV5dCWS+j1W21G5kaJAPsRiO2JuckHoaraZqby3F7CsZt5bWbyWQsJA46g/j6UtlrDXVpeT2/noEkKNlgBKQeuM8DjvQotMUpRkk/n93yFOm2msxzWV+7QJJCypIR91z0YjvjniqOzT/DjW+nWC/bHuJPKup4yP3RUDkjnJ57etN1rz7ETalYtPJPGQjKCWjVMklwvtUXhu20l9RvdYinW/do/lSFsFZD97cP4SfpiqjpHXYyqa1E1v8Ap5fqdBI8YtJoGU/vkEcjejdDiqsekx6ppT6RPGfIZN8JjPI29/r3/Oq11rFnBpv9oTJIiO2EicDeW6YI6ZFWLnT11FY7aWaWExyCYNE21geuAeoHJrNXT12N6lpQfLv5lvwb4pfwNqFt4fMc32G8QoZ92ShzwwGOvPPtXvV/Pp0WiW9xfFZbVApU4LAkjHTv1rwTxHKY7yxZIWlM4VNy9j0yfT3ru/DGrXltHDp9zFFLKSH2zc7V6Agdxg4pThzHkY7AqbVWGj6rbS3cnvdf1W206SK68t/NkMkMiLgLEeigfyrgL23TxTptxFMkkfkzbWlJxnngjjt+Wa9K8SX6ara3EUIaae3ALwhAu0DkgfSvI9ail8QxNBpWq28TiUq4MjBMHtuHHB5561cFpqjbC8sabko2fY2NOjZtCbRbkxXNtAd+5lBJ56irVraLLaSfZ1CiH5dnoORwKt6l4es9Pt7SKLUopryK3UyPHlkzjoPXJzwazrfUYrm9ltbG4jN1EoFwkRyV54JFFrnZSqRmuaOlyhpunTw6/P8AYrKNYjDveWMhQcdmHqPX3rfvtXlmso7WOUW08cbCK7tl2OF24IY9+K5/V7uLT7G4vIrpblYBteOI7mY/3frUfhbVI/EGmyXD2zQGN/LZC+7I9f8A61Di7X7A/ZzkovXqv1LXhXR72GOVorya5mALKXzkqfetW7muminmcso8vLnP3+ccepJzx7VYtmcOIYzlUXdGuPlYjsfaodV1Oxs7hkN1bxJdKPLt9zEB/TBo1Yn7krW0OVk1LXJPEttBFbltKwEdwecY5PJ9e1ek+F/iOtpH9j1SzRo+kZtVCHHuuf1FcncWgurmNp0lhEUZWHyoyQzdBuz0X8zUNt4WsLrUku7y+kt3A5LK2CQO2B0pSSktTKvQpVotVVdfPT0sSeIvF8fi3xHNYWQlhSzO1IDkk4OCfr7VuW+i6boGkq9vdSTTy4aNJeHhJ+8rCobIWWiNLdpZQTyswC3VzEVAHYL05z3NR6hNe6jOsMrtNczDPJ+6voD3o22HCDVoR0gvx/X12IPEV7CSJbVE8/7rMFU8gcAY6/WuJ0zU9Xnv5or9JBEATu5HToPetm0s7u6kvPtlp9ijhbAMzAFh7VYaBkhVQVYDv1z+NGqOqEVZJPYg8N/EDXHuBYuJ7cWylody8YHUHgf1q83xFvormDUnVrw20g+XlAueucdqzrfWbM6kLJ5d1xEQpikBz6nB6V2mjSWUr+ULVBEclsDJ9qq3kc06NNRfupvXojWh+Keh61psU7aXcSSbijxnHyMOvPcUVzN8thZ3zrGrTBnG1doGPqKKqlhpVPg/U5Y5fQhFJJ/e1+pm6LazCBZ7lB9rcfMnUFu/61Q8TPqsWnpcaLaNdXQlKSIqkkLgHPBrrNLn0+R2gF5HFOHUyh+ijnAz7+tcz4v03VP7SX/hHNXX7OB87KpAJ7/XnNKCS3O6dRyvCN7/ANfIu3y3kHhS/khih/taSKNoVmYBtxIzgdDjnrwawtV1IWXhCzm1233X0ORcxgDa5J+UfXHXsMVto13drCb+ZpZETadkYyQPT9fpUd69qmmvNqCRtGPlK4wxz0J7E9+aIu6SsN02m5X1/D7jnJtdhtdAj1OO3lWBwNkIGMH09sVp6az39lbXyI0KYUhX+968irsQF1pttKm14SCFUIAc5wQR69Kx9LuNZN/cprUcCWkakwNGQC/Pyj3GPWp5Vy66GnO1JLe/l/W52GnXlxZ6ojKd0TNuBUev3vwNcL4ptLrTtcS/03Tor1CcOApMi56dOg9663SW33ayiQJGW27T12ntisC5tLnxJ4hubSC+axOkz7Jotx/fJ1DD+WDVw6voY1kk0lo3YsaXYCS/a6ZZ0kdMvvbcq5/hp994jtEv00iON5JQBlhGdqn69qp6hpGrx6JLp/h9meZpCZJWO0hT6Guy8HeC5Z4rRdXkvCfLEjbEBMwzhjk9OfbNKTSV2TUqxpfFol/Vkcf4W8SRQavPHf6aunSOcedFx5nP8QNdb4h0y28SaPPZIYmEqEJLjkN26ehrttU+GPhrWLTzLMMk2D5U6y7wD7+vNeJ6Cj+FfFdzYy3zyMGKmLkjIPXPqKUZxneS0scmHxNPE3VO91vfQn0jRNQ0rUVkvLyaVTbLbeUx+VQD1A/DqKg0nWpW1U6dLBN9ri3F3A+RF7An6f0rtvEWuafp1zbR6hDKILxS4df4CMZHr37Vx+pG2tdbW4i1Jri2uyYY/LZWiR152sw7/wBaHGVrvU7qVSLtFaa6mrqVhY6pbtLLE3mSJsl2OVdsHK5PpkVjT6hD4Ygit7u5miuZSPnmhaQsTzuPGCD7Vpajc3cltFNpgiW6ik/eQvwk689T269RTI3udZ8QWuoSak6f2e2ySwljDKuVwVPYg8c1UXdXbCrGUX7kdf08iewnt7iNnYFlnw8LkZG0+vtUcsSz6bNbSqktu8XlunQbTxj6Vl6hdW8d5b/Z9Sigla4OYnOVlHRkHbnr9RVvUdUs7NdNER8xLuRo2kLBVUjjoeo5/CoUJdDWVSCvzEljolnY6E1kjNNHNgSqwyzYHy7j6gcfgK1YbmKLRxaQQGOYsG3deAMZB9ayoJAmr2oiuYo5QWJhfnzI8YIxnrUtvKlszTvO8AgO4t7Ywcg0rt2GoxSa7DfD1wGnmh1fT1jhY/LJFMNwPQMcdex5rJ1y2+yeH2jsbS2YG5WSePnaepycHkE984xXR6gYLlLeSCWGXbIWRkGCox6/xKc5rL1OO12TRzFZLIH5jIMAqPWmnyyIdP2kXruV72T+2tTtbiOaOAWiBY1s2zuc9Q2OCM+valu/Dc2kCS7srRYtQuAhkEjYWSNmDE8HHTNZmr63FBFpiaHY6bZC7jIBkXa+eo3HsvHB61t27aqIm/tK9W6L4MSxnckaBRgKSMkVUk4rmbM6bVSXIl6v9SDVNLj1WS2jkb9zC5kGee/FVdDll1PXNSvJc+SsnlRDoCB6etb1nIiyYYZYcliOp9KdbW2zUl3BdgJKIBx0yTj8cVlF2R1zim7m4xWXSbtzDvMIby0UAZIXIFZfwp1K41fUxc31oQpJHy7iNnb3wKoaveyRhQpZip+UKcZcnqT6Vc0LVLm1iEks32eZ1y7xrggewFXfSxyVKUpRaT3R6b8R9R0fRNAmuBB5l2gxELMDzA2P4vbB6HOa8m8Dr4Yn0rUcafcWgnYMJFkOEdQTjk8Lk9jUzC4FzJ9onE7Nk+dz8ynn1rcj8Az6xZ2c99aEWbNuQbjjB5DMB1BqYtRXKzkhhYYWmueevd6fcclrB1JILNNFRJkdt8rZGNoGR+fNc74YtIp7PVzpbtZ3sytFJG4yUJOQxP3sdute1y+HWtNKF8EP2cjbyMEc45FcBI1pp95di2tGBZg0xijzI3Pp3qlOysdcXCu+eLulv/wDObw7ax6DFpEsroshLO6EB5Gx2/z0rNub260GytrLQLL7RHAXEySZMmT0J6d+fwo8T3uraddTT6chk8/CKWAPlfUHgVvaBYXJ0uG51hANQYHeQg4z0Gc4pttK97j5YuXKk07b/wDBKOjeJNVltrOW4smUv8kip8rKc/eA9DWhqSQ2+qWurm3e4lt0KgFemc4YA8ZB59600jCBV3lY152nBxznI/GoZbeeCeSUujQADKnnPr9alt9NDSMdLS1O78EX0ul280GtSxz6Z5JujfzYYktjaFH49McGsefxNPZ6/dpYXMOrWKoFjEjhA2QDuJAHOcjArD0jXrW31Z4LnQZNTieIMZF+VYjjnnHYUy+1E2n2i9htY7O1RSxjYg5HTgkZPUcCp5Xfc4o4aPtZylHf5L13vf7kVPG3iK7v9GNlqFlHbSzAP5sEhMY54HPtSeFXju9PtrOHXrVtVWKRhGXIkCDqRkc461HY65FfQqE3EbiJBt2g8cDFTjTLKHWoNSgOL2GA+WUH3Sc5U++P51UeZaPY6ZU0or2Wj+9eZiQiOwtLq71G+vNYeQD906jCjP3iDz+WBzXRaFD/AGvYtNB5gAXKRY6gfyqUJA1shEaAnPGck1nLqlrZaj5InMVwwDEEZXHYVScpaM0cIwV4OxW1qxu5WeSxNvb3UWN0hUbnH91Tg103hXUDp5tpdRWGaRAPNAA2scdqSWCa0WPUpZkWRMGJFxxnvjvWPfXvlefd3zqpZt7SkZyxPbFJPoJxU0+zOsvLjStduTeaQmwI2JEJyPw/worntIv47eFWhhQlsBpUOVJPsO9FaRgn9qUfT/hjBQlBKK1SJI/DkUU0c0piS4iURJJIuGwMnmtH7PNaQAwo3zDDugyD9K5m+tbm58RW+ovdyhYVYGEdGJzkn8/0qDSW1218RXlxLd40zZiFAf1x2xzmo0Wx0Wn1XX+mdIA4UlYAZDwMfwnNQTWMrof9HC7uNp6H6g1Lc3lzPpjtY3EUNzKuEmK71z64/rWLo+ma7PHb2+rTLeys7F7gSZPPTB7UPRXDnfPytWXe5qQRTLY+R5aJGhzkcZJPGfp/hVTXNDfWbdFy8aqQS6cBiPSvRvCGjxXd+Y9Qw6LlzEpyhPoa7y40PTbhkaWyhJQALgYAAORwKzlV5HY8zFZrSw8+RxueGPbDT/D8s6wyefHGW8xlPBA7Y5P864Sy1e+XQZNStNP26m9w1pKQjMpUAESZPJ69/Svpy00bSrqGWCFpGVWO5Sc4yc4rG8Q+GdHskLQu8M7qSqIAxbHt6U41IpqNjOOZwqVOR3TfkeM6pptpqt5az2l5cG6to1WZFbY5xyT+PPNR6H46v3069vJFubf7I+0SozM4Tpit3X/B1le6haappl41jdQECRosgSjtxng9j2xW1rekQqQNDgF1tiDXMqsSSxzkCMccVrzaJSOtzjKVrb/1qc9ovxCnXR7hrGf7JA7EM8iCNnY8nBJ5J9RXJyjVNWvRdWlg8NxkgSORvcH1/Wu48S/D5dR8Aabq89tepehQ72n3fKHORjGRnA69M1Jpun/2HpySWdtMZY4wYo7gENnaCB9eetKM47xClKEuZxt8t20Q6r4Zj8RxWI1vzTFZJtZ4W24LAAk98CrejWvhqWyu9I0PaIrE78Ig3A8fOT/Ec1j6be654iuLu11nSpLBBGZEIyVcE4Iz61e0rR5NM1K0lslS2tolYSW6naZWIwM/hzQ+zBLm99aMwLq11hfEErskcWkIm4FV/wBaT+oqzaW8KzS3FtGiTSY81lHJx0J/Ct+xa9uLuZtVliIaQm3WKHaNo7Nk8ketR3Og20HmyaWoWWR/MZCT82e4P9KiS7HZTq7KaONhNh4l86CSJrVobraZNuCrA/fUn1xyKsatZR295MJbY6haynfYFYBIlo4HLOCQOemBWrJDNZF45bYxMx3BCMcnvWdqi3z23laWRDKzjfJnBVe5Xtn2NONTWwVKClDm39Opj3MHnRWesak00F4ZBFBDEm8ROx4dh+mM9afqJZNHutMmgvD5MKSNfphzKScYOepJJ4rY0zU/tG+GVppLmDiSQwmFm9OOhq20yrbxpEzDyiXCuucsfcdxT9pZ6kqg5apnMXFpPodl5S31xFHLa7YJJ1wlsykHG3GctyParnh7SL26uLm71bWbS0tIWH2mT/WQSKVyMr1Vs4GQPStH7FFIbt7vfeJOxZxM2QBjGFB7VLZ20NvaeTZQmOFSD5SHgH196UqiasCw0ujt/X9flsUoR9s1tWaPTrrTUUGC6RMOsoPoexHStYAzzsxVsgcBO3p1prJiISb1BAyV/iB96rSatb2+pw6XGrTXtwMsUI/dqBnn3PpU6zexulGkrt7lud1gQDIAJJZycBcda0NPtZLjT45LbElxdfu4WcYJJ6HHp0rOS21CXXLO1GnSGyOTJI6hsnsFH1xUvinWzppt9QjUNsJwgP3ucHNCjYzqVeZtROc0u11XSZr6w1q9ju5I5isbRncAQfmwT2z2retpIAFaXDEYGRzx6DisO9u5ToxuLSEy3ToGUP1OTk8d+ppttNLNDYm8kjs7iQhTCT1yccjr/wDrofM9SqdoLkOue4WGKGc24FuXU4I5YDsT0x0/OvXNM8W6fJa24IaPftQKOcH/AArhrv7PLo40Vke2uDJv2ysCoXGeCOM0q6bbXXg63gLILtiC7AlXRewB9D6+9KUVLc8jF06eKivaJ3v/AEzS+JF7lFWxud1o6/OkbjAbscdq8lnv7iC7tjIjPggNLuAEQ9zW9rr30VpKLJI2nTADSfMFHTJHeuQtbO8eG7XWb1Lqd1w0SYUwg+pH8u1Plsjvw1JYeCorXz/zNRLYX0xuZLnzLMsRsjP+s56E9vQnvXQ+Ho7iO4lkv5zb6ay7gYOSoXJCqD3PHWsbQ2s7e2+xGaECMbAGYB2fAPA7nmt3QL/ma0hTz5FUjymGVZT1GD0+tKMEtV1Nq024tPf8jL+2MXlkwwBY7Ubk4z3b1rU8kC0WWOdZ7dkBmi+7JEfp3HuKhuYIVciAbHkIzHIeQfY96t6rpt3p8VtbXMHlthpFGPmIPvT23ByTcUnZlvSPsUqbGRPNY4jkYkhQB0wO3WuL1vTbp/E0N1d3SnSGbZ5BlwcgfcCnjk4NX97ISrbgp4JqvqXhq08TyW9jLNOJ7cF0WBl3EEdMHjtw3Xiri9dTKrTcLzRK8dlo8q6dthtpZG37CPm/E1LlIsqoB56tz3pyaGNQ8T2UWpWMpeFAoiDksVVcqrEc5OOtVNC8PeL59S1Ga8tS2mMS0Cn5SuT8qqOCOOuaWncPbqNlLrb8S+LgyIQSoJO4KqhefQf41j6rqOnW0TyXaQT3sI3pFIefbP8AOrWqyajoGtwR27wywh/JuBw3U461j69osN1ey6gsr/aYpl82CRgEXnGWA69OgOKUZR3bNZczVorfb0Oth1SPWLe2nRlaBYgV2Dhj7VBf6WJbQS32xbeQYVC45PqAOa5iw1m21C5n0eETWzwocSR4URgdx6Z7V0Wh6fBols13tW7t2TLtdncF+nPWqtZkKXupR6aMjs7dbUR2sEbvb7/lV/m698+tFadqfLCXEsCSWcbD92H2kk89R16jrRW9KdKN/aptmdST05VctalYRWsd3cXkqxQRytghsMMcn8MVlNdadf2lxGircafeIVLKcll9j9a0otIuvE05gu4LloLs7JGZCrKCeSfTFd94R+GmnaHEYrnyrmJceUgUqEPc9e9c0qihZ9TDEY2lhlas73WyPLLbRrfRvDFlGfPXTZC0YlUlyrjk78dOeOKl8F6hp1zdy6dapMvlHc8jNkN7jvn2rvfGSW2nXa6bo+IVVd7oDlQzHPf2Ga87kntPD1/NcSzwyXlyPKicLjaT948dSeBnsBVJ3jojSjN1qaqbJ7enQ7pPFCaFNi0O/actHtyNvcZ7c1auvioxTFppaq56mWXI/QV5RqWmalfalZ3FrqJggT/XRY5cg5PHfI9eldx4d8H3esXaiWGS1tXQsLgp79KzqRjuzKtg8Ir1MQture/yW5PZeO9Rs7TyrW2tkld2cuQW3Z7fUU3XrvxWIE1DURLbpIBCHEYXhucHHIr0LQPDlj4biB8k3Vy55mKAnPoB2Fcn4r1nVZku9J1KJbZXbcmBnKg5HPcYHbvUxfM9Dko16VWv/s9NW6t7teSPN/EPiP8AslYpdRO7d8i+VnJxWnH9r1bQ7ptCnnt5nhDQXOcbG659RVeaxh1V4Y3t1mhTkBwDg+3vWvPqC6bbG3sjsHoV/wA+lbKVrNdD2KkHJOPc2vDt5rlpojvrniYeZ5C/MYxlpMYIGT09+Kq3mt6VJaxnSbie6v8ABEksyYHHcD615pqN7c6pr7aZcQSNaMufMBPBxnOfTtXqHhvQrbStGjkuDbrA68ITlyccH1AzU7M45UadL379bWStfy21OY8JveWk00l7OXaWXehBJUHrjHp7V0VzepFeW2+3aWaY5kMYGIgM/Nj0rGMrwTCJYt0DMWZDnpnt71Np7M/im01RpY5IRby2kwkyDtPKnHY5H61W+5vWi0uaKNbUr+0l1eG2t5FBl+QSMQqbvqemawNd8XyaTOsS6WZpVJVgvzYI9xTL6GFbrfIp8kv0znqf/rUt1aw27JNA4cDjG7P50bFRpR0jcpeKvF4smskubKKdpIRKF3k7FPOOehq1pkVrqao9vBFbvOBIVLcHIzznoeO1acfg/wD4SwLJDaW6vGvyTOhKZ67SR60228JeILCd/tGkGVEPLq42gD0OelTKUdEZxrUoScXNJroY9xY3Dw3I04ebdRg4hLD5SPXrge9NsYZpQzXqRwyIAGRH3DPfmm6P8M9YfxA19pkrxo5PyPOudp6gtnLL+BrX1W11fw5cSrcWcMiuCokKCSMj1BHQ/Xmk+S9kawxSlJx5lftdGZcRlAUfaORhB29yajt4JwQ7ZCD5QR0Jq7oX25pcpsSQnjzcbQMe9ZupeFfFGua/YR2hS2t1bKguBGcckhhkHIzS5U9WzWpiPZrW33/1saN/DLbxsLKW3nmdcrxtCn3zj3p1nokNvqa6gFiN1cARG4THB4GKr+NINQsL2ytXgt0aKPa5STdwOmSKlt9XSx0iSWWANaQKWluZV2oGPuBk+w65qlvZGUpc0FK91/WpqaJq0N0+rw6HcM91p5aC4u84Qc/MqMeM/T865rXobqOKV9PSG6gfCrscMFx3GOlXbNNPvvD0UWnxBLC6DMRAvlhsjBP4/nWD4Z8Pw6BdTxx3vlwOhby5PvNjgEH8TVuxnSjOLu7O+7EuPDtxqYtbv97AtuwbdyVI64B9arL4ZkbV0vpblJFSQSFefmHUCuosfNsWYvfyyZ3MkIXCnIOM+p561HqTSrC0lqyi7KgqJlKbfqP0qItpHRJJt3OsFu2qXwhtT5MssaM5n+YBsEY9uK15EhSwSCcwwSRjBZFxntg+tedeHbrWZE36nJF9pEhZFBA+X3bp1rQvXvLpyskkeQMkB936CnI5Vh5Sau7JfeSXcdq1y8QlJQjBcE4A9agOk2q6sY4Y4JbqUKDLC+VYtjA+vrVXMReGSSSXyYSTcIDhZVA6ZHQ0lt4p0zVwZNGtY9NW3mUBASTJ1K5Y9wOfehJ2ubSm1JQS/r8zJbwrdnW7zV9ZjtV1KJxHbiLcBCQfv+7Y6VpqrwXnmxyEN3bjPvVu8u7iea4luZxMJfn8sJ/EO4P496paZc/boWbyWjcNtKSDn60SbZpQpxjF3Wr3JfDaXStYw3U8c9xFcZ8zP3hvyCR24/lXufi+x/tbQ7iGAxpJt3x3L9Iu+4Y5PHpXj1ko06+hufLjldTnynON3HTiukvPiTObM20elxRoVKN+9PQ/3eKymm2meZmGFrVatOVFfD5nF6mIbF5o7i8RrVOWk6L9eay9Xgt2sE1GKMTT2nzRPHLhmH93I/PBzXd+G9S0Y6Ff2/iawguIHy8EboHMgORgH+fpVJvDmmJpVxq+h+FbjTWz+8l81ipU9SEP4cgValyvU6niHz+znHS9ru39fKxy9vr5trqH7TaX4edljikSJt6NjGT2x756V10muao1tdxpqVpfQI2y6Ebh/LOBgOOo4HXn61gXGof2XaySi+W3idSJC3ocDA+uetUdJ0/T9Ps77ULaVYhK6uZDL/rGJwAvY9en1qtGaTo3acrNea/rqQa/qAubKRrOGK9nByEVs5XuOOe1YjyXNxbfaVguLNXzJ5bDHK9c+oPr717T4N0DwfqdxCZVt59WeLzXhT5dmMZ6Yyea6LxF4C0W9tLqRQbaYxbfM80hFA55z24rnq8r06nL/bNKhV9nNNL009e58/LawR2jS+QsRlHJty2XAPp1JroNLH27wxPaXluXjt2G0qhBCEfx46AHvVhrTSLm0OnzXDmQzk+fGd4U4wGX1wQOOmCe9ZOiQ6nbgPaytHp99Dcxyhfm37Sg5z7k4NEIOM7dLHp1qqlHRWd187/8DUsXzW2h2UBmnPltKqI0YyhyOg9xRSeFvCCakY9M3yXkZnEy7mI2duMfjmiutOkvjv8Af/wGediMSqLUZySZ9PEVk6xrdtpdrLJMQZFyEjByWPavGtL+ImvXOvjTtXv4reKTcimGDYEbGQCx9u9eh+HtNheRNS1NpXQDNv5gOV4yXb09q4YRjuzwZ5X9V97Ev5Lr5XOJ8RapJYQ3VzLGJNVu1aQp1aJey4/vH07VxfhWxvdbjtLm9sFbVXZnghVSSoPrnocc81r6xqVlrOs37/aQ175u8Ww5ZU6An9K6H4d3U1vrxjt4DLJIBEWz90d85+mfwrqk2lY+js6NF1Vult0/pbf8E6Wxs9K8GQW82seVPdXAYO2MlePuqvp2zXNXnjTVBO32JvLRtygBMHB6f8CHSrPjPQI9FnhlkllliIAkaR8tKxJLYPVeOK5GYCSRFtmcKpIQZyVGePxqEklcwwmGp4he2m+dvq9vu6GzJ441Dw/o8b3d19qEeHMj5eSPP8HPU9RV6Xxnp/iTwzHcnT5Wa5YiDe37zjjLN7HPyjg1nXzQQW0U1zpUZZoiWDucSnoH68c9q53w0l9Jcyy3APkDaI1VNuG9AK05Va5aw1JzUlG1u3/AZ2PhnSQ0m+SQx2ccix3FwOqsw4/DPGe2a4z4iaTqNzrkttod6YPs05XOT869unX/AOvXqFjqEdh4IlspYyl7MXEqsn3Mt1b6DFcXFFcaxqsw02NTI+1VXIBOOM5P0qYtrUKUpVZznU0itO21tbk8WkXGlNDPcgtMSB5SpuJb+6fQ16FZ6Lo+padbXF7EYPNiD7WYq49/YjFb2mabcrHE+ozI9wgCFolxvUf3vfNa5AbIIB+orF1OiPCxmayqtKLs11TPDdfS0stQY6TeG+s2HXfuZWz0P+Nc7JJI07yxMUyTyozkn2r3oeFdG/tIXosIhOOgx8gPrt6Zrz34lR2085vIIo4DG72zhGG6Rl77R0+tXGfNoetgczhWkqST23dv6+f4HJQPHdWbxgN5qOSRyBnHQVjSagttIICM3LH5YiQrdevsam+G2jmz1u4lSeSdpJVBguidrBsggEd/rW38TPBltaeILSc5VggljKHlgvJB9QD+hrS6ud3t1GapPRvX/P8AzOu+F/iaGB4tIlhbNxIxSYdm/ukfh1r0y+uYLO0nnunCwxoWfjPy/SvAdFPlvDdQTRwSwNuUM3A5613lz4i06703y9T1e6W6ZNjPap19RnuOentWU6d3c8bMcu56yqQ672u9Q8Ra/Y3a2Nv4Zt5JxHL5nmWq7So5yqjvnqe3FaEWgxr4fWc3ciJORPcjUFyzJ1KnH3elcNLqlloUbanpOl3c0dqVyZZR8mTgEBai1vxtqGu2kcVzsig4JWMEb8jIDe1VytWRv9Sqe7CjpFbt2uc34z8Sy3viKNtCjsLZVG02pADsM8HPuKdLrK6dbpJLFLIoXa8KMQjE8YGOaq2Wh2cOqXOqTqFkkIb5iCE9cema6Pw/d6Jql2mUeWJWwY0bkkcEZHXr2rVvsenGCpws9v0HzpYLZWl/pF3PczMoeSOeMYQ9wAeep71R16K31S2tItfmkn00kExF8Zf/AGegB6V3N7oEdwi3FjoslrYo37zzZdruvcgHkCud8eeG9J1SO3sY3vLVoctstj5gkHUbcnr7+1TF3OSGIpzSjZyeu9vxsZzLp2mxeTo0U0FtCuFiclvrn2rn7rToZ9VgvWuyZLdSyRKpBZuThT+ldHJuNqJlcoLYCCGOQgucDHI7muM17T4o9eXWBdSwRLtPlEHeGHGAfTPNUrXOxX5UkiqvieW9s5ftFlc203nC2AyTt3c5HTkcZrei03ULJ2i1K8W6uX27HyXxjgZY+vtVhx9rtraeOBszbcSAnDMeh+tO3qPPE3m7kwYwvTj1z2oc+lhwptWbdyjNp97oml3MP2uLULyBwVdM/MrAHHPUg574xW34evpdI23NzCD5yDfgA5P93J6VzOi2d5b+ILq9vroTWkhLLAvT2A7AAccetX9YlW522qTRxXUy7408zLKg6YGfSh2ewoxvHlnt5myiC7lnitZvKtApnETSYUDGPz5/WsEaRDZL51rawlwGkjj3EKz9ATjrzVC/h1sapZR2O1bRlQSlsDo3zbh1PHYV2Wnw2k8jmedLSNRgOVLZxngD60mmlcaa1utF5f02c9ocmo2mm3H9vxI0u1nb7OAxRcZUADqevAqxp155zRXFvKslsygqV5z/AJx0rV0myvZhdSWdi135MRfyv73t9etZiz2kV1BpskKWdy8X2hVbChcnlfUnr27UW5tUNVIwfJJnuGjjSotMtXWOA7ovMMzAEgsOQD/SvF/FLOmqyR29t+6dz+8RhheeuPf0qpe3Wq2V5ClrGZbVsbykmNv68U98mRpB5jGQgY5YA561FrfMwwmE9hKUnK9ySM3KQ20q4C25YK/+1kHG3vW5rHxN1uaO00qG3lj8xdst8mMt68YwPwrl4byC6+0xQyEfZvkdjxjIznn/ADxVbRba4ghbzdTN5GW3JIMEbfTPem49zadClWalJXs9C9d6WusQvaXGWEncHkc9c9q27bS7c6Fe6VNbRXLwQo1uVAYb0IyT2JIqis5jfO0AAY4pIb2VZjEheP5dxdzhTQtFY1qw532O10e8itvE0OtPp9vYRFCrbGA3jGDtBPX6elYHjHVNQ13VNUh043ENvdqEKDPIAwCR06+lY0x8wgsysFUKGLZx+dVn16/0nUbKOzinKynBlQ/Kntj9aSSb0Of6nGD9r1tbr8u/3mt4TgtvD/h+aw16B7qeWMRrIgAMJySGHuCR+VaXgKCQa/cWMkytaeRN5JZd6o7ctgemRu/Gud1W6upkaQDz5S2TuNdBY6jpq6ZHh/s2sQABZYn++f7jr9OM0fE2xV6XJTcVe8vnbpf/ADLHge7ktfFcDh1iiJKPIVI3jPPHbNFM8S6hdSSafK1sbaMwrtkWPbvbcST05opSgpbnBjMAsY41JaO1uhn+CvC1xrXiO3/tt2SC0cSDPzMVHRPYH69q9Y8W6rBaaXq1rHGYrhYNqbhhZFI5K464Ga4zwRqTWupXKtd2zTREMYmfLbD29u9bfj7xNpP/AAjt0bsXSXTI0cIRPvOeynof8Knk5ZX6GGOc6uJg5K8Vbbv/AFueF+FJLO91jVb63imSVZBGWdsrjvgdjx0rtLO4kt74S2+8zgfK0fUHsa5Pw1rS30l6r2sVoIHByMIrjByzHpu4rpUngYC4hmyzLvRx0PuPatnq7nvQScLb7naaQ1/exXE+owSXMcRLYnkx8/crnvx0rP13Vhf3qro+m/Z7sgoxiAO/3AA4PvUEviWe0Hn20TJdyxBXXdmONv7yL7j1qnot81jO15KEkmYEM7/eBPU/jS6nDToSu6rj6K/36bWH+I7DU9Uhgs72aGC1Qo0yKAzNjGQD/Dkior/VbLSbiGApFYy4AjiabczPnqfQ0y7TTr0tf3d9dpHGdzCBgyOo6gc8H3qhpNl4V1zUEudQiuZFtyFYM2JVAPy714BGe4q0u60Q3JQVuv8AW2up02u3jXHgxrLDx3TyFmmX/lsrcn5v7wJ6GuQ8OQ/2U1vHLcSymBwzEkqy85x7HFdCLvTdSuZtOi1OSC283AnQglfZx6VRutAh0ubAaSS3AaR3BAJPYj2PSot0NaPJBOPe7+89i0PXtK/s+1hGppO5UbS5+cg9M/TpW9IyIC5dVGM5J4xXhWvW5ttM00tGJNTmTMkEYAEMYGFyB3ORyarmf7VepZ2cl0seQhDzFuenArJ0k9bnivJoVXzQn3vp/wAMeja746gguLq0tuDGPllUglsdQB2z2NeJ+KxqkmnuNGkQXsjiR9x6juOeCa6DVmt9I1RtPupILfUoypWOU/LMTgjB9/Q1S1bUYJtZks4op47z/WyDbwrYyQPb3rWMeTZHqYXDUaMeWls1uej/AAg0ONtF/tnUVR7mUeWAfuAJwW+pOefQCs/4jvZeKtV0S10y4Mdxp900rXLNtTYVwy59Dx+VY+nazd2XhU2kZVISzMWU7flxk5Hb8K59cajEn2O4tVTGXJn2tt/CphB35mznWDbryr1Jap+6uwt/YSfPBa3MZjRiFkiIJx6jP4Uxg1pZ77qZljiGGaQfM34e9ZeuSxaYbd5Ee5MLfZwY2KKCeQc9COPetS8v/J0Tz/sM9+ycJBGn+tJ7n2rXl2PR9qrPyLun6qb/AEaW20qO4mjvQEaBnChiG6DgleasSW97bIZdU0u3tJQgVAkpfcB05wOaoeF/Er217bTpHGupRDdNAFyqeqj6ZrXtrbVPFGqTGwjMr7y7qX2LGpPXJ4/Cpbte5k3yPndlHdvzMG7ZrgMk4URkDKYyCKrqbfS9IuPszLHZowkkRVG8sMDIPX0rrvEPh3VdEt4Lq6soZLRJR5nz7888BiACAenFdDos3hi88KXzxwxR+YxMkLxeaYG9FIHI9KjmS8xVMbHkU4LmV7aanI6VrSTW5nt1u543i2ujuzYPcj6/pWNrGtalp+mTvptlcveOUVEYHdgn88YroNJImvSulpiaEbmFomGZRwcLnj6Vm/ELxSsFtG91DLIzOsJYgLJxyMk/55rRb6FOydkraa+Rg2utRpZrJqBNpd3WCiXEm50IOOD2B96vPpVvqV/HJqMga2tQHMIk3K7/AN4n09qxruxstVa2v5IrholjDCOMYLL1GRXT6bGklujSRhIw2SuT15wPei/VG1ujLHiLWYNM8Hu83zQQ3AmiEfbGMD6EmuPsJrzU7uLV2nZdOuI+ImT51k3Y7f5xWx4kSU6JeLYBfNdQsYJG0euVIx9KXwfqGoadpNvFeRRSXLfN8oGFHbgDHT0o0sZqMlN8q8/n6/oWdO0jX9S1wR6dpazWbH55XTC9OTnoPpVXVvBb2niyC51C0lW/XaQirvRscAgd67e28WeILJFNsIWjB5hkUAepArbf4kqlvGZ9JkjupCIlbzEA3HsCefwrNuSeiOStVxUJfw1KPrt9/wDkcXJo16ztcfZZUVTlnKnH4+leheA/Ctrb266hO8d2JlHlxvFgRnPPXqaZrni7TpdJjtjeTmdvlmjS2IZ8dfoD6g0w+KvD1jaWMNo0kcNu3mPBGpLA/Ukd+tTJyaOPE18ViaXKoON30XRfj/Wp3KxQ2cTm3t1UdSsSAE14V8V9DfWL66DpJp/luHIhUNvxyOeuCecCuq8VfECS/t0t/DBeMscyXD8YX0H+NeezabM2qNf3uo3FzKeY45JP3cZ9h6+9FKLjqxZZgatO86q30t1MXwlqMM9xNqNlFOk0atD5j5fKpg8qevPA79qo+I9VvLq8uJ72W80+C1ARFhQbZicEhOgDfXPfmurSzeNB5r4UkkCPChQe9cu/h/VDezmyvUvdMaQuILmdjuPHDN1GD0xXRB66s9apDRWRc0ZLRobnULiL7NY6mvlyQyHJyejZHArc0nQRbW0UNinmW6n5WB3c/WuD1vSdT16WaTT3kdY5gqxbDEhXpwTwQCO3auzsrmTw3o7TXtv5BkIaZLdi6o2MYUdfSnJK246c2m0l8yxcxyRsIzG7Ettyvb3PtVNvtF3qfm3FyIAgCCAuH3KB/F6U/Rb5tU1qe5t5Xjs44181JoSCcgEEN689KwPEN7aw+I7y00q4vbq9ZED2isPKD9cbuoyDk4/OoUHc0lXild+gvim61FJHMLQR2YYPHK7KIpFx03E/e9qk87UB4Ze7vtQ8liBKpsoRJtj7Y/vZq62lPN5S61YWJt4GDwW8RYmN/UnoRW408r26oiQoUBxtUdaG0lYFCcpN30Oa0/WmuLGJ4UnVlOwtcoFaTA6lex5yPpWPqcNxouvNf2kQvckeYwXJjc9VwOnXv6121nGbaKcm3td8pDSHygSxHTnrms+xn0+bWb2MWZS8UKssyEjePcdD/OiMrSbHKnKUUnv3PaNGuNG8SeF7XS7/AHRSxouNzfMj44KtRXmMkc0SK9lKZXVlPyOVyP8APaioVLmbs7Hmyy+rBt0arinrbzMXSTGutxanfARnYwRsYYrnHP8Ae78fjXa6xHe6lDDHayAWo/eCQouPQ8nOCR3xVG/FkUjnuYYS0D4RxwVJHoeMVMtpczWUIs5EiM4YRpIxUOQcYXjrmmo8sbN3O2vaXvtWM3X/AAdpr6fPa2t/FdwyEeaqAKyk8jHuKr6X4dTRobWzW7WZFBVQzZz7Vz/ie31PQbq486yniu3gCRiDOXI59MZHr6VLHe395oTX1wsun6hFtiHnpuBOCdw9uP1qU043QYefM1d3dt7fd+J0VpZvEJ3nmaYl8jKhdo9KybhPt9zfQq8hWOI7wqE9OeAOvTpWLp2o65avJb6pdxXiPhvOjHyx59WHQfUV1cM0dhNJJHMG1CKIuyQEebweeK0pyTd4mlXm5bSVtOpleHG06TR9Suft9vPp8w3zOEKLEMbdoU8gmt3w1Z6DZxSXTx30kFwoRZrZxukxzj5s8DiuTiudQsodQuW0e3vNKus+dCYwBKCc54Ocg88VvXfi7R5PCm610O/soYJRKyLKewAIXI4XgVc027Lqcl/stad10776/mdRf+C9M0/R28Q6HIZoZ13NHIvzhT16dwevFZeh3iazp1yolSH7Ou9FIzkdM+39ar6R4yOs41CG08iyRfIggXOA2PmJJ4P4Viy39gUv4bYypO0u17S0G13fG7aAevHOB6Gpins9WFP2iguaX5bdvP1I9Q8X61o0UUXiWCCcTMLeC9tYtplQH5g2fQ46c1s6dqOlS6rDFp90HvLOYyXQbPTjaOe3UVY1AnWdAbRI714Cp86J1A3JIV7nr7471R0bQ7m315Le3t4BDcRgPNuACsB8zEHnJPPtQ7NXLppwbi9v01LGv3unJv1DV5Y7q+W5821eVegz91gevQY+tZD39vHrEgndri9iH2uWNSMnOMDd2/wNafiHw7p1q89lNINQDN5jbpGYKc9AfTP86s6NoGltqA1V4WSR7cRybuUIXoAB9OtD5XoXG8I80dvxtb/hjI8f+Jo2meysdIkit/IwpV9sIDHLYfpWLbeF7S+0q3uJYpdMlz5ryW83mB1GFGW55rvJb0RpPBFa2Tp95PMhDiP6AgjOOKveCI7Ge4mtNWgt7fTHG3zFAhVZG6KCMDJ5OPahz5VoZTh7OLlNXivv/r5nIW99aWOjyQmO4u7K2j3O7Ju6HvnvUSS3V/eabqnh9BLZSZS4V2CEgdAQc9OTxXqHi74Y6JJCJl1Ge1DAoYXn2Rz8Z2tjGSa43wvHJoVqkIaBoAJI8wxhdsZ4GM9WA71MJJxutwpYqGJTlR2X3lWK3gs7+aWJEL42kkde/Sur8I+I49BumaW3Y28ygTFDzuHQgfSuavkVNQkG7zI25SQjAccc/X2qC5k8ycgJhAvFKWqszrqUIV6fJNaM9R1jVrHxtp02kaVffZ5TiZ/OQgNGp5Bx05wax7Ow0vwxbfZru9jnl3+bItsoKuOyYPtXH2+oXNvlYp3iEq4IUdVHr+VR4YqzltwLck9SalRscdHLvZp04ytDt1v62Oj8HJbQeJrzXoFFvaWwJaEuSSrDAGe5pnjHUf8AhJr+8+y6dbeXaR78zRgs+OpY9OO1YGl3cttfIysyruAcK2Nwz/SrazTqNSt7CNnFyNkjBckoGz+vFNLW5rPCpVva7uyS9Ot+/UxrdpZGQkYfPJXuPT2rVuhc/ZSlpOtpISP3jQh8L3XB9fWrFvA2LfGwBUKsM/N1z/Wq1vqizalLafZrqPYdu94ztY9ePbHeqSZ0SkmrMqZuGklijvbRphIHwUxti/ujHOepyag124Gl6deXVmk9xOuGQ7sMTnrx0A61heKE/tXWrJNEukt763n5dkI3juoYdR14NWdU0m5uY5lv9WESTIYYgFMbJKzZz1GeMAD2q7bXMnJu6Rr+F9ck13SVlaPbIW2MoO4FvUE/WrviCzthMmla1B+8cCdFB64PUEdwRWRcN/YuhRXCTtMVhSIMWIQlc/PjsT/OsLU9Yv8AWL2Au08d9cRFUkY/6scj5eM7SAc+maajd36EOUlaP3naPLbiXYJ8ngMpkG8ZHHHWsLVH0q2v4Zb64WGRgwjDTN82D0bHQZ6ZwKteHPhxfrb2t9dqUlWNgrO3Ep74HUgA4yaytT0GxillS9uZEkt+Xy2AR6HPaklG+4/auatFq5tHVbOPTVvyDGiv5RiRPnBxkYGcHP6cVKup2t1bxXKMfsRyVSVtuSOo9hXHaL4cv7vUGvftCXOlRsV8oOzBlA4XHbFXfGltBbaBFLeWrSW8c6AIpKBQeDyBnFDSvZDjJqLlLpc6uNUvJGRCohfOApyAOmP/AK1Zokt7a+n0q0jlWWACV3cHDA9MHvVX4e3tlqGnvBZ20lusD4ZHbcxYknOe/SrfjjSr7VNLFpYPDDHJIjSu6sWKqckLjr0HFLls7Mp1FyKcdSKWM6vpU+naTdRuwcQTESYaJS3ze+cZArQ1W4Sxl0xI2iFs8ot2aQnKAKcEevIxzS6Isq3d1eGwjgGFRZOskyDucDj6HvmqulaPCIr+PVVFxC9680KSAgKG5p6bMl8z1XobPgGO68YWk8kUa2phRmiSZuJDnA4rLWxNlcSwpFDbTqSsgiULuI7ZHWq+h3CWNpfJp32iHLgOso2vCW7DHYgVueGpPLnIYqVYfMzru57H8aiXxWRVNVIpzk010/UrX2pzXcMC6lFloECJLEoVsDpu7N9etZ1vnccbmzzzwTzXTazdxSmKOS0tQ0eSSg2k+3Fc9LPB9paISIsmN3l7ssB6+tS0bUbKNrWLHDcY+tQG3xMxUJz1IHzfjUxMQiyzMwYYwp5B7ZqSzjE52OuxgOvc4osauRFbGK0iaa4fbFEd7P8A4YorL8T3Vxp0mnTIY3sIpwbmNQS7gngqQD0OM0V2YaiqkW2/y/Vnm4rEck7XS9Tc8Xvpkd9/Y1xiQzSGSN0z86gZyxH3Wz2qh4kOp3GiWMOnybJIZ1+ViPliY5br+B/lW3q0UMeuNbThcW0mwyDBLe+ajgMEKzpdK0kTIT5p6q2OCBnp9a50zaMb0099ncgvTd6hqIuDPLLIgAVnJLYA6j04rQjuNMlgaK9ibz248wDKn8q5rUrvX5L6zg05rZ9KACzEAox759a1tOtpFuAYZWVkPmou0EFwe/YfWp2L5bx7W7El34Osn0yfVJUECICgVG2F8nptzjd+FYOhaJ4Y1vU2nTUrsXQBUt9pXDN7uDlW4710mk+JbfxNpmrabdSzIfthFm7puR5B1weoBORzXGXSaL4eVpPsa2s91IIpSqn7wOenbnP509VdLc5489VPnf8Aw3Rrv5nWajp13DYyx2cbQ3qg+Slz0bA6j1471x6a3rtpM9hrmiyXd4yeZEEQKCg65PQ9q7VL+61LRba3cq0+nnAZ+rRt0wfQcipkuIzYSSX1wgWLvnIT8fyqoyVrWKanvJ2sZ+nmzudEhZR9mk5EluEI8l8dQOjD3FctcWSaj4gvrVzcfbJbfyzqKW3l7FHO3Occjow5xxVjxRrt3O0VtYeVqFjC4cxRSbWVvqvOPaqpttUbULS5u5o44YYhLMYwV8wluIzz0APpVpcq8zOSc91e35GVBaT3Wqx6LZ3QiFrGnmTj71xsOdrNnIb6fjXb3+tRW1xZ2ssvlSzMybiCTgDsR0rTj8J6fpqLrH2h7iWQh978iMkY47dOM+1ZV7bRPMHkjVzG26NmGcH/APVUTkm9DbDQjKLa3uMZZJLg5+djx35/xrv/AAz4cSKySXUpRaG6VoIonGXYt3A7Y61yFhcSRXkc6Dc02Yx0ymeMjsO+CcV0kOoiXU4rHULiK5gtSZbc+cCqyAcBmHUf41lbsRjXUnHkg7Ld9zl7hJbW/a3mH7+GTy3ic4Xd0zk9PXNdPd6Be6pZW8Vu0FvocOWVzKGErfxOxHU9QPpisTxteQ3muyzIUbzEQNjhS4UZx61Yji1iTw3YBLhxZBnXyVzgAHIbAHOSSPwobb0CopyhTndJvv00/Ptcj1rUZby2i0m3kkubbTnZ4ZX5kdQCCfcYPHsKwdXSe+0W509bhY5JVOHdQdpPTkcgVv29sbfWtPudKuFvRAFkmdVIEeDhs5/yar69Jp1xrDS6ZFJDHI+CiKDuY45CjoTyacW4u6LgoW9kl7tr38+t+19zltBvZ9H1OXRPEdyZHUg2ksoDRzE44D9wc4554r0C40bTXsFksdRi87aHaCUYCtjlVb1HoayPid4QC6LHLo0MdxqlnhtzJuII6lQTjeBXEeFvEt6s62WrvDHAhCte3biKRGP97sfp+taNcy5onJTquSTUnb+t7nXadaqNVhjuJTAgbMrkE4XHH1zyBUO83NpNyymJxsRj1UnHH+10rRtrzT31CeyhvZJSinbLFzEW7HB7ZIGenNc34i1rWzqlzp2i6bHILcL5lxIMsA38SjpjtzUxXNsdjqtO7v06Gpb2co3GVfLz/e4rcifZEiRoqgJsJHVh7muc0qK4s7eG61qeS61d4gHXf+7jBPYDjPTJplvrpk1y5srq1u0WD5i0bbVkA9Gxx/Wla2xo5cyTkjduHhgjwcIW6Fhk5qsvhzVYdQS41CfUFJyVDReVBjBP6D3q3oPijQNZ1GVv7PkhsQShO4s8JPcA8EHHpxXX+K9VTWLN9Ns5Yz5iCezlT5RgdUbPTpSu07HFVxFTnjFQ0e7f/A006nKWGinUHW5tChLZzcA4KeoPGe3brS3Xw6uLi0vpZdRu9St2hw8LSMwAyCCpIzu4z6isQre28/M08LpnKBiOa9A+Hvi0m6ey1eVjLNgxTu3XaPukeuO9KUpLVCxsa9KDqU7NLp5HkOjWOq2ei3cF04kfz91urndsQN1JPHPpRreuXln4o0zTvJR7xdvnNtGFB6BR6Dqa2PGGsyaX48u7SSykbTLpTKkkSEhDn5i3oO+PeqraYs0Ms0ZngN5AVIfGV3Dn/wDVW1+sjWHvRXJ/XU6S9+Izw+HY7RIIpmD7UkjwxAx0Hp3ry7ULvUtd1K5WCHzoJQpErgKBjkbj9RjFdBZ+G4IhKbq4llmCpsVBtAAz37cYrcsLSBdNSZPKEC52+WQenXJ6mi0YfDqFOkkrRXKnuc3Hqcvg7SlguVM8szlmWA/LnA7n0rctdQj8Q6CY54njtpwUKNH8w+h7npyKp+HtUl8U6jcWNjYYhhQyySyMuxUH8TnotdNqUL6ZY2d49wstuoLI1ifMVgOCDnAHYYpN9HuUpw5rJ38jO0nSdN03TZILVprQKd+JQwZ2+ozT7O/lia/a7s7hba3w0VwWD+andvl6HPbrWZd6vdX9hPJpbNbX2PkjmTgj0ye9TeEzqFla+ZqUqvM5JeM4bjPRux9aW+rLcWmlEyPEcNtqFrPrVnrOox6epxNBA+0knqAp6E8ew60kvjCW3t9DjtIIxDKdnm37HgIOzD7zYzz0qfWtb1KG8u1t9Exb286J+7Td5oI5x26d+1c9dXVrqtqINdmi+1jLQxSxNEtoxGBuIyMkEYzVq9jCVujszrtE1O11XXZ7mJbe50912faGJ2GRc4GO6jjNPS31yzv5N9p/oLL8k8ILK30I4/DtXNrYJp9zpmn2NjcmS3Tc12p2oBgk8nhic+1XvDeu+KzdNPDv0+wbcv2eRtrNjgE8cf1qHHsaqc1ay1672J9Z1RdNTN2cSHBEbEKxBOM4PUZrP0o2l/4jilFvNFdlM7yeMY9O/HFQxSa9ql2kt3b6ehWHZ9suoBJLIwPXHUK3TjGKvw2N0Lvc1lZlJIiARu2njoSWJGSOqiqjGK66jdWrPXl09Drm00W8anOeN7EjGcd6XQ5Vlny7h4zkqVIAHoBjr061xEmiak2kgaZetY3TOSbFJzImD1LSP1G3t2rW0Ca5so7PTZNNzAzeWZI5VZQuMhsjkDPHbFLkXRgq0paTizY1OxttQukKu8bKQwA+VvoT2ornoNb1Jry8SbQLyCW0dNiyHduXdgkN345GM0V7OWUa0oS9m7fNfqc9atS0b/I7rw/Z6K2oXja5qEcAkXzEjWQM2d3Pr78e9VfEb6etxIunSobAZ3qSTtT/AGu5FcVqNja6LPLqt5JLI8R2qAoAHYAD+lXn1nTxpA1cq5s9hdl2/MR0Ix79K8VRfNp1Ojk5ZOcp9NuiRoWGs2TCFbNWuIJDsRlJVcDr+Ge1TpcyLeMgDIiEAlwQrA+hrP0DXLXUNDh+w2UH9nbmaKJ4drIc8/MOT+Nasq3s2k3k1lHArLHkB8/JzwQO4zRo3ZGilaPNL+vQljSG1LPDHGr4+UgfdJ649Cc9ay7zT7PUolOq7SscoO5wWIPODjqcHrTIlu/7OjF7LHNOMeY8Yxk9uPateVI2jW6hQQGVcPBnI3DqfUA9cUr6ltK1u5zur6tLpGm3k8DKxjdUlBHysAefqMHNamoWEut6LbDTLn7MXKyidRw684H06Vn6vqGnSxR2P2JNSuTMolt1wWiH94j26101jpRtmikhWYRxriJQ+2Ir/u1Xw2aMJycm0zDtNITTJXIafL5BDABcnkkcetb2maZFfxB1uzayxncJAAc/7JB7Gs64s9Ya/nae9iSwcgxRCHLL65PStPU9Knh8LnULTUbCOQ5K28pILHOO3NS99wqVYqmltfQ6W/NlZ6HFBbSQSFxhgGx2rirW1hF7KEl32Sg/aEU/NEfUein36VzOq2j3MEaTs8TPy1ys6qsZ6dD1zziksfCsVvPHPHqTRtbq0MjDc5vYGzkN789ewFUoq2rMaUZ0bpa3N+68WRXF21n4Qj0+c2qGC7sr/j7Uufm2MevpkGtGCysrnSXlsxcWdy7JIltdJ/qlwQ0e/v2x9Kr+HdNsLQStawwedJsjDhegHTcM+9cX43S+sNdv9W1y1tI9PeYW1stvI480YzvIU4OAOaOVS2M1ejLV2/L57naWWkx3V2seqXUdraoQXccsR3x6fjXp9h4u0uTRpotDiG+BGit4XwoLKPlB9M+9eMG5uJvBtpqdpdWsN1fAFPNk2xhjxhd3XpwtV001tG1OK71vU421SQgqkBEcb7R93HTcc81DpKWrFiqNPGNczen3f8E6iWPUFs5J7zTxBKXw0oXau49hjiodLsZ38u6Z0jjiYbZUIbJB7r/WsS31TX2vjb6jcafEt5E6oJpRvmwcqAMYDL0zWVpnieTTracasYpG3qYVhcMXJ4I46Yzjmr9m/U6I11yuMrI7Dw/qGp6pcSOhd7EzMhc/MOD97OP51y3jHwgi+JoJrGCK5jWYSNNdthRkcgL3H65pvh3VNZuL8vpeoyx6bO7MDMT5kOw/Og4x1xjPXmpPHF14jn1W3g06LzWfAyuCXcnjg09VJmcYq13qv61Jte0S+tdASHQrdmlnuAJJxgMkROdueu0HHFLqVzr9hb6PFYkXToy/bGCgs4yCQM9Vxmuq8Q61cnW7Ow1a6tbFrdFhYwgvFvAHBXsM8fhU3irRUtPCz6bqCXsMk8gEV1CweCQk5G1v4PxqIySsiZVXK3Po5bamHcu/9oT+Y2G3k4I7dse1a862kGiWJgtPPvpdzSzb/kjGflH1rC0KS/v5tRt9Ws1gjtJClvOh4kTnGee39as3drKllbvMUEkoYtCDnYAeCfQH0NJqzO26qcqu1+v9f5Fb93HeTeUkYXecFBgH3q79uktoGS1lkj3qFfaccelQ2VsgcByAmeuPu06/gAYiMhtp+X0I9aWps1F6MghJZt7H5icYzz/+qlZjHKjjapDbvSljvrXTrR5NQmiSAowIA5DHoQexqhd6hLJqWn2/h3TbvUXeQRSyPEQsLYBBwPvDBz1ppNmc60YXUjpvFe14Eljf7NcyRAxhmA8xyMhM+9chpq61e3dtJ59xGsZCyIUwpwMkvxwM4Ge9bl1pC3PjCDUdbf7Ra2K/ubRTtLPjktjpg8Ae1dhcX1v4q8Ltb2Fvb6feWk4MturcmPB5Bxk9vxFJ6STOR13TgoOPu3Wvb9TzfXtOvdTtbiKbUvKsy6hfsylpGUHnOO2eat6Xpd2lzc2dhp27T4Yw6MrEvIO/H55Ncf4h8Qzag15ZWQv7F7eZCJguBOoyCuPrz74rX8J+KL/Sr+1stSnu47qeKaSEiIPt9AffAP5itWm4jdRRk3FX6X/rzNnRLlU1uTwtbadIG1FP3bqAkakg4J9QP51pabZXvhayn0TU5VubeVA7TW7ZQyKD8p9M8Z47CsO/n8Q2viO0jkiaGzCLKs82VdiSCCv+FOey3+M77U7u5neC5DERbiIgQOrY71DVw5ZOV94/r3RkWzapf3V99j1C0hEUqmFoGJdF75PX8R6Ukt7qumSAyiWa+kbZtu5AVlUc5jRTknAzk/lVdPDkVvr1ndlTYxW0jCJlny12zDJTB6D07mtCHRtXvbCNdNuvsjwyMq3N3HmTHcoeq+me+O1aKyQS5227ai6vqGrapZ6c9rJHZs1yFaF5sMB3+pxg7RzTl8OW0eqPPewrcuygjzQeWySTtPGOeM5rtvCfgXRJJH1LWLlTdQLI0UsrgFpX5Zwp+lYd6DFdSLjOD3/nUOdtIl4dqrOUZLVW/r/MaqPKVCsWUDpn/P6UsrzHC4GANuTGCeOuKs2MoBUgZB+XitDxHpU+nJHMrQyRsoZ0RssmTwT6VD0R1OpFSUW9zJSHjLtuOOoHSmvbkiPEzJsPYYGP6Uq3JcDhsHqO+aeHBAyNvc80rmjjfRjQVUbot2/nDdMZqaGIIBL5YYAHPYZ7VFG28hVXk+lWoJH8soowuec9QaEJixPY3UQsdThMlvjb5m87hk9Qc9qKZ5MbXC7DgZHLYorpoNWd1f7v1OSvRi5XvYu67BputgW84hd3BYxn7rgHhhjnjNZ2t2Vtptg0kYgSygQKEPyjb0x09TVix0eKCQPDbTL5aNEjbuEUnkAVLe6YZdOFuRIzMu0Ofmz6HB4yKz067BG8dEZlg1jK/lR3MSyoP9XGw698DHQD0q/LO0EDRWzeYjAGVW+U7c9ieuOuK4jWPDE+hWdhqkLyTTw3IZ5ZF5IHO0AHHJraj8ZyS2pnn0e5eFcK8oAVAfTmqdPrHVCVa91PSxo6bBqE+qXNu8LOjMXtpQF+ZPQjOc1R0zVNXg8S3trfWsKwwRiaN2UhHG4A8+oya0vD+r3mo2U17FpZhQI32WKY4aZh93n+FTUTLfwWZknEttLIodgHDmKTOeM9cdPQiklvdEzk5W5Xp+ZFpvhuW38b3V/vii0+4XcIV+d3ZsZ6dDn1PtxXV6nc2VpGyRJf/awVWMTNgJ6nHfI7VxOoxanqNrMs8/lebGNzRjBL5zn5TyD7dKzbLXf7LurbTb6We4uGwBM+SAGPABPOBRJOWvUmMFG13oXz4nbxI9/pEYureRlPl3BwpGOp4xgexrU8D+AhqdpewDXZZTMMCXaSiEdhk1U8Qahb+Gb+3urK0a7v7vPmZPyhO68dWPpW38O/iZEL66gn0OK0lVcAwZA2g8hkPRqc+ZRvFaHNVlNRapK8v6+RU174f3Nh4Nkt7OVdddJ98qxEh4QAfmX2FczNd2+g6PpsVqLnURLmMyQ4JjfqQfXrxiukvPiJfXXiWbTo9DtEt7p3jLbXV1U8Ft+cUzwfYW3hpHuLCe6WUXAZ45kBjCcjIboDz1+lK7StMui6yTb3/rR/5i2+qWMJs1vW+zSFgoJ6v7AdQeeldBr2q+GV0SVNUtP7QuLXJto44syMT6Duc/pXL+LfE+jR6ii28vnaq2FVQhkG7OMsR0Fc9dW11qo+zapt0q8eQJFOCD5xJP8Aq1zkAcYOaSi9GbVVGtu3ddu51PhmLR/FOl2l5qunNYmynPlQFg2wg9RjjqOhFXtf0/T9YIikjM1oG3qSCp3dOW7nmm28trp2nC2v5YYdSZApaUqJJdnGWxwTirpWG5sB9tdkhGf3aHAweN2frSu7jhBR95u55l4zsrq0AsFVbyzkTB2ptlGB69jwOaq6NpVjqMFw3z2zeWsvlHjnGGJBHHTrXqGraZDHpiK+5jJGYg2NzBT/AJ61zFvoDQyLNHGb2dPlIaTZuTH3fQn61qqmlhewu3PdGDPZyW/hm4uNPmupbP5AiBtwbLfMcDpzW5pNpNP4djnNyEuefLeQFCD/AAnB7ZxWxZXMUHzzW09tEr4KiEsrA8ZAHas3xNaald2V0s0Udtp8ZGyUMWDxYJJbuMegpN82jGlyPRjbG51q/le+8XW3mKmMBdqmduhwfoByPSuu0/xA93Y3OmXe1bG4jMSLMdwjYfdIPb8elcJe66W077L4ZggvrmJYiFkysbIe/B6j8OtOW6kjudN0/VLq3staukMqQJEz28sfO0h88E4IxWbjdky9lyqE/l+lvM0/mSYO941mbMFpdybgw/iQ4/T0qLTdaS90htTaxvDayfIoDAOWzj6f0xWzawwxwzb5YHnCb1VZRubaB8u0+mfyrh/D2nzaD4iuYYFu7yzu1DeSCu2NmOPu5yfqMcU1a2po5S5vd26+R1WkXSasiiyYqwYxssyFWU4744Ndg/gm/ay3rdWrSEbjGmTgY/vHH5VxXieN7CG20Nr1LF51BtxFkbCF7t+laugXkc+jRXFtqTX6rtjebOcyAfMMVLj1QpzqysoSS/G5znim7s/DpubbUp1WeSJjGGi3hWx8uRjkVufDO+1PS/Ddrc3UoJ80gCMgb1xu4xwDg4xSyeGrbxgDDqEKNPvChg+GI9Aeora0zSdZvYVithbRWOlj9zBcbQij2HQggcmm5R5bGVR+8/atWW/zMKCKWX5oiTGGLyOwBbk5ye/etzTdHa1STV4dQ06S2t2wtzuYk8c8Y4ODWz4s0WG40601W21Gzt4hFsmSNDhn77SP5H0rL1yGCDwhpdtZ3lqHOHuEOVklc8d+n/1qzvfYX1lVox5Ha7s9PvORnsbm38WrJfGObSiBIIxGpYHHP1B61uiW00lzqcUcU+077e3lXJz6juPp3puqW86/ZhF5cxUBcnPT0/8Ar1za6iJtUurCa0ltblMtDMGJzjpk+9Xq0dPKpKz6kVv4w1jxDqt62qAxyRI0sayMe3Ydlz7VnX7ap4gvNLsIbc2tjLia5uIiW8sc5Uepx/Ormp/8JFpEd01ulleoCrKgXzCy9SozyfwrqrPVL6CySa1txbpdwBXjdFypK8jJHGOfSqTsk0jOVO6dKD/T9P0Ksmm6RqNzaXFwt5JdWR/0cBsxhfUjufeup0SXSkv431iUpCrDggkE9gcDpWBp7pFgxhi4I+42DjpnB60sk7z3CW8cbkyNtAGMk1Dd9DWdFNSina/U7H4nJDdXGm2unxCWYAqY4VBxnBXp68mvO5HlmCqxULG23tnGeRzXWaZfX2kzxyk+VfwhYJopwSxTsw9sVgeIi0mv37MWy8pbBHAz06VCjymWBi6UVQ3SW/z1/PQgmkzxw6YwCVGQo+npSJcymSUnMm9NgJYjb74P9aidCjrzuAP3l6VHtjBYOOn3QKd2d/KrD4n6jGQRg4q7arCZImuGBj3fPuyAoz/Kq6xjY21So6UyIHL4OCq/XNC0HJXR3+p+C7LSrKXVYLpriDh1h2ZDA+h61wTXZM023dycgk57+1bNrrp/4RmTT74vcIsw8sFiGQEH+IHkZrjNZvZLKOMWxQXbn90jg4f1Ht9aI32OHCwqU4y9vK7T0fkdDZyQNdhJpgXOCu1hgj196KwHuYp4GuNPsjJfRIpCNuwpJ5A7HH60V6uBwVaum6aWndpE18RGDV2/kjsNP1LxBcwXVu2iCOWE+YJi+FGOgx15P1qGTxJfp4eV9SEYltyTI8I3qEx0Ax16c1T0iz0vTNXuo7nxpNqlzKMvZSR7liPXAIbqOlUtO1LUodQubLU9MkjRXyk4O5HXHAJ6EkYrgstbbIyouNSza1e10zR1WCz8TaFEs8strFIokV0OCxxjdj159Kydc0qS/sbTStUu1IgZRC8eR5qAY+dT/F75rdFlamQ3IgXY4OcuQW7Yxn9K5XxPqFzpTNMzRCAADEnXcemPwojJ6JG/s4u7lsdvZ3Fnb2VrZLvMNsojAc8kd6xtY18N4it9JaCSTenyyEgDHbgc47buma4G28QSnXIYmfyYzxIpXCMMZzn1xXUp4ksIliuo5fN3Ex7go3r3HXkCjka0aCPI9YvY2dCv7S6vGk024ja5t32S2cx2PjOCQDw3Poc1R8WaZeXOuJeaVaIlurBhG5DFCTznPOD+laOj6Xpjau+qK0UWoMvmRs6ERzH88BumDWXfxXo8W/aobqV5rm1ARCTsRueMdD3z9aTkottCjGU5Wlv/AE/6+4lgTUmuj9vuYGjUlY9rAHHYY744/Kr25o43lYM21QQFwfMPTqcfrXBKb+HxLDp8UliurBhP5M6s+/dk5RhxwtdHd+I7Cx1GBGcMTcRxXMTA4iLZwcehxTcX0CNWCT9TlbzVL6+8Qzf2Np3nXcCCKVWQyKnzcFR0/GvQzZ+ILzw1cR31mdO82Pb5rL5i7D97IAwD+Jq/FqNrDcvLpN1G0fmbWkjVfk55XjnOAea6zx3ca3/ZDX2kXVvL4eeJdyBAxC99x69e4PFTOpqrI5pynGUYt6S76fL1/MyfDusaB4UsorZdJa4kVRicBDwewzz9fert1q/h/wAb7tNubRdOvSwaznkjVvm+uMDPTFee6XcQa5FczaE4uvs5xNEvLx/7QH8Se4rQsIV+xyXkoaMQSIvK8NnJGPU8dKyt71+ppLA4ed6kZPm7369NBury32g68LLxB9ik84bLe5WIgyyHggnoOO1c94ymkjvtGjs5Xt7mOUkgg/u1AyXf/Zxn612N3qM0uji2tnRo2m89jtDOH7DkcDit3S9Us9b0maPW7SGGeBMC4jHyyA8EFe3vjitVOz2Cp7SEFzK+utv8jn9Nu4tRjeNrpHMMYkVwDghhn6D2rLl1CzDmGK5hDGYwEBuTIBkqPcVg6697pQuoLCS7ns7x98V2I/Ma3G7G0ADkAevWub0OCa11G9s5HSW/t3Qw3ksYVQzHk4OQBjjPUmq9nobKs4yStv8A1/XQ9LuLy4nihhLKqL8oCDqMdTRZ3c1jOJLSYsEO8xOco/YgqeCP1qG613TvDd1b+dKgvEjMkiz4ChDwWH6+9S6Aia1q9xZW1wkUyEHyj1lUkEMnYgg1nyvqaSq07NO1itd6RDskjmtBCt9+8LxZTf8AxAg/lWxP4Vkt7vSltnh1EOBJFCoy8GQMbT0UBucZPrVbXBO2pXAuo5kKnaVcEbfoOgHFdj4J1qz0Xw+Ejsy9y8j5ZSBz2Bz0HSk5SWxz4qU4041Kau+y/wA/L8TmdK+DZsbiP7XdxG7IaRrp5W3N825iQMD0/KsnxB4V0a5Mjx+INl+jDFxBbMCdpyATnnofzrrNe1rVtcvXgt4HhVQY2Cgklc8nHbisfVbGw0nUobO5N64MSuzxberDOAD2o5pXu3qYYeE7KNaWrW0Uv+CUfAvw81HUIZon1W0udJiYiGC6iYzRnrnI7c4962L/AOGGqW+m3FvaRWiw7SQLeXywT+QIJ/GtnQvF9vBFZabo9obWIEiWWdlORnls9M1c8eXGq25nu4JrqCzBCxsk3DjHYA9DU80pSMOfFQr+zVop7J6ux494Hnbw20rR3FxPdRX5FzFMCO5+UdgMY57100sV9atDPbgiF3IjVW79SpHX86pukd25jnt45jJKGbMQy75zk9ieO9Uj4j0yKefTJ47mSWBspniVxnJ2ZPOPT8q1fvao9LkVK17HVWOiatqPkPqwNppERGQ4C7l9FHf6mquo3ejnW9tsyR2umR8AniL5uWJPWuOhvBapcavFfa2LAtukt7rGwjOCOpwB6AVXn0afxjpkcuigrFeXAW5jiOSy52k5J7Dt70KFnuYu+spdNl/Vz0/QpY9fuLZ9PnEqykEyrypXP3h7Vu+NrTwjqPnaXd3BtbtV+doVO5BwQfT3rl/F2k6hpPhDRtN+HstvbzwS7LiKaRElmwMAHd1GScjiqMmnzWenw3ss1vNqLuVuYnVXMZxwVznI6/Tis2vtJnLBfWaifM420SX6+WnbsVL7wfqulTW1xHqtrq2igfu2VSXCgHv2aoYryDUv39tkWoXHmbvusDjYQe/etbSNU1LTLwzrCssE3yyRNGFSRT1xgcH0rOuRB52oS6fbpZG7GB8ocIM90IKsapNP4j0Kca8NN/P9P6/AltVWG4VQ+ZWwUwMhvUH19eKlvIZbfEoWSNyx2yb8/UcdOtZWqaY9x4Vuk0yYRTxRHldyhdvJ2gHg4zjFc/pks8Him03avPKIrQG4WRQsU4xkB16IRkZPf1BquW60KdZxlZo6b/hJLexaezu7vZLKoU5Ygj0yfeprlHs5/nxjaCjbsgjtz9K5Vhpeo6tcQny7q9Nyo8pYifJjPv0bb6+mK3W1UaVp98NTvLdxHP8ALL9n8lACMKnOdx9xQ42RSre9dLT+v8jXi1ueGNEWK1KLkbWiByPeqd3cW07mSKEwFvvorZX8PSuR1bxBqV/b2snh2yiZEfbIIkEm7J6EnGK7rR7lbeCK7uLCAyHI8qWMSKfUHBxUWbVx80YP3Y6/gyjA3B8vJAzu7ipYCJC85OwKCcKM5+go1HXDrFu01vbrpU9vjcj2eFCDJYAA4JI6E1yUXjH+1obue0juLeztQE8kLueYntxwDwevYmqUGxPELaSs2dhZRowS4VXHG5YmGDntkdqyWur5LO7uNetkR45HdHUiQsn+yB09Ku+D9dTUdLjuFtnhR2KbXGAw7FSD07e1aLQXF7qt3mDzLK4hWPajEOvXdg/w07WuiXNytIueDtW0XVLBJLyGLzGUsFcbZMdA2O3NFXtJ8L6LodsrW2+5aRBl5n3bF7DPfH6UU/fv+7vY4NJ+9r8jz7w3a+HU8f2ek3cMq6vPL5AmijLLvIJJIJ44xk+9eka/4estBy9rOl24UloFOWzjuM964vQdLube+vbjUSqan5n7yWM/vGU8A9OAehxW5daha2QaYwKYSjMSW2qgHUk/WiWstHobRp1ebm5rLskji4PEMer4u9ZsJLJbBnuYwgYKgHy5Przxj61E/htbzw7bQXtwL7zZGnaYvzyezdsV1ulavpXiK2XzpohbOPLSQDdE2f4HzyPxqFtNuvC9vDoEyKbK5d3juJRyjbshVIGMc4PtT57/AA/1/WpoklLllrdfft9/RnJ2FjY6/A+n6M0a3tsAqyyp/rox8vDdf61q3nhSz0vS5NK3k3s0XmZAJdmx1XPbPGOtRxG18KXDXccSw7pNrspyo5/Qc9q7fxRptn480231LTwYvKILvCdzIcdu+D+hpqdmlsuhFW8JJytrv5f8OedeFdZ2iLRL+8uJbwFgpkjPynsmTyK3fGmi65N4fQ2qSRTMNyEDAkHdQ3Y96ydS1S1tL+21Z9OkeeGXyzI4G5SB1I7nr1r0HxH47iufCWnW+xzPKcOQny7ccNn8elKT5ZJpDlKp7sI6q9m10VjgtUtLi5l0SJrv7JcwxLBqGfllmQ45Vscc8fU1iQrpcitpeltFp95I7Rq81uWd5Mn5lck5OMj6813us2X/AAk2iXMlldpaeIlQRgyHAkHHI9yBiuVttQ+26JLdwRQ3GuWZ+yyLCAERs9QOvB/rVU5Nr+vx/roTJQUne9+t/wAbFvS7NVumS3a4EUAWKaKG32Ik2Acuw6sc/rXqfwveQ3F9pt04azlUsLdxxk8NgdMEdq8ysPE32SPWLO+Wd5bgQsWjUh97JtMiJjK44J61veAIU8P69G9xrV1JbFleQTvyx6ZJ/pWVaOnmTWUq+HnC3pY1vEfg/R/BN7Lf6JJHbichmtFyG5yBgjt1611Gv6T/AG14I0ySwBedQjgKAd/GCCa5b4ipO/ieaW4cPA0atbkdCh9D+dTLPcw+EYotOvkMO7EsCt8yZORgfWsrSlbUyjSqOjQmp+8mtenoc/aW/wBj1QfaSQYGw4QjII7Vd8VajaXt159rZrbuygSiNvkP/wBf8Kzbpzd3DO8iRyHHRcAkcc46GoJ4SLgRyOMqAGbOQf8AIqtj11TUpRnL4kv+HKeqWM97aR+TdxrbEkXNu4b94vsQeDx1qhpfhS1tbo31k0peJyJkc7l8t+FyO4U49813HhiwtZtUtnnBuEiSSRogMKyqpyCTxioPC72kWrbr6P8A4lt1BLGwBJ+U9MH1yBVqbirI5q3K3J2u1Z/8BfceaTWOszpepLHDqsiSNEjSIEIZeQ3uDnHOaPA/9o6fr0W66uoLu0i8+TTIR8ko7AEk7cZGe3pW5Nb6jp/iLydJWK5tJnxcXMh3SAK2VUjOF4wPfOam8P2t8st9cz2otLtd9vdlCS7gHK+WxPC8889hWzd1qc7p+8kr/P8Aq/6Hc+LZLptM0iWaWSSC4iLKmSVV85JY5688e1Y1zBJDbebG+IpkAJHAf6/Q0zTr57zTENhM08SO0bNC25WXPQ9iQa6Xw5r8mmzJY6hHbSRpKBsmjB2g/wAStjOR6H17Vz7G3v0KXuJStfTbQ5q6t3tWRViktZQwIkJZMr0/D1rqdY8MLeeHYtRW/h+2Qrtnlkk+SVAMbgOoOMY9ag8QNceJNTnvLeKeGCIYR2GVGOgyOMHmsvw7qVro0txcNavNIRtCNtaOQHqT/hSaJk6tSEZwdprdfpf+kTv/AMIylsLmNb6V4wvlwtgCXA6EnOMnviptQ8XX2rWS2EFvFawEY8uM7y2DwMkcDtWS0S3moNNYoscUjM3lvwsR7j6dxTLW18vUo45Lm2iRMsJw+VOR0J9aLbFqjTfvTu2tVfWxpadbWEd8w1O2kkgjUiR0cqw98HHSuO8cyaABbQeRcy3bkRwXMSqJFJOVOcgYOMVr6rdOxe5ABjVBGWTjcQM9PeuN1q/vHTTl0vTmkvblMI7R5aOMnOwA8ds5rWnrLQKsGlzSY/wkbXXIb601Bp7yPyPMkincrIjqxXLKDx14IPpXoGnW0umWNpHocL2WnwIQsgAGWbknPqfXk1ynhbTjZobiOGZLqVSJDJ80zEnnc3dcgcV2NxaanBbpHfXDpHIf9QzZxxkNs/kcUpyu7II01FLntf8AQqS6UI8gzRs5OVXcGLE+rVG1htmCOhRvvYPGR+NTSRyWiB3VR5iY5Izt/vY7fWuis5ZtQdJntRcwWtuGZcYEiL3ye/qRUaGk60qavujnXvGto/IeQlscMeQB2GOxx0NRxW/mxrLDGz4G7aFLZA6nj0qOO3k1W9mGm29w5cbhCuGkC9s+o6dK6HSLXWNNeOK4iNvI6mOKGTuD1HHTPNFx1Kkaasmr9rnNi5ntrtJbeby9pPygDDcdcHjp61Q0/QdNlmuo9SgmEVypaSSA4kJyDz2IJ7V1mp+HJ4fKe3lDpLMY8FD+5Yc5b8K9Bs1sPC9i0t3HF5rEfPCmd/0Hak5cuqOTFY2nGKVOPM5aK254dHY21qGhijbyCAhR2yAAeBxjp1q5qltJrwi8+yiuFt9wiUoQhO3HOOpxXZ+Ob/TdUSF7BbWJwrO6SRssjN/d6fj1rho3eJw0Urx+6EjHampvdnXRftqak48r7MyLnwzYNZCCJLmwRyHDQTEdBjADZ4611Wg2FppmlW1nbu+xBkB2yST1J9zXP6lFe3dpJDZ7ZJiuEDt933yadoHh7VrGeO8vL9nuimyRZASEQnoOeTWivJXbJnGNOSUUdfcRQ3AMEjNu2/Mu8ZIPfHWuJiE2kOll4gvrW5hWXzbeRIRFIpB4DEfeAHHPvU0mkadP4pe9me6e7BUCNhhVx0Oeop/jiOwtbI6nf2ZvEgdQFD7dpJ7n09u9KLXRilC3vTW2xrBBcGM2twkMS53xqMB8++OBV+3EscbCNyVICgdB/wDX/GuS0zXo7rU0chU+0nbYwEbVdR1d2xweoUD0ruNMsriewa9uLYrAgJIz+uKHFx3D28JFWYTXJRImPl5w3zY5+lFaVy2n2kVtLPauzTEA+Yvy5+o5oq6en2WyJ1n0Wn9eZTtXW9VJZSVjg+SWQAny89CcdulcvrVvenXRavFby6O6bJ4y33yf4hx0xXWeGJ4dN8QvbzTQSQXRNs+Sdu0n727jJrN8V+GdQsJNQ066eWeziVTb3qN85hY8K/oykYz0IxWcZWugdWPtlSlpdXXn5FGOytrOz8mxtY4oVH3FAXj1+vajT/GQ1x9T8H3MEtzCkLiB2PlyRbVzhHwecdAeuKr6TALTSxatJJK0RLKzHls9QfapbZJYSksZDssnGQN3qM0X69TarQVSKi+n9fIptIt/NfafPAZLGBY1S6kG0T5UHn0Ye3pWv4I8Xx+F/EcGitD5VrOoDkjgLnkg9cjrUMpnuZZh5pjUkySFuI2JB4f1HOcDFZ3jSO+tdPhl037LLqAQGZVG7yweyk9c9Qe4puKmrGVWKcHSq63/AB/4Y9QPw/updamkaeG502dt4dzk4PPI7nPevPfih4cv7KdooryG3toQJPM37QD6EjnHevTfg14lk1rwfZ216yLqtqoilQkBio6Nj6Vg/FHQrdJZEuw0kN2h3SMeSCeQcenWs6M2p2keVh8RXniHQrPpp0v2Z574fu5p4YTL+8kiABnXgSEfxA96szWyaHb6/rmn2rPdSKskluThdwbJYfXk1Rh8KkW4stEu38yzYysM5b5gOcd663Tr9U0s2d4FE6N88h+8/GDkfhWqaj6HrzTmttV17HDWeg/2/ajxLPO9rfOSbdQxdYmXodp6/TpWp4h0PWrvw/ZSveQxXMTGTzpYBEs+Ony54znHTBrX0m4nnm+zyW0IsooN8d9CQUaYngBfT1zWDr1zJq32T+37O6k1e7LC6e3iLwMi4CDcBweASBTlKS1SvYxjCN+VaX33Wv8AXX8C9aeLIJtHggvIkv4o3aEvbucWrjkglui1cSd41iKTLuPKLuxuxzx61DcaJpOq+CNZso9NjtL+WRXSZXJSZwOpB+7j2rmI/DNxpa2Js0W7u4gFzK+2OM4wXA6jK8celTaMldM1pyqQlKLj6/8AA3/rc7K+1XTk162vZJba2t55QVSWQLvI+8oHrnt61dm1jw/qk0kVle2tzI5YR7Y9u3b1Ukemetcj4Mhuop7pPE8cKvBKTDLPEHUl2I3A9sccfjTtE0qwtru/udNZ7O4kaSyUSNhNwOWdVPJJI/Kq5Er3MuZycWu3zNxpksLVpZtRghXds3+ZtDE9Bnsaz/EuuW2kaXbSs7zW8xMQaGTPljvt9+SaotpNzqEUNnKsb2UdwJ7ia5QlpyOyL2GD1roLPRNGj0yTTfsipYuxzEWOFz1Oc5/wotGO5q5VJXsjlrzxTPpFzLHDoSS2TKFFy8vlmYbQd+epOO9WNa8SXmr6Za6xpdvqSW9s/km1RAquOzMecr71t3XhHSbVfN0Wa5tZJ41jkjnG9Bt6FS2Qcj1rlX/s/wANS3mk6KZbi/ujtkW4mIt1OchQFHDA4/OqSTXu7mDck+ZvR/evQ6j4d+INR0u1N1JbWkEnl5SBVALoeclR0Ixit7WJrvxNqIvrK0dneFW8tcLk4GetcPD4Wu7qxLzeTY6hPw/kzMyLGDlVX2z1FaPiK5k0HVIL66uZ1sng8gRw5Pz4yZMD+dQ4Xd0WlGDVRK0rWu+3nsdbrnh/UtLtLKVJBMkjZeBJN3ltjptzz36VQurae209JrmyMUfbeu0sB+uORz71zVl4pvbaPUUnMS3toBOLq4iZVMbKMPgjG7Bx+FZureItalvtJtjfB4IT5c8v2YyCbPKttxgDGOlCpyFTrTilzNPzOmjBlPlxKVckBQOATitmTVLOLSF0mzgiuvP+e5uACm2XsF9s9+/Ncv4nbxHHdo+jxaXHZbcyMPmIPRsd8HIqWdrxEjewQyQGEmSOCNXkZgQAF3cDv19Knl1SubznGoryTsvz/wCAaOm3mnWN0YdTkRWuFKRxk/NvJ+UqO54IrmU1XU5tYkt7DU9GdUdmWMo7OIwcYJXoc8VuabaS3Uyte6ZOGjjKpez24UkHPyhl6c1zVr4N0eOwlu7q4l0y4t3P+hjerTMG5BY9jyR3Pan8JnOXM7p9e/y7P59jtbO4ijnacTsUi5JgIwTjkHP1rakjXX9QEtqsUcqxKFQtgygdCvuK5XTLj7ZZ26WEdm0QcBspsIBbktnB3Y7Vb1fV4/DKR3ttb2zGCb55XYqYVI5K+p9hU2ZVSz9+L16PoWmvbeORbqSBpF2iPkD5WHtULa54n1XxzDZadpcn9nxQEQtGf3YQrgjb0wenJ61Fpur6Z4mifV5stLNK/wC4RSgYZxvB7An8aZYfFCSytbvTUe3sTBMbW2YKzLu7ZPc56ijlb6GNZ80VKCV/Pbb8flb1GFJ4LlUWSSKSM7cg7HRhwRmrCDULG7825LSeepI807lYD3zwe4rnU12e48QjTtZujcXM0hBnitivzkd+3pVl7yCPUnsPtcX2oME2MMbj14ocWuh1xnGotbX6nYXerefJFdNMBMAFaMHaR6cjr+NOsLjVNZla1sl80QDLbmzsQnBPv1rnpbC+txia2dfdl68dqqvrN94fljWykk+0zKwSHJCOMchsdqWr0SJnSjGm3TtfoWdRkdtRk2zvIEYqJVypOOMjp6Vg6lfiOBZYLj7Sd6o4iG9x65x0/GhpdcmsFvf7PWzgU7khVDucgdOT0NangvwytpBLq01ukVwf9abYlkiBPcdee+f0q/ZpazB4j3Vy/f8A1+RjaVeeIP7UlaS1gW2KlRAjZdcDO/HU966TRNbj1rTY7yKF4lJIJcdCP5fSuT8Q6PO1+1zd6bcyzWlyJba8tZdoMRfIJPUbfSu08O6RNq2r3racvnR7y+5eQoPJzz1yfxpS0IhO15Tdkur/AK08iGFZbm8mZ4HiZGwjBctKPUe1T6np632kS214pNs52vgcg9iT61HrVxc2apGjt55kZW8s/dwcbfr3xU96DbFFZw5YZfZj8vrUp66G9+ZK73MjwcbDS7K8TUEEkNs52SxR5LegBPQ+uBXRy+SbeAWV9P5dyglaNclY/UE9DXKatrdlZahYafcGY3N6cR7FyFBOBu/H0rZiklh1FJXwZQ2xtygj0zjpn3q5NvVmKhHmtF6rp+Ro3Wg6rZ3R1K0kmltiiAY557j29jRStq7vJBbxCe6CZGx3I57YWitaLnZ8sbmbU18djnPEd+tpqES29s86yS7fMT7o98V02m61dszQ3EryZjMZZ/3m4A5CtnrzWff2rzTqkOZmU4VXwoUn0puhJdW98ILgpCYCcIRjr61izeUYzj72pWv7JnvILqBnijyweIH5Qx9T2FQ+KhcafDINOt/tFx8oMfZs4yf/AK1J4c1O81a41i0mtWiNtPt8pjkMPf1HpUniD7Vp1rLci2adkjLbVUg5/uH6etPls7W1Gqikk76F6zVB4fvbi9WSJgYzGwIAz/ECT1rW8JWdrqlsIbyQ+RHkoU5OCM7QfQ+lcTY3Nx4m0uBdTt5Y1YA/Z5mOAAePp7V22kWFvp0UjXFxJCmzA8k7cHHC1CM62tOTvq9V5HJ6ppdzpt7Lq+heabhRhSJCqluwJ9cVasfiFL4mtBpfiLy01KDOWj6pjqT69s4ra07xR/Z1pc28ht59OnfDo+Dg/dyMdCcD8axLzRtIuLqedI4jNcIY2bIWQqe3v9eDVrler3M5U5SqKUorTZ/0rp/gde0+kXHh63i0u9ij1FG2vMMJvX1Ld8cVa13TvDtxpUzjUYxq1pbieV42BE/y+h65xzjmvJp/B0UFlNBFeToshDoTwFx/Oqlh4RSz1Kzvbi9uJ2hbe0e4gMPQdcCk4pfaMpYapdODa1vuuvTzXkW/h9qllO2oDTYp4o0cMUJLbgeAQOw9u1aulXts96zwanJcC8kyELkrujGCEB4GO9S6F9pt9ca1g01P7PMDTSuihdj5GOmM9adbanb37XqW9stuttKYvLIG5Sep9qqXVnVTV5KD3Xl/XQv3d+0hPk7iG4BP69KpSRyysfMYk9SemOcYqaGIKjHB5PX/AApkjgDaTgjj1z/hWW+rOtJR0Q/BI2AhkUYOTnP4Usu2e5gkkSLzEOYnI5jJGM57HHFAVgDIgVl3AZA4pgGSUBJOSOBVXsKye5JHKfK8tCFHpmhME7gBjPTBqILGZG3T24lhXfIjSAEL6kdqjtZobhhHBPA+MOcSZ4PIP0NJA3FaIg1iyu9WtJhNcTv5bRyWsUMnlk4GCGY9RzwfWqVhaXN/pC28sV5p+oWzlluHZV8x+RuwPvDGOeK3b65axs5LhoZJUjH+qjHXntXERzz+KL/Wb+ISQWnkCFVh5duMlFPcH1HY1vFuxw1IxjKy6nQ6M+p3FybSX94kK7TcYAW4OeHBp2l+IrXWZTaWkjGWIldtwmwAA43Z9M/SmfD690tfCUcsttJbtErMYpJMiNgcFuf4eDinWf8AZ10j3WilJ7mZuRAqje2eme+Tjmola7HTk2k09NyG+iEd3dabqt1aXrTqEMaktlck4z1FZ3hzUooNZfRZ5o4dpZYgEZyh/ug/0q9rGneJZPEdvcpa6e8qx7RO8mdgHY5HY5HStiLUrbRNVl1a70izur2FC8ksCZLkjB+v8+Kb0WpN5NXgrtfL8zAN/wDaPFJiv9DvEkRGhS8EhCgYPzFemDWpPpPiDQZY9Ws9KuJLadU826YZwoPCgA/KMknOOc0al49tb+2lu7XTLg20n7qSIISG445zkYqtqXjRrBLKxFtqc8MqoRG8jPGhPG0AnqPTtRq3dIlufLut7u+v5HXahrWp3eiJcCXdaIAwkiXHA7H9eK5X7Jo/jJYpL2S4uYdwklVWZBuXhQ4PXjPSoLbRL6DUtRksNQQSSFk8lydjZx+Y9OK6nw/pVzDpqpcCFpAS0ixAKCw6Y9an4dUackVG0kkjJ8VaTpN/YWsV9dXlnYWmG/dSbcqFwMk8596azeG9ZsY5IzFdRWjiVUJJIcdyPf3rM8VXnkyvZ3dqstu0ZeQSPtBGf4e2a3fCv9g6XpNyJLSK184JMkjRljt4J69Dim7pXZMlFN2V/wCvyOe0XxEXu52NjFZWG0qZscJj7oJ6YPoBVjUzp/iOFLMKk/ksZ4p0+VUkGM8+pA71bk1Sy1Gd4tGvZYTDIs8TtHu8th3weoIJH40IFsNPvry/m85pSZp3VAgbAxwBwOKp23Wg4qTdmk0V9YutbutPgcRQxxxtKLh/N2hVEY2yZHUk55GOlVPCv2bVWLu6309vtZiLcl4/lwcnGWHX5jWx8OdR0zxDJNpR1CKygmYtL9pC+Y4xgID06elXb8eFdI8YQ6L4fnk05ZU2m4j5V5OeGPYcY+tTzW91bmHtI89n5vyX9dtSj4ntE1XR4Y7zUJ4bcOrJOiGRo36fdyM/StnSdJS006KzW4n1Iwp5YuDHtkkzzn29KLto7e1lt5jbztlVUqowR/ePv71am1qaLwuI7NljuZZhE7KBuAAJ+X0z0z71DlZHRKDupRW+nl6mVeSPBciyj2NsAH3920+mfWsa+s9c0HUZNZErto4RmAQbXdSMFcdDz3rpPDHhm9vY5b50P2aJjIDIdu49lX15q5qmoPb3txbahCt1pF5Gu6MrnaOhKc8EEEYpKVtWh1Jpv2VN3a3/AMv1OXuTB4g0G3R5pVspcNLGrbfNXspI5wO/0r1jw3Mmkmz0/QtPtNO050+UYwHOOD6knivNX8uzIghWNrWEAx+UNqlT7dvoehrvbvUtIm0C0mmnWV4oG8mKJiC0h4CkDnIxzRJpq3Q5MdSU1C8b3/r+rnJ2czXep3M10kZ8p2baRxnP61k/bGMjRyIj+ZJkEfeBzyBVrTJ5IGuPvASDazBc9agsdNW/1hLZnQM8h8h2OP8AP0o6HpaQu3sjr7HwpaX9zbvqn+hSAfuhLES3/ASenatfTfh5o0N5Ldz6lcTSN8pUMEGB2xya6PRdKvbfSreCedZpEO5ZnJLL7DPUYrcS2gjk8xIY1kP8QXn86xnVfRnymJzGpzNQn91v8rnmPiHT7fR9RtbzQ7K8HlyBjMVPlknooyM+1FekahptpqPlC8i80RtuUFiBminGsktV+QLMaUoRVWHM11ZwGu6ZoF9ZR7LlUliDfvAFG49lYZyefxFebahDqVlrFoySRfY5I9zx4yc84IP6Y7VqTHzXG7jJDED1wf8ACtDTZHbTPsrtvhExYK4B25HOK2T6H0VGlKjFe82r9Sl9qt7TV7eOaVY73UFwp4XIXsT6Vc13UYLKwuJ3jknVQMJGhLtk9celVToFnf8Aie2vLlpmltkBjAfC9fSl8QsyLPNGxRxwNvGOavqhX1fkVNDv7W+tvtNtZXluE+VvOiYE+uPX+XFaPj2CyOnJJos8ktqYS00I5kDAc/QmuM8Y3l3D4fjmhupopWZAXRsHHNdH4Q332g2txdSvJMYySxxk9qLctpdBP95O13dL5alH4Pp4bvkuNNtBPFLEpeKO7bYHkP8ACxP6YroLz4eLrenXVzcibS9U092UMWBhl7jOcY+oNcj4p0a00q3l1CxV47pnX5t2cZPYV0EHjDWNS8INZ3k6yKPlMm3DsqjIBPelLmi+aL0ZzVYVdIxfb5eny6fiZ9hq8V0LmxSKSS4tRtYTDAkIGMg1Pp15bXySRQxRrPAis0Zb5gD7VkfDhH1KDVp7ueV2i8plBIxlic9vYV1N9m3kkEXy5GSQBk/jTkkm0d1KfOk0Yjz3CNchXu47O7kES3O0KhkzjYr9Tz+tBS0s7qZEhW3uCwM29cFmA6nPWr1mG0nUre7tnL7MskMwDxIWIyQp6f8A165vxvqt9qfjOSeS5kiKqjKkPyqpxzwc9fekld8qM/byjUtNL1Nq7vLKCIz3V0II/wCJzyoz9OnUVlSeKNKhumtjDfsMMRKIfkcDqdx6D610y6fC8MjtklhuYEDDH34qhZaDba5rd3DqM1xJbvbBDCGAQYOcjjOfxpxSlubVakoLRkUWs6dLp7TwXERtlBPmFvlGO5rM0XxTbS/aXurWaGGPCI8agrzwGz3BJ6CibTrfTba6srRdsBVsg4JOfrV/QfDWnweHrdCJZVLBsSPkZ69KI8rT8mTOU1JLuhuv2miQ291eXttChuoxBcTBipcZB2kj6CsDV4tKvYbLToRZx/ZyCkTo3RhkYYHP4V6Le20FzoMdrLDG0aZIJXk/X1rk9YsbW605mnt42aGMlGxg5+ooU2nuCjCab5UXdOnmNvH9sPmMi4cQHGMduc1f01NNgCpPb3cUWcj7MFIHPXbgVkaDboqJcRlo5X+clT36VuSyOufnJOM571nc1kky9N4fSaNprMwTC8XCPcDZ5yLn5P8AeHpXOx2VlZ5uYLRYRnZvjz17jAr2m3Mdv4RjuUt4TJaxmSHcuQrY6iuO1XN3Fp88hx9pRpnjUAIH2/eA9aUajldHl4XHOpOUWtrnFPeIp/fLI5yAwLGq+uTwafGJfs8xjYjgJuYE9OP61KsSz2FvJISXJIJGOa2ILSNrONjuJCKev1FOO9j1Zz0TRyF5rulaZqFlaXsN5F9rGUdVBAJPIYdfxreNna6cz3ET+XsbzCZD8pbpxmq99DbNcC7ltLeS7gUpFM6ZZAfSvP8ARhNq95qUeoXdzMqws4BfuDxWkYqWxzzrShK0uu3/AAT0O41UXG6f90wPR9uFAqlaTxSaew0zUJYryNzhQrTrNkZ28dD6dq4nw1ZDWzbR3dxcLBA5xFE+1WxzyMe9dRq0Mfh6CJNMXYs8hLbiTjGOh/GpnCy16jp11Ufuq1jpLKK6v08vV9MU2m0FWmwrBgP7uTnPrxVLW/CSyajHd/2g8WFC+UeVZc9qfZzSm2ikMjbvLyTnqcVhaFq13rcd495JhoDtQxjHBqVJxVi2lzXNC70zTPD0P260t5r2Vl27I2LbcdvarlqLbxP4aEpt54EJyVf5Mdsfn3PWsLwLG1qszpPO5aUKRI2R1OeK7xrCG7klWUvt2g4Vscg5rSTadnuZwknFSWxw1p4OtEnV1tpEdP4lOOc/kc1vNoAuNTtZpIVkWEGRyVJYkc4BHT15rpLMn7CYM/IEMh4GWOe/tUviiWSzsNMhspHtlkXzHMTEFjnuf6VLm1qTKa5lTirX/Q525txPAbqyt3EAYJICSXRvp6UkSFYCu0fIDIBjoR6/hW1aarNPZXcssVs0gUvu8oA5Pf8AWs3StTu576KJ5QELAEBQM9vSpur2NIVZyT02Ow8CXtpqNzHZalM8s6rtitMfu4wBktXM+Mntk1y5BlluZFlIxvHHsoHQVGv/ABJtQijtMnzLdyzOcn9MVhXpFnbW12gDzT3KxsX54J5x70rO5lSoxhWlVTdrbDJ9RjaCVI3jMkjBBEjgkkdVHvTtLlmXULdIliDlhjeMFTkjOfbjrWT4ktY9Gh1Wy0/dFEQbnOfm3swyQe1dOY40h01wimSW0WVnPXcOM/jTcbanSq1/ca3LmuXVha30Wn287NdXal9oXCll9DVXSNSXRtWtpL2zFyIT5iB0wQT3R+309a5tAIJNLuz++uI9Qjt0eX5iEkJ3CvR30e2vIl80yAs21irY3AHjNC96N0Yy5VejU1R1fgvx5pviC9l0+CSU3EZwvmYLEY5Bx3Hr3rrb68t7G3M93KIohwXIOB9a8Gm0e1h1p1i8xH2q3mq218/UVPaeZNbXNtPcTyxwtlN8hJHWsXSTeh5VfJacpqcJWj2PRr/4gaPtZLYTz4O0sAYx+BPNFeNaBK97rFys7fLEwKhQAOMUV00sNCS1f9febf2bhqaSSb+f+R//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A section of a renal biopsy specimen demonstrating numerous intersitial polymorphonuclear cells (PMNs) and an adjacent artery with endotheliitis, another histologic marker suggestive of antibody mediated rejection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Helen Liapis, Washington University School of Medicine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1814=[""].join("\n");
var outline_f1_49_1814=null;
var title_f1_49_1815="Hamartoma with fat";
var content_f1_49_1815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary hamartoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows a pulmonary hamartoma composed largely of fat. An elongated cleft lined by respiratory epithelium (arrow) is visible at the left.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Colby, TV, Koss, MN, Travis, WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1815=[""].join("\n");
var outline_f1_49_1815=null;
var title_f1_49_1816="Varicella lesion close view";
var content_f1_49_1816=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Varicella",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDu4I3dJ55Io2hRRsDsB146d6mFnL9nilbATIxkfeHfGe1QSBZGdJZGk8tcRsqfL171eSaZ7SC2ukZIo8sqZ4b3z2+lc0LN6/0z2230KccMZaY524BGXPT/AD7VLYSBkUSESunHzZyR6Y9KjvprddqG3wxY7pTk5BpkSxOJZWkEMSLgKp+ZzQrJ6BursueZfG2mxlYYz1K5Ayex7VFbzLbRS2sTRMxlLl8crwMc9xVi5tXupI2glkWBztWOdueBnnHb0pk13HNPdw2lhGsJwAoXG1sckGtGnHVsjyRSkkBUh5yXzt24JJz/ACqTTpWjkbYiqN/BYbuOhGO5qfY8cDyxCKUIqqxbrk/3feqKvKZVEUbEkd/vEf4Vk01qXo0aMsX2O5cSeVlo8Z67d3PQ8jHSq0hDT2kl0wjhK/KUPz5HcjsKS4jjaOFdwnmduZNxXYccD86dLb/2dqFsbaVbpn4IxySeoINObd9tBRXnqSxywu6gHyowNvyr8ze/vUxMFzlocwNkGWUMQFGOgHqajt7SWaK5lMixPCwDR45256j6d6IZBBdyXBVCI5MC2ViGmyOgHpirV9GyXbp0KhaPy87HMXmYXJ+RvUH0q/qckLwKLW2KyFefl6n/AGMdhioVXz7NtsPlxZJG3OAx9T3IFSHUJI7AQyhvPcjY/wDEqj09PXFKLsrX0sNq9rEUKeZJlvKlmmUHAwqjtjB/ip13dSOwN9hfLfCkEkhR1UDpUKurA2/lRq7EYuHYgn/aHtU8MdraaTOzKlxdTHKNuJMa9+KE21ZMHpqxdsRa5neRJH3bkU9DnqcetI18H023t3LLMsxZrrOdnse56YplnHFe3UduipCBjLD5gAR1PvUGpQtbM/nOGZXKLHEQUYf/AFutF2ldbBo3ZkgjJt5ZxNHCTIpUscO2OcgdvWrMWm3OoXUYQQqvltJ9oQHEoB5Y564NVgY5jHNcyxRNjKLj06BqSe/eZ9xkdbZI/KjVm52+nHbNK6WjC0ug8LF9ouDb4FtGATvbh2zjJJ5I9qW9Ii1GOSRvOyvyrHHtA+gPQehqrfQGSeaaV4URFGDGP3ZPGAPf3qzbQb4Wlc+Vao4UTMvzNxkEjuKavtYHpqWLi7kN01zcM8dvONsuzn5RxtBPf39aoWiWtyZo0ZLaBSZF3fMxHZB6mtKOwjub2KG3iaZ0TMvnPhVbPOPXiqEhS23pbuuPNPzFcM46BQf8KbUt5bCVrabkRYMNqfuYgoVxIc/MTyQOw74q9Ni2Tfbyl5FAAUruXHI3H09QD2rM11wJY0tovs6IgyGbcxJ7n0PtWlbXG6dWggLW8Khn3uAZWA6sT1APakmrtDaejGC2X+zGjhi864O13n3ZESk4xj3PrVeX59SiDIszRsEEajG84/zzU01+0sPlbRHkLG7w8bh2B9T3qaW0WBop7edGiVsbpPl8zuRjqR2oaTXu7CTa3KYgvfsE0210hGMhSF4JPHqRRZXyx24MTfZZYZQxlzuB4IG1eufxq3qdw+sXKMiLHGigfL8qqM8cGs+ZFjdo9vmS5CKCCChzyQo4PHrQ9NVt3GtVZlyCzubq4tp40Aju2ZVG8MzYGSW9D3pGtfKmeSIpbxwgK7tJuMp7hT3z7VWl82KN7eVJYIxJu8ok7j7+gqyqhkcwoYrVv3ZkcBmB67Qew9cUfLUHfuVDNcTD/Rw0MIbamOvP9ferGj20PmynyXuJATsx092LdvrU2qPImnxNGqrawMUiYR7PNx1bGc/jTVZ5reCPTy9vEflnnZvlJIxnPXHtTslK7Fe8bIpxbIpmkubkfPn59u8tg4IHp9ankP2zUYrdZD5ZfYJ5cgsp5G704pkSrHKVtlWXYdrzMN+FPGcdKS/8iJEW3aRkJZlBPz7ugY1GyK3Y7UZ5YJpLQfZ3d2ClYVwvHAx9akkiujeiIRNLfyrhhIVyB7fh3plpp0qol3eTQxRzZUM+GIx0OOx96it4WuZzMszhQwR5C/zueclfbFV727QtLWQ+cX2qakILGE+Yw8ox5GAF7Z6YFRC3eK+8mx3ZjG7h9zZzgqewNXY7uW0gSCO3Cb28yJ24I7flj9aq3snn2NslnP8APEpLIse3yjnlmbv602l1YJu5nzRLbzpBegRmY+YX4JQD+EDsfapBZyX6veQxNFZ26hGdn7j69/apL21jhuWljuY9RkCAyOegkPPHqB60QuE0xJbmYBwd0QQ9DnuPWs+VN2expfS6LVreTW2mzx2sSK87BYQGO4A9R9Tjk1lTwyWtxI0js0hx5scTYOT7+tXBMbaDzJMxTSLhVHXaeS3tUYhuLR4w8RRblWVVZdzOCPT696cndK/QUdGyFsyqFKeR5Iyeu8n0Oajku22xBgio3O5h94f7WK1r6JUZLjU55Guy4DhMEBVHf1OOKqyXktxLIZbdIbeRdi7EADqD29D2NEodAUiBpReRx5/dpCDtVnLA88BR6VOLk3dixmEwtw7O8hII4GMAflT3tYLeaG3vM4k+bFv8x9h+PSovtU7RRXEixloyYordVG35c8sPxojdX5txaO1i3HbvHBA97E1vaTRlocYyQPx6n3qNZ0a3S2thLFGCTNKP4z/dHripLnTrmZrK2urlnACqXzujj3DIUe+OTSaheJDbm0gRd+7bIkY+QYAA2nuT3qmrJt6EX1KskcccMl1FHJbwgALk8M3pmls7WS7kt5i8amdtsau+SpBxk+2abdJKbe2WdsCMkLGQfk79PpTdsl5I8tskaoW3O6ZxEPf0zUOyepethreZNI0UqSyzh8vl/lIB5/Cr01gkNp9pQ+ZAWUCV2+WPnkBeuPepvNs7aMyW8mNz7QnLSMuNpJPoeTj6VVRJLq6it7SJhAxKrv4MhHrVqKXqTzN7DJZjEsjzokxk5jXk7AejD0PA4NTRtbWXkz6iHvHTLG2H3OR8uT/MVFLb73tEMqlSrMYoR8yAdc+/vT9Nt4GmDXSzyxIdxRRu3KPU0JSvZjbVtCtasxmYwNFAnlsxmZfm9SF9+wp1lObKaG+gmaKWVmMbk5ZT0yfrzVPU1k1G4WSwWXaGYYPKoM8KMf54rTvraC30+1uA3mXTMBKxYBhgY2qnbHqe9LV3fYbtou5UuZbrVLiB7kxxRK3lKFwPxOOv/wBetG8NzJDcxy3W1wEjS1KbS6noAB0A61XkuzbSpJaBXtIwBFJJGGbrnnsT70yS55e8mlJkZtzMW+Ysaba1JttYYgS2jYlw14M/IQSVPYEetEFzdzwtJHtCW4bKhdxTPXr0psEst1qIjtB9lhncLuI3OAep9feowDJc3As41+yxt93PylRxknvnrUX2S/rzG0LbxGHT5LmRCPOO1M8nb359aKlD+ZOzRoSmRmUjHXsB0AoqWpP4S011N9WsbmBz5c+5+AsXIU/Q1S8qUztE84kXrz0x7+9WbHmQJ5XyEcrnp9KSYo9qsEcKCdCXMwb5iP61q9Vdma0dkRTsqx4knaRA3ypGARt+p6VZthFbEhYYrh94ZXJ+UDH3f8aqorCAvbOsjk/vFRS20Y65qSwtftNy5tQXCRmRjN8vTrikr3Wg3bqSQxTMFukcRwmXymEcm1uecc9ahukT7eI4WlWILkkjaOO/5etSasZVzaosEkMh3gxHcAT3GKIrZYraQ6hJKkkYKoMA8+hq2vskp6cwlrdRrdLHMNsTD5mBCkKPQnvTbi2826ht9LkB3YZpt4IRhnuOnFJcW5l0lTcyxKz/ALyJeCzjODn0+lMjY27Q+SyeYq/6xeiZ5ww74qW2tJbFWW63G3MSQJIJ2mlupHGMD5SOmD3zVnyYWkCGJ1uIRk+WpHbke2Peq940txdLIXEMqLvaeU58xh02jsPSrUM1xcaXHKWKQOx3B24kfufU00lzMTbSQ+2S5uEjs0lhhSTON6jL+pz9KrW0h03UrlIMuAChcYc49jVksr6bFHbNK0kUoOcY2luoA6n1qFhGtlPDFcuread/HDqOnvmm+lhLrcjVpJJDbwwOkZ2kJv3bmxyfqR2qyVtUlvWuGLSIQhEi4ce49+x9qzZUubUxxcwQswdVJ53dQf8A69WIZo5kaRo97eYoYOcyN647YqIvXXcprsLcTzCX7THKkccuYuQCVUc4APp/OnXH2KGxCpKzykblRVAzn1PU1NI+NaSC1B3IpjhMuDtHXBB9Ki0qCBbu7zKkl1GxaIkgRsM/Mfw7VVtSehnxGUl9zeSB8vJwXJ6DHp71I06LEFCBIl+8EXDlyOMn60mpX63GpBo0ea0iJKsVOcE55/HOKjS4WNXWEfeYEySjGRngH0qLpO1zRpvVovnNzar/AGlOwVOiJHnew6c/zouAbiAJHZFpwu95t4OB3wBwPpTbu7e6nykQ+QY/d5wSOr8+vrVRTIkbwoxVw29EDZLH6DvTbS0Ek2Tm2czW6LcRXLsA8igErH3AYDuancSXMUkayb5HXzGEY+Vl6/hiq4a4aIy3DYiMoLCMBWZhx29qmtpJbrUWh03bGZfvu3BA9vb2qklsS79QMZtYAs6b2CAw5JG0f3xjqKrK0zy7U8tmDEl5Bnyx3yOw5zgUGAxS+U0sjFpjGkp4QkcYz2HrU0Uq2RdIoI5J43bdORuUjpgeppdbPSwJ9SuiW0WnzO0gN0Tt8tkzkZ+8p+lSSTSTWkCTxlIlJMSIuAB3JJ9q0YY4LSa4kmaKaUovlxyISJM9QvuO9VLGOZrmJPNWMRIwLff2g9SB06UarQOZMjvYE02a1M8rywyYmCwkDI9eeQaUGGUublWQtkqoHyqfRj37GgOgUW1rCXRW/eyHlpOeMHsPan31jOsc8DtAJVzLLEhJ+Uc7mPTHPalbsVfo2EVzdoUhtIvOupciVmXC/MMBfbAGaZZlo3uJkZ1lOAZ3IYoAOcj346VFcpNbW48uZIwFXjlGfJ+9tPU/0qG0tMQedcFjFu/1S/xDPOfT8aV3ewWVrllbr7QVRQccs8jrvLPjr9PQUyeG5gwjRG1SPnMgwTnvj86Vb4wT+YIwqOxUxY4K9h+FWbiKW6zPL+/whd4snMI7Ak9++Kpe96kt8rGS2hRLaW7ZjHPGzIrcuqg4DEehPaoL1IBbQbDK9wCQ6HO0ehUelSXM02qamFjBDiMZ3HIX1/yKu3kDwW4kuJ0eYN98NzsA429uc/WmkpJ8u3cV2rXKNpubdBNc/ZYJRk8cMRnGfxq7bywRmKOO2VPIYNIf43xySSeg9BWbJGiWhkeXKK+IkA+ZiTk57gf1q2u6aK2VtqpyxdxuwCclj69O9KOg5K+pFeXg3m5NtiSOTdGjrlWVuhb+nrTTbwjSzNfCRZ3YtFGqYDk9yewx6U64b7XqIOV2RqvmSHLg47468e1I0UQjkurgmeM5WIsTktxzj0xniizcmPZJFWJbhkkjCeUJVMhaQZJVeeD2/rTHKtpMaW0IV9wEkiuf3m7oMVqafGkqzrfTTCKRAsYwNrrngHPIA9qyoPMWcksY7aEFVQDufQ9ifU0SjZeo07siaERWyQxGJpzwyoSXHsewpZLFEthP9pgeQuY9qnJBAHbsO1JNPAxNvaZSIvhpDkv0HB9avXUSSWEPmxLBEinYIx+8f03npipUVLboU5W3LVxNHDYSmOyiQyhU3LLudfXIPIzSWNupuo7u5vI4w+Rkk5j4459e1Z0Hnh4/KXc56HPT356n3qVImmu9z3A3KTK5/hUYzk/yx61XNtoQ420HQQNOJWkaJIVRuTyWPoB1JNRXlwJbmx33JjSFNkca/M6Y5Ge3X61KrySg+RahYpMhSwOVx1IP60640f7L5iJNDI7KrrKSAjLgsSCemOlJpyWgJxT1JY3ivb1hDCsULFVd2clmbuQT0J9Kgvbb7Cbp2jMQYEJk9Wzzn3xTJZHFirRywpaRKGPy7WZ+nAPJPNMitGmgW5uDLHbupaN3O4SsOuM9MU27qy3BRs79CYPK1mskQZrWI5eR1JXzCPTOCfeo5VktrWB4mhT51fduHmAntirE94gtYI7CJ4xEVZ3c5Vn9SOn41WnSKC6Z53E4Y4E+M54BOKGraCQkyTlUkn8xBMNwklxuIPU/Q84q9NFZW+jMVOZw+1AMguD/ABEdgOmKgv2F1NAfOe6nlO9kA3c/wL+A7UktpczzGGYxtLgM4HAi9j9KErN21E+lxjxu6gzOsduydM7TIF7A+tRW13JNfp5MZJUeXGv93jqAKtsqy3MSacJAZBsV7nGHYHkIegpyy29o/wBkjtUnmKFJimSzyZ4AYdPqKTTuVddNSpvcebbxx7ZC26V3IB2jtntTJLyaSYxsWgs7gj90GxkdAc/3altIRDcPFLEkkvLMsjbRuHUH1A9KztQlne/jubhPNuJMFFHCquMKAOwFDbSHGz0NBGMTYWdILYOWRIWP8PQ/X0JqO4hVgbuaZy7vu8thksOPmLUttbO8UplaMohUySDkJnOFH5dab5S3AnLs8K5+QE5Z/c9sfShrTYFa46OOSe0eaZpEsd21VU/fbsAPTrVq5W2Fkk13LGDGiiO2j6yfU9uM5NR3Cx/2Z9qZRHGX8qFFOWJ/i/D3qOKW1Ei3EsYxGMCEdCe3NPZWJ31InvJJ5UlumMXmNyFbDhAOOnQY4pLiWOWd49MQx2/BJJ5GOv1p4ubma5dQUMhTywzICUGcjHvVqwt4UeVfNhjWQFXafkjHOQB6kdalLm0T0KbsRalAbCOBZRulIztY5yc0VX1Cd4ik9y7zTSKfLXqVXtn/AAoqZzSfYqG2qN29v1klSNbZIii7SVJJb39jQXLLIjRqWTJU7ecDr+FWFezhspB5i+e0mNhUHp35HSsz98uJI1wgPDd8ZrSbcdW9zOKT0Rd1OM2aQLa3UMwlUE+WvI9j71VeV0cwXZlicKEVAuOPer1gtvceSs5htEVyRMVJ8w9QD6CoJZy8kyxwm5jd8KXXJX6Gi3VOwRfQdFMlhLZyWdz5hbOQFG3059vrVfW5w8xLMskg++FHygdtvrVWKORb+SFWaJOwdMktingh40hjXc5fLPnLH8P6Uuf3bbFcut9xyyPHDHM0cbR52qG/rVjT7mMXEl1dW9u6BSqxo2xQexHqfr1qm4D3Um9VCKD84+Ucd8f0p8lqlhJ/pILynDLg4PPII9R70k2tug2k1Z7ll4jdMWuZTFCg5JXO30yBUXyysGE0AtUbCMOFJxkkD/PNPkDSXEUV/mOJoyw3HBf0H/1qrTfIymeAKGPyqq7RyeD+fanJrclI0LeeNrtEmu/s1tG2VKLyGPp6Z9ac7LAJDbhjJIzYkJ/1injGPWrMT2tlpztLFFJds/yFMMQR/ezzzWJJtk3honR1GUPmYCHPv1+lU3yrbUlLmZYeE3O0STrmFNzowIIweRnue9Jc3KSXPzLGir8gEfCfn1qo7/YAGuYi7KD8jjgfX/A1a0sRonnXbpE7QiePcoIY5+4R7iojroW1bUjaXCmdXSSZhj5Scp75p1/bWNjawRHnUA25irb1ZCMhh6HnpS+XOY7iR2FurA7UA7Nzge1TQXNnHYyB4oI2lAVd6ltuOp56k4+lUlcTJYLHUXiWNIntbc/KHkUqGJ5GT/KqUo8xZoJE8yJjtMyL0I67fQdM1NfT6g9olvcO0VpIBIIi+f8AgXqB3AohuEEqymVraNgIl+zrkt0BAB6E+pqklfQWtrsmvdQhjnmLLGJI7dY4Y4l3KCO+e3/16ybeWKOVpppvJD4+VVyxBPOOeOKuiGHfdyqm2KJgXd2yVycf8C561StYo5LyYXCu3yFkKDo3Y49KU3JtFRSSdiWQmSV9zy/ZtpeOMsNwA6E1anu7Zru2lslkOU2pCGOY+em735P41UeaO6l8pNkCOfmcAk9PugdhxU92kKRo1tAIY9uYzkluDklz3JP5VPM9WgcVclEDX1+y3NxuKkyOifMAO/1Pr7VErzxybbfbO6yExJGpPlkfxYHYiorOznkijuCpjgd9hcnBHc/hT7W5ChkiaWNgrfMjbVUZ4LHuKE76vS4NdCEyyxy/vIwZJc7RnnmtG7/0doIZZWGF2PboCrD/AHiR3zVUSRwac/yiWdpN7YXOF7HPbntT5XuJ3H2iICRj5vmzHaWA9vSjbqLdl2VDbaYyRssYDh3RW+YyA4AB6kVmzzPK0nkKUMgy25iSwHXn+lWbqCF33xStO5bBlPG71wPT3q8mkRTafNdajNHD5DbViU8N7HHrnrVOLloiVJLVmQ1vu2LFMbidV/eMBuCjHA3H8vaprpv37H5muZF2uMfdHTbj9KfFBdJp1x9lAS2YATMo468LmlSKJBFc+aIlIDp5wLGTBwSR37/hQo26DuJDbtBC90kaccBpsHy/QqOufelSGWKMi9a4eWQiRol4aRW/iJ/pTbq6ZbgwSKkEUp8wMVy6/Q9gfSmPKkiwoE8pUTaH38ynPJJ/lS91MPe6k1j+7u3tbOBTc5BMxk2+Rg8jPTHr7imtB9ovETz/ADmQgSS/w9e30qC4uHCSbI4jbuowAACcdCfX696SQR/IpxbKsWSzE5J9QB69MUcytYOV7lm5t45tMWeOFEiimMbzFvnc8nd9MVRGoTLBLHGU+xgBpAMqZMcdfx6VLBDdO8nmwkx2qB/LkICAZ6Ee+aS7iUylryXN1KnmmOPAWMn+96DHaqd3qtAjZaMrxXDOi3hkCiMiNI143L3GPpxT9TfzWEs+EuJOTCgwEXtnsCfTsKl07TIrq8ktbJvOk2AeahARPXOeo9xzVSO5+z2txaiPzXd95ZRuO0e/vUa2uy1ZvToW7m08+UJdXEEYiTeVRuiYHA9T2x9ar2cT6lK8UbmFHUbjJJ/CvX6+vrU91psWmaZa3NzcJJNMrMEQA+W3BXIp1q0motHawCK2gZAskxXBYLyT7dfxp8t3bqK+mmxDBbfY7kPpk6PI25Y5CBkDpuOemRTlZkt4ryeRLmKNzGsDyEjI9vSi+a1t7kRxyO1ooVZXHPXrj2qOS5mFlcQ2kYSzchfMZPmOOn0NDSjdCV3qWYmtlsx9qLySyRkxwheDk9faoYmgsLeeG4jaaaT5QqnADA87j3AqWxaS3gW306dGulJklZU+Ygf7R4AFVQIY0YI809xLgARcAjOWBz3zRd2Xf+vvBItXMzRSNM4RLl03xxjnaD8u0D3qRBLbrFPePBJ5eUWN+QuOcAe2ah1Ozjs7ZLmWVWvJif3auf3QxwCfah7mI29ldC3aOxGFcA/vHfvn2NNvlepPxJWK1taNresgvtDyAybpSQrkf07Uk91JcWgsWLP9lLHYMbIhnue9WU1G4u1lhR9iSKIoyQCUVckKD2+tVhbW8Nk5S4ZyzAtCo4OOpJ7+1RZNaddy7vr02NVbiK006FIJknnkAc7QDs4xsPqMc1n3Fi0c6LeMYMLvEedwVSOo9ye1Sfa/s9vDLeQI8PIiRMAqc98c5+tR6jqL312zzgyykcKBjHHGfYVUnFrX7iYpp+QC4RkyjeRaxj5V/jyOc8e9Os2kvYr+4kuI4Hlzu8wkFwf8/rTrKA+Ysd6+6CMea6g4VgOgz7mqkTm5vbif7K32YMXECnCAdgT6UJ7Nj3ukWb26e/mhW2VobS3jCIScHnqQPUn0qrZSC3vJFsY3W5K4X58leOc1LZOz+cqQQu7AuWc4VFHoe1VZI0gtftEjhpZCSMdX9TSvf3kNJfCPKzTwrFbHMuHMkp4+TuPz70lzI0UUYihcOIyryM+Sx9R6Y9KsiCU2wa43pbyrlJEXOQO2PTPWmKybgLJQ7bQ0jPzuIOcYo5fxC/YpNJLb2AZpMq0m4p33Duw/lV6CJ9SjkkubhY4w4wH4JJ7D2FSzWovNXMrzw75ofO3MPkUjqg/Cq9kqXEitcwfug+5ih/eP6KM9qOXWz2G5aXQs5gjQLjdbrJjzerSKDjp2FNvWSaKUxxCBUbcHLdF7L/8AXp6vBLcKLtjbQEZHlqNzAdj2H1qncebqMkMcMaxQxoM4XAbHU/8A16U9nYUVqiSO8j2bXjxGybEAXnPZh7n1q1Hb3U8oQWpTChiqgZHHf346U0yWVvDAtvHK9wP9YzNncccbQO2ajnuZ7KExzlnLMskjSLj5j0HPbFPRL3noD8ie8eC1lt1Ql5kBZpWJJb0GO2KKqXOoSaxexhLVpbjiNFQ4Deg96KTk23y7C5VZcxfjbNyjagkqGTqwP8PqKtSs0skcaygw7/lm6A+tNe2+yzTiZQ+zgjdkAn3qGZUk8tGnxGoLbumM9qjWN0y9HqXD9jztiWSeYOWZ93ysO3y1MLpCsHmO0TBzgRjkn6Dp6VTs5omGy3VY5vMPzFvmwRgD6VCYGa5WKLClxuG9sZP1rTmaV0iLLZksgnhn/tAq8kcUhjId8tnHAOO3vU0Mcl3Di2MNrbw5dS/3snGeeppiKltvkuz5pK7UUnHPvirdo8KLH5EaXgIIlJLcZ77e2OnFNK7CT0Kk8Zmt3cYWENhgnVsfXknvT91sy29usOGVy3mucOy4yB6duKjLvDfgyxkThSIozxtPY/59aSXT7jzZorpoTMANsauCGxzjj0oevTUe25CXiuZppZGd7jdiNW+X8fTNWLpJIJQLyYSHAJEeHxxwPY1XDwL5TqG3unKMAeR3B9KkuCv2R2fhnbI2np78VNr6jejJrLy4ZZZVkSRuMhgST9D3PNVyrJLKdQU7ATy/8LHt9asR3MkkbRqnI2ne5x06EDuRUciWkfnbd9y7gFZZBjYe5I7mtN0rEp2dmVJrg6gxZo4woYf6w8Z7n3P1qxaRQG4K2dwRjAZ5hgHPU47DPFS6ZKNPuJWvERkXg27xhg3pn3FQ2wS5E7SGOCOSXyx+6LY+jdgM1MencG/uGXVwWkDBjLI5+bd7dv8A9VH2hZblI7p43wCBkE7QP7pqSVreSRYBGUjiGzevIIGdzD1zUdy0K6dCsUeyYqVfevLDPBU/Slq3e407El61v5AkgZpZZeT5nVeeAPX3qMwQW1inmsHuGfLKM5iwM4298+tTyx3Nu8a3CwxTqBI0seGbb0UKOn4e9UXCQybpElADESZcq3sfaiTtrYI9jU0m1nvIxFmOIeU8zMcE49CPUnoKrCFzdRwWxFmjRguxkyRgc89s+lV/I8ki4WVvJ6AnAdvw/rU1v500bLANgALvnkii9kkOzu9dC60sIu7KOzjV9yfPb5woOMcsfXrkVFaxytM0sweaFC4jCtuRCDz164qIXLJbo1xaQvGh2M3TeT2J9f5UscdubcTTT7YOSkG4sXYeoH3R71XMnIjbclkvbySCSJiSVzJIRwcHrxVW7SCG3SKOL9833pC24YPcDtW9ZWkB0h7q9hdIpG4aFxgexHWsK1hZ4ZWJAhJAMjj5iB/dpzu0vP8AAUWtfIC5mk8mzHyKoLyN0OOrE06aPzTHH9oe4iVdvmYOW77eegq3YJNcW9w0CyRWTsqsiD72OgY9qj1BTZIYX3NNuBEeAUAI5NQo6XZXNrYWY3KGKOVEssIcBum3+uarWrQIGklwyHJCF8Fj2JHcVYkh3XUbagHmQR7lXzMFV9M9zUUDt5i3r2Ufk28nK7cJwOA1N7h0Lf2i5jU2Qmj2SkD5DmNVPYfiaozzmOVLa3H7yImMyqSS2fb9MVJcLJdLczSssM7c/Z0TBKgZ3HsB/OpXmSK1UxwskZGIQQCSTyX3dSff0oab6iWg029xp4t/tcSJG+SjSDLv6HA5HsKswaJcXCXFzLuMa93IXoOp/wAPWmNaRyWA1GaUCQPsWBCcn8fXvUa3KvpaQ3F9IsSk7LeNdxZj1Jb3NUlFbrToJtvYWS/toryC4t7SFZQmWRx+6HbP5DP1qW2tra3uFu5pYZFZDIgCblBz3GfxFVrWQw25hez818E5kG1Qp/iGf0qC2f7RKA5dLPcwQ7Ny5xkDPGecUKWzeoWFvJ5LoySb3BkJMpPO8DkHHbFP1owWUFolnG7uE8xjMvLk9z6+lF3Itp5Jh3NPLHuZUcfIScYPrwOlVPOKCTfEgZD8pLZIbOen9KTdr33KjG7T6FuS+C2sduLX7FKykeZxvl3dvYVnTTTWAP2aLBf5WGcgAdc96naOe4k8uWMfapQX+f5dqAZwB2zjNRlYlkia0mE5RU/d+X8jHqd38qJNy2KVluSyLEbL7TdMftJAVY2G3Kjuf71QIbh4pGSRgPvu0mMBR029+9Swyi4vYo9XnlRFOGLfdRRnCj0q3dxRXcds0t6rHkDjCRKB6D/JpcvNqv8Agg3bRleARssv2qGeRypfcOwHc4pLaZr1cQx/Z2RNqnd8gz95znqcdhV3TImuruV5nlWzAJkVODIOmPxxVKZt1zCqo0URUcEcLnqR+GOaWtkTdNkOR5Udpbp++GRLKDndk8AU0TfZI4SIpBIcqd/QnPOKsxrEk8cayhIo/wB6SnLMw9PU/pUOJbnChGkRJGaNMZJJ5Oce3OBSs0Ve7GYSaMzS7mcMFjgHI255yamns4klQZDXEn34UUhFHZifbvQbycQeQh2KMAxheBznOeuc4pY/MZZ2t3IZVJklc4cjoQPb2oVrA7k8dsY4JJLSaFYkDgTuPlfH8IB7ntVG2YSTgjckcQXe68gEjGfen3NvGtuskbtJBGFTGMZc9dvtT77UYpSIRAiOGyxhXA6cD2oaS30EvIjht/PiuFgQkBsyuRyo7H2NS6fOYbNFt4C+xhIzyAYU9st6e3eo4YlksJ45J5VgjPmBFjPzsf7zUqPaXEiqy+VZxqA6Kx/eMBkj6n9KE7WYb3Reuo7ma0S6vNp84kRopA/EjqKz7hjIMSwnCn+H+Jsd/wAqsWiPeXLZAW3UM5Dsd2PTPfHAxUMSRXVwYd4lkI+8xKpGevT2qpPm1RMfd3KksrbI44X3BgN6hcA/X6e1T2OwyGWVo3EAD89Ov3V9+aJNTd7Q21kiKPM3FiPmU4xkn+lNs7aWz09LueIy7FD5JBTkkAkdTUJa2Wpo9tR9tcXUsZjLPHblmUsoznd1APYYq6FzdPJbJFYwxgIN5I7Yz7k9aoWyCBIri4VkgHzRoW4JHP4jtTru6edXu7nIEzgrGW4DdcsOpFaRlpeRElroSyWf2hlmGxkVhHtB2789SB6H1q5rk8VpNLb2MEsAIRJi7AumOqq3YGqdzqL3Fvsjgj3ykbphwobP8Pp2qG7gl8lokKvOZMMoYsxI9v8AOaLqz5BWd05CI1td6lK00G+xI2RRb/lAA+UE1LFO1rZzq65W4i2hU42rnjHtVcQhra3WWSFcAliFIZh7+p7VbeR7mVJblAkEKcLEAp9s+pqdd+pT7Dbe5l/0cxwRpJCQw2cHPYk0y+k+23kl9q5W6dzsC5wMgDBOO1NszIbfdbRtJtUtKcfLHjkHNOBgW082dw1yzgKhG3YvUmjWwaFm0jleK38tLaEOHKNnAA6Fie3TgUVVvr6eeKWbauJAC+xQFVRxgCih11DTUXs3PVmu6xxReYr7I3fBHXIps8tlJfRkQPa2w5ynzvkfXj8KVJorkPGIAFGVUZJbnpgCq98EtkjBhka4j/i3/L7EUpPRtbAtXZ7k0qXkEpgO6MO29FKgMoP8WOuMdqW/vXlmaFxGVACqUHDbf8aTybq+nea6kLXTfMqLkuVHXPoKs20luLjyTbx4deGcbsEd196qCvotLg9PMpuIpL63W2bfKx+dZVwinsP/ANdRX1zdeeYpCoRTtAj+6p9sVd1BoDdSJZTbIljKSyS8eZ3PXnrUGnxWby26vHLk/O7ZGGXsAKUlrZMadtR2y3uLuNA4KlAHc5Zge5X1qkEXy3jgKyb5NqyHKsmOOvv71ZvWCyBbBmjIOFdMg89VNEAWGM29rIiyIw3tJgoM98/Wm1rZhra6KcS3CP8AZ4NsxcgDAznB6A+laRme4uFLRs13vESRxgIoI6df61N9pXTrm1mtYPNnU5d3k3rnscj88VnPZXMsdxO80aZcszSMVdu5wOlPl5NEJvm1YX0lyl3G97cI0xBJCENtb0bHGasIzzxLDAgeVurkYwf6ioYUgiuVYK+oIF5YZUM3scdquy3Vi0cTJFJFhwPs6yFsjHr9aIx3d7A+y1IJZzBJLc3LR3EzgJmQ5PoSB3Ix1qA3crqzt+7tGbbsLbdxA449ccZpfJtg37x0gnA3DIIKkdB759ahPmSWBmkK7UbAXOWJPoKWq0Q7It6Xq0Wnfa/ItvOZ4jGu/ny89ahaT7HaRNdo4yd8ZaPOT6A9xiqcsxup0t7CBokYKrqCSXYdSTUks7LI8Ui+bIcAF2OI/YA9KlT0HyJO7GmNZfLuDl3IL7E48r0yf6dqv3UUpWSK7P2eI7ZSkgz1HHP94jmpJWiSOziu5SJ2yXZR8gA+6oUVUtri3edn1LzmgKsQkZ5LDgf5NVypaNiu7DFtg90n2YNJBJIER5DsL98AHoMd60xcWMlvsEMouUBIMJAxjjk1nrcPPJEt9ugt4EKqAMk55wM8DNMtbpwZ4IlIic7to5K46H8KalyvTqKS5lfsXPsk1hbypLHDvcA7XOSoP8W319+1JNbJa34RhHKCoZYEPmKXx3xjA+tVJj++YXMsjsehUhyT061IIlFvm3aJJCnLliMknBUDvRo1ZINe5PZyQ2r3BvGFy8bbY0Vsx+Z/ex/F9KWeZ1jkM1wE2ZYxE8ZbrgCm2y2yLJJLAWunVUgghONx6E/yNQrHDDH5k7KbpXyEjGT15DE/jRqloFlct+ek6NHbW/kwKc/aCWBcYzt29yaLm3ht7YPJMWumIJHUEEcAepHeoJ1vZBFqd47i2kYrEU+UHAwMDtTW8y4VyIFzGNzso3YB7k9hSv33BLZipCn2VrmRhFOgDpl8F1zzgevtT98kksVykUj2ytgM42hmznLY4zzUcUflPGRE9xcOPkBQ4UjvjvVqwktIY7j+1XnZgD5Nsmfv/wB5uwotbyBsdJgT3kuoyyM04+cwkcn+7k9hxxTLOT7HvkSO1YtARs38oDx3796z55f3imbcctn5fmJ9TU9lA893KSiKNpk3TkDAHv6noKSnd6IOWyuyW3W5khHkQkRSNgL1JOO3ftk1BsS3jWVWxIAHXIOCc+lLbSvLMBawyF1TAZj055I9B2q7arshZ2XfPsxFvYERgE5bB7+lO3Mrg3bQorHNepGbmcrFENhLOWAzz09/Spf3UljsuJ5VAIcRrhYz6gdwaaY5mSZ4oVjhjQsZJflPtn1PoKLSJorWVrqMuxiym48IT6jtRFWdgexUJt4pIZmiaL5S20A4AHTB6lveor63isruN9UmUz3EXmKpJZgD0yR/EKku2vNSmSGziM6rH5caFfmCrzkD2yeaz7a7t7R0upYVmkTcm2bkyMRwce1S5WZtCJNYq17clp2aOHbtMuCSF6/hmrtleJZQiC3aPLEyZZOSewz3/wAapqLp7b7SZXitNwUDPLk/ex6irKrB5YllVnlLBY+xRQeTnpkinHTbfuTItwi0BMup5kEqMdwbAD56n1FN0q1Avk+0BLdShkAZTtcDpnHqarywW00PmXFw8bhikcWNxA5IZvQdBxTUl8+eRmj/AHmQBuckL2ob2ZNm07Fi8v55Jisjs8iuxwGyqk9adbahMlwgWQK//PWY5VR7j8Kegs7SY4lEgjAkWMrlZW7r/PnvSXd4ZZbhyUzdDDLtxj0PsBRdp3ctSXrokQRTyx3xnsbkGaRjiZwAOepx256VYl+02TSWgf53xcMw4Knn5s9qS2O+5W0tHhNsq7VkuEACjHJqnGEW5kHmmV1B3MSecfdHvTTstB7l64/c6cjWZZWkO2WXPyNzxjvn1qKJ2ZYnnUi3jUr93hgDz09/Wpri/miukeAwyRKfPCuuEjcjkD2FQWdwvlkzhpoTkqC21Cc5OR3Ht3obV7XJSaRBf3guVKqpjg3ZAJ68YzjtTIo1SWOSEIkoO5XJyW+oqZLqRrtpExHCSGwUyvHqOwp0U0108l1GojjgH3mwduTjI/kBU2u7spaLQivFeG2aORwzz4ZtrdME5J/z3qS48izNtLaS+ZnayyMOren07Ulz5CMIRbmbeMFgfmB6jH171WngmM/2oYRnLbbeMEiNBjJGegz3603rewK+lya8dl8l42Hn5LFAeFGeKtJYuYVtLlGilY72EaZbaf4i3p9Kin+zxyRxOVjidgZCjB3xjjH0ospri6iWIS+QiZHmkkOw549s1SSvZi16EWyK2hS4hnZ5kbc8ITd8w/jJ7L0FVC0pvxNLLEZXLSCMD5QT2I6Drmrunw7ppG3eX5KmQ/KWBPbPt05NZq+SxkVmae5ZSU8s5G8ngEfnUPVdilox7mSNPLu5AxyUwvzbT2wemKmmgnkuYpNRSTOzcEAGdoGA2PyqvbxzQ2pLMjFX5Zm6ZPII9M96vWtvd6hdNIJUMY+Vrh+FOBnAJ68D8aSjcG7DJ5cWkEkr4w4UQYwP94VoWepwWU73ctvNJkHyIyu0AnjcT3J9qz0Ks7Ssu4Rcbpskuc8cdvpVjVPOhlSSRQJp/nVQPkjB5wg/StE2tUQ0nox1tEVR5JYGW4ThckYTucjqSc1FLLHNIqIDLMcvI3QLjqMdzirLvHLqDFhLDCNvmM5B2cc8dz9azLiclHhtFkCyHYGx94d/xodktBq7dy3b4NtJuuhDFa4lMan/AFjMeB78YrNljYQveTrvQPsUM3zDPPPqKlt7eZCuVDSysEiRsEDtyPWn3aPI0Qu3ULB8jso5UA4wR35qJaq7RS91k0cd08K2/lhHlw3oSvr9KKkWSe/jWS6laK2UeWrbQX2jnaPailKCdrivLojVllX7SzqVgByQQOnv7VA8kAtTNLOZJ8japJyR6g9OKtwak4uYGiSISICvlumQQfX1qi5tx5hddzk5bbwCc/dA9K0dt0KJJp02yOOdISZFYMxJwB9fY0l8JBNG7bozL93aeAD6e1QrbzGRGlDIGUhBIPl20uqKEso3lZ0m3AKm3t6g1Kb5dR2V9B9lse5c3MayNGAUUk9u1VpGkurue5u5J8BdpKg4A9qfa3DBQspdo3YOVQ43Y96fpwkYme7hma3yVUqpw3coT3x6Uk1JJDemo1Z1ki+UeTaRYXLEF8H+I+pqWBtOis2M8bzs+4L5Zwyeh96qtcxrYhViicbsNvU5TNSaWjotwbJnIYhWbYMBRznJ6c04ttpLViaVizp+VTbJcC3KxZUgZVQe3HQnjmkimuDbvAxlmiZtywAcMxHc9ffikij8qeV5J4hF99gpKxs3YDjnmqcU0yx5RdrsxMcmec9aq7Vkwt1JZnk+xJgrBH/EEY/e7t7E0ySILBK0YBIIL3HIK/QVJOsZtonbK3TEySlsbSe2AKpzFZkLPcGN25KYwCvp+dRKyHHyJzemO5aZDJMFXZ5ky7ufp2HpU0Ki6m8y7DRGUfKF4BPAA9h3qDTbiR7jEweSJMO0W/Akx93PsKtXMjSSGe4mljZ3MihVwnuQexpx1Q5dircSypMlpaLuMeUO0bhknOR6/WkfzoI5VZhFIgDHf/rCfr/SrCSGPM8SbIY2+UrwUyeuR1NQX4ee6+1yyAmQ53uMDA7/AKUS6sSd9CO1ELyJJqBeQnJB+7jHTPpVu0ETW6zXAiMaOcI4+8eoyfSq4la7nLWhKxM2R8p2nHrnripIZooZXjKLdzBsRuWyic5J29+9Cdthy11LV9dzXzSSvkHbuaV+cjGNo4xj0qONxBbXFnErCe4IRmdRyp6AZ5GfXpiptS1MS2ssRJO5xIRwoOOAcVRja4gVJXAiiQ7WZlDsCeRlep449KuTXNvczjHQe4S2hTz4VfgMGB444Kcf/rpksEDpbyCJraPb87l9xJz94Dt6VPYWyQsLiaVSJslBIN2MHB3AdDjpTWED5hWN2mdiRsYAYxwpqWtNSr9izYxQxXcbSRFIFRpchgrtn7uSfzAqCe7At/KtmVlK7pJSvzbj1UH0prWXlWr3c8rTsrABUU7Qc4UljwR1qeMzRWKyNHFLJNkAsg/dDPp6mq97axOl7kF3qMl1plpaXRIt7ZgQg6Y7/U0y2luJ7G4FrtitlYO6k4LrnAUeoHepGSKKCSCceZdsyiPbg/Keu33+tN2W8z26XTQ2caqVaJMs5x/e7Ak9hU8rbtcpWS0RYtbiZDGLOVYZY1IWRnxg8k8/0qNyJLSaeNzLK5w8knUHPIA7E1WvXQ3DxxuGjGAAE28AVYntJLkW87yW9slzhI1JxvI43EUau6WtgaS1Fhndr6MWawTLwCjLu75x+BFWNTEtreyK0tvcTMo3eXyiZPT3+lUn8xLl4bZIzJEAAFJOzHJYn+eaba3duhVbxtn7zeXUcMPb0ov0Yra3ROr3dtE8scMwB4aVeVPsf8KjZJvsS3CorFGywb0z3U/ypzXEkbTSDKxyvvjUkkHnhiPX0NQFZbmCZp5Cbdcu+1eXPpS5l0HZiXkt3dSNLNJ5kQXGVOVGO1RPiIiSNhNKxxvznbxyf/r1KzRC0tzAjNI332BxHHzwvpn1qoLdPOuhNet5RT5vK+7Iey59BSas/MuJNp9/Na3yfYkZrkqS0meB1zk+mOtKbYX1veXV/OoVMmNFwoYnug9KY0aTLCGmjihOVYRx/oO7Z7+lNNjLcpK4YpbxDc4Y/cUfy+lPVLuPT0Ib25Mr/Z0KCKMcRx5KD6Z6VctnRnge7lk+RQDH1I4457VGk6waa9tEIo1uHBd9pL4HI57DPpQtvM/yXM2wIDIEZcM/Gcmlre/UejL/ANszIDDHBBIB/rMEk8duvNZYuJ7q5kgtrYtxldg5IAxk1MvmTxLEqlVf5VkzjDHvmi1lGkXU8EV04l3CITRHCP6Hd2Gabblu9CVFLbc1baKLTILx7loJ5iFRcOCQSM8DHPXHFZ9lJ59xGbrfcfwLGG2kntk+lRBXtpt4eNpRwXByCT6UizQCdrojyiigeUOPMfOOPTjmm2tOlhKO5tajtht4kmhKTK5VUiwybe43dazmjU2Xl26FWDBppGI4ycAD0NQsXNo1482MyYVOpC96JHkUMqOqhTufnj2x60Sd3dkqNla4raeqXiWonG0thpN3yLk9T9atXDxWytFNFE8gb9yY/u8cHNNF59nSWG3EMk0hEjTLlsY54z0qW7S2tIIIpWE1/IFkyOkS+hHdqEkk3H+vITvdXFt1kltoXJja3UsDFG+1pO53d8Gqphub28aOJAWOcRR8IijtTJo/J3NeFrR1PyjYQZM9Oe1W7bV5bZI4LCOF1gDO0oXIyRzuPcDpR7r0YWa1RWR4FtljWH9+CvIbLFccmo7uYusUEUZW4Y5klH8QHCqo7Dvj1qW1hjKCadso+SSny/rTJIzPNbxW4baTkEdEb29fU0pJ2/QaauSLax2+FtFaS4ZyTO3VR6gduvU0+9i+y3S288sKJjaHjO4D3Y+v0pjsimW3t4ZHlc/6wOTwOvTrnr7VX1OAwqm1lLQLvKg52g9Qf5072WiFu9S1sieOZo5Wht0Ty2dsgy+wA6k+hqLRrRZJg8qtDZAeYzcKWC5HB+vGKz7Bppla4Zn89Wym09D2Y/TjFWZBJJHAJ7jzmjXJQKSIhnPPvmlF3XPYpq2lyK4SGa2UrEYlRuQrZeX8Owp891JFp0O1GEQlyGY859PT9KsXCzC1Q4MVruHzEYeQ98HuKpCZbe7kWSJ3OTiH7xUHuccA05aX8wSuaoglis5jdNEGaPOxsg+oNZ8dxdaldrJalmYYiU53EZ6D61cuLye/0y1t2aKNV+4hOXkOeST2GKqBo4IbdbISPcAkkIfvn0x7etOVnonp+JMU1q9y/PDFaW08WoFormDawtihYytnnJrOldh9muLXe0hJYQqhxHzwc9z9PSlUSTLLdXDby2fmzn5h71VtrmQOBFIRKvIfP+qGew9amUtioxsi4julxFIIz57N5m1jklumfxNJcMFaRrxPMnkGCWOPLb1I6fhUaM88vlxq0bjLO7csB6mp4oIJHtjNmSMru8uNjudvcnvSXvaITSK9yz3NyY7VpZLZcKh6FwBzgCimWpF1eE3E3k2sY2Fl5IHoPc9M0U4wUrtlObhoad7IEXfCjW4yG2k5I+h61cW2mt7UXQ2uJOAw+bGaoRxjBMMZmc5yT9OlWLGCeRz5HmJDEu91jH3eOuD1NJau9rg9h2pXCQ20LRTyvOy4MbDOBjGaq3EohtvKCxSvJtO9skr/ALIHbNPs1jkcSi6EI+YjcOmBkfrSeZdXVtLcmJGUONzbRwewH1oldiVkXp9sFmFnZFI+WO3XJZT/ALXp9aqSSyzxxwtxCGyADjB7ke9SvamaKZkLyGJQZZXOAD/dFMdLTyLffLOkzcMv3gR2x9aqV35CViS1AVHkMEdyofCCUnGfoKWO6MKSIIk+cAFSx2g9N3/1qml+QG8nLKGfbHCSMKRx82P6VUkL6hOyQxxL8nJzgD3ptcuwtzRkgfQtS3zCO4KIFyy7lUsMjr6VUgP2e5V0dLi8ZshQcKg9M9PyrPYS3pUCaMqzbflOF3Djv39DUsm2zuLiKd2iO0Dy2jOSQRkY7H370ubW9tB8vnqTiyKW4nmuEHmKXQJztOe/pT5hayW4n2uekbXMrbt7/wCyB0GKq36RF9kW5MZKwyE5x647D2p0cSRbFmQsSPk2t1PXOKL20S0HbvuFzFFJdxtbs9zwAuyMjDdgAetR26SzgQ3NwIbQN+8bsvsRTnlmEDSxMokjOQwfDLkdMf4VC1s9vbxXF3Goif5gCP8AWfjU9bpDXmWoXM8w8mGS4tgfLjbGwHOefx61EYmnuEW7bENurKg5Kg+n51YN3DJbzOxmXZgxBBhC2OB6cc1TiRZlbzGaS4+8ipwBxnkVTsJdWSygmxiktZX+zoMlQwAjfuT6Zx0qCylaSZY4/wB1JIQDM5wiD8OvFWmtkFpN9tdzdBxsgxtUDGSx9fSn3Ev9oeRaWbxiI/PkjYseeMfQUNdXoFyrMkQlJSUyfPkOeFcD0FT6fZ3d7feXEEMsgLqH+XgdDzTEsriGFblYhNAPnLE5x7n61Kt9cC4ieac+ZIMeYD8wPse2KSjyv3tAu2vdFjjjMix3Fy6yAs0jbPkX0HHUmoZWkEKNGF27Sfm4wfUepqWWe3RAv2WSRAcuVb7x+vb600XCzXcctpFFAIEU4J4P+1z9acrd9RK/UjZJre3eWeRhOOAjLxg9/wBantr67WLZBMPJQEbnTk5GMUyKOO5nzLcSSbX3SPjKICeSPXmnpDaJcmWWaVYVdlLRjJGBwR9aVne62C6sVdVi2QwNKHWZ5NzSnqQB2HpS2ltLLK81rzax7cySLwqngE0apG7QRS3MjO8rbUiYkuF7E9hn0osnNvZzR3c0vmDhIh3HPf0FJ257Mq/u6EtsI44ZFXGdhYuVJxycAfWkvmfU7eGQFobWMhVPAO/HLAUkMUclw8UTOIcL5mRtJ45GPrU0GPLMiSKpikykIyWkY+g+nWnvo9iXp6lyTTIobtbX7StsWjDvOwxGBjP1JOOlZNtdObj91HG+GJMki8EHoSO2KsM+cxTYD7/nQ87R9faqcW6e7aCNHa2L5AQZZhngZpVJXdor7hxX8zJLdIo5FSKQytnqw+Ut6Y9Pepp2kRHS4P3XJZAeN3TNPBktdTkjgtyOuY2AJH1+lLDDlpnuZISwO0oWIA9+PWqSdhOxQvTLLI8UW17UANujUhAen50+OyikhELzSttjLkKuBnGce56VavHZXCWsYjVmEiW6vvAA9T/jUUYBE1vLL5kkhVkYNtijz/Ee+cdqOVc2quWm7BayJazWkMBt1yu6ScLuZM8Hk8Ain3cv2wtawNugDbVx1OB1J759apmS3tLiSK3EUqq2EmkTdtHche+TVi0jk1C5Kq9vaW6KEaWYkBSep4/iJ/KjW1kNpL3hJ78S2lobqTMkBIjRUACjH6nIHWprSW/1dnEdu9zfztuM3Qg+g7YFZ9zZQbnSFvOljY75gfkPPAU+hxnNXmuLrSLiCWGQiUxhVEbcgnoBjqKFe93sDWnu7jWt1t7YtdvIWLYWBG644JPpVjTHs7OxmnngSaUsUMbj5IlPRh6mqbLMt2W1MvG24eYYwCyk/oO9VLq3tlm2WMrSRk4klk42LnuKLuGqVhcql7rHRSw2gEVknm3c3zswPCHJO0Dp07021uJdOu1cBDfmT5AwDgH1weO9KH+xLi0iEjjevnjqc/p2/WnQ2gtrQS6hJlLiMmEAgsTn9Kn+vI0aJZ4H8iW7vbhf3jZCk/NKxPJx2Ap+qySX0ELQQ+TbFgiBgFLnuAOpHvVArHHJ5l4JI1AwkTHc2AOAfQVplH1I200oEUCSLHjkxxKe30zTtdNE7NMpw3SR2ZiPyLGW8xwo+Yjpg96utHaW9ity7TG+kkBSAnkRjqSe+e1Ytw0st9LH+7SFX2M6L8pweuK2VtFfT5Z4xIUjbAuWb7/OAAOwojdt+QpxSSYklpJNa3N5d3KrEEDxwM+9jk/pVYSNJtjidLaFwvSPCsvqe5qxOIrqMP5YgjQZmYD8se1SWYkMb3ULOwiwqSMwBRenAPX2FJq7S/piu0rj7KK/v7eeEwsbKHdO6RED5gMZGe3HSqF1cu4iUSMCecg4A/CtC51B4sW9u58vyiksyHiQE5z/AENUJ0hexmZSTKpDMxHb3/lVO1rJkRvuy5eeZpYEEO9Z3ILSbgffHHQH061BbzfbCPtrofmLTxj5S/tk9eBjjpVBpri7tiXmzZ24BVejHJxlfWrd69h5afZkEm1cKjHp7sO3rRfrsuw7dOpHazxrA8cUbb2fK8keWoPBz3/+tU8aSxNFPawNL8wed5AfKc9s/Sq9ugRo/tEgTKhmkxkFfpU1zeXV7bQWjSy/ZS21Axwr4/pSWiuwau7IimneR1ld1eBXZgsfC477R2FXdHtZ4WV5PMtbebdKHKbiwGeT6jNZ9m1o1+7XMr+XwoDR5DD0IB6VekvLm5hdJiDFAoIVP4V6AHv+FJJXcmErrREO+I28hXMs5bDSsPljjxwB780kpt4LUR2mDLJ96Rh82P8AZ9BVsQKmnmVnX7U7gRx8AFO+ar3VsFuFvGRVt5FLR5XCnHBGB71ck7XErAiq8JSOP/QAfMlkjjJk6Ywp9PrWYFbyTJbpsDvhckZbnGPw61safOsvnKiMZ+fLKNtT3DD+7WRZxN5Tl/nZAWXngDngDvUSSlaw1o3ck89hD9mhZw8hzPK3Un0BpJJJLiJ7ewt5Nhyzt1cKO5x0qGymlubmXZINuz5y+BgegrXs3gtYn+yth5wyGRXKkJ0y3sfSiMebrZDehElulpJZvPHDcxpEshQnjBzgNjvRVNoiiylHfyk4bA+96UUOTWi0Fyc2rOnmLxWE0NmSODJNGQNignqD1JrNW8aG6jtbc5/dhG3HC7s9feoLi5S5e5fc+XHyxx5wfTJ71a02O2itkn1B42cEKIiuSVx39wfxq5S5pe794+XkXvGe6+TIyXG1nDYAx0Oa0Z/K8pvKQRiUgxqCPk9c1DfxxSXMS2sMceOcqxOR+NWItPUSIIGNxO+Ado+Vc9s+tRFNN8uoNp2voRxbtpitjJcNIMGPsD/X60wxJHbhArCZMNuYHGc9Ks3kDafPE5uNhUkEIPnXHUGlt2hRm8x2mV1wE6kH39xVcqTaZN9Loi82O7lQsXjSMc5GQefSqzxG9uWVZN652sSAn4VYuLczzMIYhFHjdt3cY9Sag0+SBQwEfmTnnkEjr+tRK732LWiui/OIfKhis7fAjB3kdSc8En2PSqcjxxzwmTbJcFyZGZy3Xp+NbUE6tayI5McIUhsdQeo/WsaVkvHRkI2Ff3kkq7cH1rSdrXRnDcinJt55ZYmY3CsDG7cqR3zmrIUbiIzl2wxlc7VU9/wzUMUtosirKWIkIJkJz+Y71Prd3PfXeHRI4+EJC7Q2OgxUJpJtvXsW76FJZorSeSWNTcFMgMF4z3bFNimOoTE3huJmZdsccPIDehHpV37GizW8kr+a2SrKqlQi/wBaild9PeQ2bIgf5THuyw9/Y0mmt9gunsJHZ3aSpFfNKkCHcVAyVAH5ZxVmLyxZTmEskZYZ8zHIHv8A4VHegz2odEFuemxWO3d757kURNbyW7vIreYPlEZbv/ex2A6VSSi9BN3WpYiE19eSPE0cq7ST5uQGHp/+uq1qYbKaRpo96uhAQf09qQRtvQPJ5UL4DMnYdzVwPHBH5turSHLKM/3exINNaq/VCf4Cm1vDpgleIpbIvyq3TH97Hr71TjWO1l8/O+Qc4KgnkdT2q5FNNLapFG7hnXa6KxwV64x/Oq7WxVkVMZBOQ/TpwKJJOzRKbWg8OUsImu5SVjJ2QYILAjPOOxNUnJZWaXaYxyAnXOPzwKtQQxXG6a6mAZF27dvU+gHcCmDg/ZLUiQsd5aRRkHHTP90elS25K7ZS00QvnSYSLyAu+NUAVcEgdyO+aR42hsmedgQDgRr1Oe+KIS8MQld87skyEnco6A/Q9qIR5cE5dVklMeFHUpz96nr1BkV3cgz27SD7RhA33twI6gH39alnhbzXkmtvImfbsCDCKB1+p6VMzLOYpbpEtwoxshixhQM5Pqc45qVrm5bSkjldDEZNxBOWOT0J/pTitfeE3skMjt31KSUQxwrHEu55c/Mexb15qvORazHZ5vnEAK33T75pxl2xSwOfLLkMMDA69+4GO1TWdwlvJJcrGZriP7rMpwvHvxj3pXTQ3e5DbWoa2cu6DDhQo4kkJ9+w96uWcyrHcwaeVhTbmSWRuq46D3zkCo4ILeS2F3fThlRwGjB+ds8n8PeqbFTPNOYhHbo/EannB6DJqleFrCtzXRftJksbWG5hZVkDOsj5yxyOAQe3HJrJUzXjvdKjJCz7iB7nqB3p+7zIPMlVlXcETjIPrzTp3hSOB0unZlBUQr8zbsnkDsOlTfmS7ItKzGfaIFEmzdGzAqQM59+ahiTAWQs0cO/D4Pzbf8/zpbaGJLO8mmXdM3yISfu88t7+lSaiIojLGRKt0QCFUAoPXJ7EcU9bXkXbWyILfUFthILK2V3bdxMgZoh0znpTLyWT7RskCxrsXEe7IJ/vH19avaVBNEskb3UNs0xBkdky4Ucgj278VQsDD/bRaDN385C+amd/H3iB29qTTsila7sXYkWadBY24CRxgyNMc5YZ3N7D0FJZrp41GP7W0zwAb2bOxvqPTHXFOvVld0W4KxRxnY7Bht3e2OvFZl9ZzaghuV3GC3AwAOSe3FN3jsrslJddEWhcOqzC1lcx3LESbzuBXPA92pZLCK2mWGZyiNJ+8z0UYyCP5VHbXDW7/ZY0jmaI7klVdwZj39sVNqNxJNcySXipHcBQp46e+PWhNNXe43dOyKVpE91fGMyRxxcnLEhBxV5raxZpWWWaYQgB3J2+Y2ei+i4FQXd5dJYhZ2G/flYyu1iCOT+gp8XkkWa3jpHFnLeWAXAPdv6CkrLRfiOSe7JLv7LLCXQBcDmXJLSP2HPp3rNeOR08l5iiqSETd97HU1ankSOVkWDMUTlgejMM8bqzXlkuNSR/s6OV+VlHC4HrUzkr6hBaFsII5JleRGgjjwPLPGT6Z7njNT3R8+dI4oZIYMDZGxzuOOSB6VUdIFQqHeS5JPyqvyAetT20LRaJLf3EuJWkWGKPPLqOT9B0/Gkn0Ww5JbssCKKayYK8wlQbTtICkVHaxLJEJCDGkYVWy3zSE+g7Uhi+0q15ckomfljDZc+n0qzcRz3NilxeNkxLsSP7pC9ufxqrN7LoQ9NCulw86GONss58tEOAqqOcn+dV5XdEaAbpZlG444Az/Orl3NbJvgtEkldEBbCBgT6H0Aqra26xzq13++lkbJhViB0yAW7Ck/IFa2pKTcXltJb2ys1uoVnkKAYVeBz0HJpJoWtpDaW8Sm4ziaTn5v8AZOe3vUxunXTGtIfMQySNuiH3QAeDj05qqLdntwI5xv34aLuB/eJ9Kb303/rQleZZix5Us9yI1uR80Stkr1wCvrj3pkE32+6idBGhb7xkY7FY9Tx09cUl3bRIplhuHlSDb5e9cBj3GOyj9aZos6yXdys6ny2IIiQ4Oc/w/jRf3lF6BZWbJH8qAzmPMh4XeBwfUj0qO1UpjfKiLKSSeSzAeg71p24nmvCwih81cqkZOFVsfePvWWzSRxB5drNu4kYjp6UrdWJPoXWt1UKzgtIWaNImPJPdj6VDDbNJcFbws0CAnbG2Rx2H9cVHdwSXJS8jieK1Z/LjG4nee4zV7Vw02o/ZiqW8SERBEbcqjuQe9U1fWxNyvquz7PKbZitvvyWJGemAoA71WmtZ2VTsaK3gUByOpftUmovaxSxwWcYkEbebJKRg5A4Ue3eq8BluZJLi4cuXBdhjII9/0GaUn71uo1tcm0y4nkM0FvILS1mIEjAZGB/M02BVlKWdrtUyttlnkGRGAeoP86mtJZrewiw0b/aFbNuvT2J+lQqy21s8KOuWHzovUj3bsPYUbbg3cmD20tlHbpNCuxnLuAS5APU+ue1FVkluSBawpHAmCWZVw2D6n6UUNqXQfwvexcgxbxosIwQ2/wA0HByOn5VfUteyia4zLLKxzI2AAf8A69WryZo3ef8AdL8vlrEkYKEHrgVnxkAm33NGn3jx94f4UcvK7XDmvqSyOJSFTBCHlumB6CntqDQeQ1usieS28Et6+1SeREftSW00bRx43TsOoJx8vf8AKkkEcSIiqjx7ipnPO78KdpJ72JumR3EP9o3sjmeEBQHkAPBHcj1x3p8959tureCOK1t4o/lSRE2hvcnvTNMhEl9GhjDKz42Z4PoD6CkvHWGeQW7KZ43GAOgxnIHbrQ7tXfcel7diNnuX8/7KE+UBSSeuT0A70+ynEF15ltnzkDLiQbjn6ehqsrNK4hugEwCyqiYLN6GnGD/R5JPM8plIyWXk+w9RU2vqh2tuWYzK8QBjZ95+UKeMgdKiea4uJ4YLSJisJLbSuTnqcgdadcSr9kVbRZFijwXZz0Y+n1pLaRY4IzGz+czHEcYPHvkevPFPfqC2FnQ3FxEhZY5mU73dQiKe2ABVdBJLNH9nHmJESGfqCB1Oe9O1HzLuINPgSyEKoYZ2p0yKmu7lLuSBI1S2ihCRbFXaGPTOB7etJ21aDWyJVEjW8zyFFTG/lsAZ6DHrTJSLV1cANKV2+4PvVrWEEdupkkU3I5KIwKpgYGR06c8VBp0rpqCSpEt5ICHO3nJA5H0qpWi7EJ31I1tyyg3EnyEs23qc9zikjcbViSJGw+R2bn1NXLu9S4s4ysMSIkhwDy3PYnuB2FRLHm2SPe8entPkuRhmPX8adknaIJ6alR43kdoVfbFESxdjkt6DjuaWSQx2sltG7KrEFjjGf61ZuIo5DKbD7QYIRvJcD5F6dB70g2W8rtPHFtiUP87cyE44471NtbDvoRW9zLasnlQ7SigBjnduP8X4+lG2RC0oAkKHc277uT6+1RwNcS3zSwlnncEkHkgnp+lK0aRQxrGZGuGG+Q/wbew+tLoU/wATWjd4rcxJblZZY8scA7R3YHsKp3JiVIvKiDSLjAxncO//AOunQX7W9tLbWcbbpV2TSnuOuM0p3WNsJTxcMMB94yAR2H9a0butDOzT1GSbXtS04ESblQJEMDjkknscVIqSttmVVjgwdqjC+YF7kd6qNA8UMck6oyoBwrZ5PPPv2qZGEknKtI5OMYzj2FStdxvQrxzyXEobDMqYfywCRIfcVMiztGFYjeRlF4/P605pIvtDW9qz2pchRI55C/xBiO1CPAvm2+1pJg3ySRj5s/TuKF6jfoX7eGzkge+d5JI7Z0WYucGQt0K+w9Ko6xdCUiSKRfsz8IqALvx3ZR9fxqu4ETNGQZM/wgnAP+NLA+1JJoY41dmCr6oR6D3pufQIxs7k0txHIwZLcvcucBCuF247D14qnCkjTSl41l29BuwyepHqBWtu+xSPe3M4kuxGrbjyAWz8v4D0rPEX2q0iighKK2cTyHaWA6gAdB703HbXUat02GO+6ZhFtIfKRwn5go9f/r1FBnToZZ49omZhHG5+8nqR+dPeNLWyjSP5/NYFZFHT29aj1KOSJwbsJyxXfg5HP60rdXuaLV2Eh0y6vI/JJEKpGbjY/wB4j39M1HE1uksT5c2kTfMh4Mpxnn8atm6S5hVULz6jcRlJnZyAgB6+h47VXtbfMEqW4Esqtg9OAD1p2TtYd+4+NC1jctO4WMHEcYPzDJ4yT0H86ddXXl20dlZqp8o7pJlQZ3exHUfWmXSi3unIKTzcfe+bnr9D9Ks6neW8NpbJaW4SVZBJuB64/vfj+FPo7vYV9SlFCkKJPI/nGMfLEVyFYn7p9fU1NdXc6w+dJMR9oB3xxkbnz0J9B7VWe/VZBMjeXKpLnjILHuf6VSsTcXF2XiQsU6bxkL6E1Dl9ldTRRv7zNiyntbLdZqEdbjY0jlgpz/cB7AnvVOC7eTV7ieOOOQtuCtLkhQeM/UCoojG9yZBAbiNBmaSRPlUk/exVmSO4CJHACkcjNIrY2n+6C39KpNy9CeVRfmJIscTlIUMswG4yupDjj7oB6CltktbbT4ru9cXDzo6iADDKQRtJqCdLdnuXtBcy7VVA79C/ds+uegqFRJFdIb9XkMJKsp/hHXFJys7j5boW6ikbYkbvFGwIaWTuW6nHpxUJkRbkwW24xhQM4wXI6kg9M1L5zygTXERNu+7DMclyowPwGeKjs5jb3cZs7dzqA+YKBvABHTHc4PWola6sxrY0bp7aKzBiiZL+YsXkIwiqRgBR3+tUGKxRWrXLZnV8rEeFRByfqSafLcZeW7vJS80aiONPQ4+7+HemaXtDST3Sz3NzH8sQCgqpxnJJ9KptNkpWRetFlllL3dvOV3ACBF27S3Iz+Hany6jKsL2sknmW5IOwdCRyOeoFVpL+a8lad3YRooDnduLHsfrRZPBHbSFlKyF90TsM5A9vei/RMm3VieYqOsOnEg3DclTz/wDqFPMNpBC0TCaa+LnaithRjueM802DNtdStNhJpMBSVO5GzwFA7+9PWGa3Msl1lrt8Zdmyyg9Tn17UrXX9f1cGNhYpc7U8suyFn9uwA9ae9qWlGZhEsh/eMccAdj6VVs4pBci4jiZzHkg9lH941bLW0U8TKGmkcATuwwEJ7L6nH86lWa1E9HoT29nJcxfuk8qIDl5D0wOlU9+EmFugjSP5pJMchemAferIllZHAO215PXp9PU1E6yC2khSL92xzu7N/wDXrSSXQheZbW4tpFMcr+UEUEsFz06CqRt28oXE67oFOEY4A5PINSb4rWEJt8y6BB3KQVx24+lQXJktXZLwglAGSJhkZ9PwzSb0uwtqW9Rurm4t/MuGihtUIMSocBSP7o/rVSRlDSu8rOw/1aKvLdyRTLizubjTi7hhaKuU3DG45/h/GpGm8hoYIVzOBtkcHkj0HpxxSk3uxpLZEXnNO6SX5G1pQzKFA3L/AJ4rRmeFpP8AQApadvLHyfIoI6A+v/66x7ryAd0rO0zY2xj7kY9Pepo3aJo7hnMe4FYlx91emce/NJScdOgct9SW5RLPakciuoOZGXOEYds/rUYAv8pCpA4LyPwMDrk0tzePOkNtEAIN2du3G7t1/wAaiiIW1EalUxkMQT8wz/IVTt02BfiXr2FbVVhyJNzqS6kkSD29MDiiqTSSzM37wCIHHmt1c+x7CipfvbDirbnQ3ChU2uqFv7uf881HLK88m6KHYY12gZzx9atxRJPIHMqoojyN43/XOKqMxe6Pnki3zyVJIJHoapppXITuJODfqJrh1yuE+VNqj2HvSW9vD5ksirKsca7hv5JP9KvI0ccaxIbRzG29mXLFvY9qraldre3PmXVyp3cBEAXGOnAp8qWr1YJtu3QjumLxGe18xMcNnrg+9Uo7oRQPENokYd17jpzVq/ZpLSeGKVZURQ20IRsx/nrWfCYWi8y5D+eV/d8YXb/U1M91JFxWhPDHLcNJOfMab77yHn8Sa0Fiha0UyzzSXWQNpUbUB7j1qpLdyXERgjj2k5Plr8vQd6W0ImYmEMFI3Al8dBzzSjyrbUJJj72ZDDNFbxE7yCOD0Axn61WjluLd457cT+dGP9ZggJxgj2qyRcKGntQJIxFiQ/3QTTQ0i2s/2KWdIQAJmZhhlPqO/PpVST32BabDGuppYorZIUjZj5gdvvntnPYVLcQI0S+Y0e5SE2Rfxe4Pc1RZZYhhApEh+/uyM1Na7oSr7vmRsFWHH4elRe+jHbsXpZLZI4tsOzpuhkJYcd8+/pVWaeVh5kSBN/H7rgAdhU19ceeVd5PMBJbhcbc9s+1Fz5gt492C0gKxDp5ajrx6n1q5rVma7kltYxQ6fb3FxcHEspzH/dHqPxpl4XuHDp5iw5wu9cc+o/xqpLI8CQKWcMo6FCCf/rfSlaJ2ePyneVnA5GcA+nNS9VyxRSVne5qhXieQhkMbfKBG2FYA8+5H9aria0e/ijMbeXkM4J5I9Car3NxHaSFGIllj+VhGfkz2+pNRWbQMks92SZCduxPU1XMtFsTyvdlkhLma5NnHIjbzJxjaiDqc9c1LbqhhaOSfLNyVxjB7E1HDuSywW+zryTIzct/sqBUdtNAkIKpI1x0DMMqfY0eb3D0HXZETLhty7fuocAkjr9afPb3Fxb3M7vbq2BuJkAc54AUdzTmzHkScMT83HzY/Gq08TPCqwhQxOdobJKjkk+lK3UfYuxjzrVsvceRGuZNwwmey+5z61It+bWzaFfLZpCrIwHzBvrVIzSbFtVkBTh9qtkAn+pqy32dSgBeeYKCSRtCnHTHfHrVRb3RLSW5HZM8NyXE/k5DBnxuPPb61WdryBmuIhJBHKoAZh8zfQ0XrvGDHsHnlg20gfdI6+1PlWS6h3STeaqkDYpOyM+me5qP7qNF3Ytrcm2DCBIzIRtEnOV+nvUsUUdrctuuFLBcsyjd8xP6UyGUR3qeUhdEOUGOp9/XNW9Ti+03xvbyWytS8RZIyDt9OAO/1q0tL9US3rYqTISvnFG2SuSDJ94+mKqi6udP+QoWZyCmcEbeeP15omlVys1xNJcRD5Yj90nb2x2FOvvMRkbbDb5IlWMnnn+n16VN3ujRLoRJBPJMXf5lGWOwZ2A+3YCo5jHNGUQzSMX8tUc549fzp8VxN/wAunmjcWiyO4bGR7mpL5mth5UKpFKCChI5X15pWLW5TMjWhEpnjnkclWY8Eex9uKUSNJKWgt2lt2OZWBw2CefpUU7rHcwyxDMgIBaTlc9sfzrdu7y105I7iCbznUMjx4wZSejkdMZPergua93ohy02W5nRXB+zTsqQ20UZwqu3JGfT+I+pqOW8u9SC21ii/ZIQXDmPa2AO/qOaQpBZWVxLqcLS3TgkKSUA4yOO4J/lV3T9JudQ05vO1ApIiGYCLGGbGQSfTHX0xVxjJ+6L3Y+8ZrQFtWFmjmWdiFaSQ4Csf0wKvtcR2l5JbWuUMUihp7ZiwYKCGI9c569qz9PltjJE7QSyM0h3v1Dn+Ee3uTS6bdxWmrT3U4SOJSyiMgsrsP4CPQ0KPLqurG1fTsi5PfW8Nhef2ZbNBBLIFBmfJ27cYx3JOTmoraCOKylF/JMsvytHCDlSM9WP9KpwXE8up/a9Qg37v3wiIKqqnGWCjtjvS3NxLPcpEPLVFdmQEgAKffvUOafvMfI9kWYjNGGvxs8tJAUhIyOh59sVUF3FLbyQSvMGml845OQMA549TTDJNKoNqSiY+dzwM/Wo4VSO282JCzFmxK38QA7DsB696lyb0Q+VbsZMGvbmGORVgUbY1GTlj1y1XLq7FvBbtZRxwzR5RvLLBj2Jb6+1Z9hBJdah5kkqhmYLv357c81f+0yG4dZIY50XLH5sh2HQk98elTF7t9QktbCeU9npovnltvNydqty4ORyfrUEMjXUcKXAKQKC7BW2+cR1pb2Z2hWS8cSxgkRwBcKhPfPfFRRrF9nCtblppAFi+c5Jz1xRJ62XYFqtS20gvABEh85ztjhjGQB0A/rV8wDT4oDeMfPYgJGVyAhH3vz7VV0+K4tAfsalp3Qhnj5Ma55we3Sp7hvttwoEvniNQiE84wOn4etNbXe5m3rZbDRujhknRzJOCW3MDtiOfvA9zS28BnQOJGu5HG+RTnEYz3PqTzVaR3eKCOWRUgRihGemepx6VZtZmgt3gjZMBSpLgbSM9Qe9Cte7Jd1oh+pAxzx2tvIUBADkH7319s1FdxtbyQRyneGOfLThiPU47+lT2kSzNI4SSZdmXcjGPU+1VtRiliuocKo3R5Xb6Z/T8aJbc3US3sXLdxLE/nROLOIlgm7BH51C/n3yk7m8lASBn7o9RUpihijYXRKbF/dxDne2c4z+PNP8AtDzQNLNDHFE5xGRn5B3Ax/M1VujIv1I1WKCRFi2jyyclRnceo/AVTuQwAluj50zgmNUbO09ifb2qwbcxWzNbN+8HO3qcevtUSFnklafYvlRcx7sb8+nvUy2sUiW5upJYoheyTyKzIvkqNqADtVK83SzKyqEUsPlXsB2psS7J1812eVzkIWyEA9fc1ekWJYgbt2abhVijAA247ml8QbMQyySPNDbKdkrYZgNz47DPT8qkjtEt53luYlnaI7RBvP6fSnWDpDBNhkR8fvPmxhfQeo9cU2Hbc3JSNnWMjcXf5fxz6Va6NkN9EULrDeQZJRvcn5AD8gB4WoI7d52O8GJW5VM44HX/AD3qaSRo7ySUyBjGG2Pgbcj09ajjgVo2lvJW+b5mPVj6DFQ99TRaIu2s1pEz3TRvcRKpSNJTgbuwI/oKKz7SC4MjSnyo44RvDSthV/xNFXFya0Qml5nRwTfaHAuZkjXphPlBz/eNSeUk08vnTrHGoG3cTg9gBVXTp4bG4SaZfMIXcIzyc9vrV23lW4haV4GMmSS/97Pt0pQae7JknEuzLBaKJUeD7OJBEDv+cjHLED+dZVyiTzFoTsiyWBfABI96JZPs8wSZHaPkBT1BPvV+OBv7ON7NJAqghYhMNxyOwFXfn922wvh1uU7aT5pVtw2zy8E9pM9c+1RabbJLuee42OqfKCMrj0z2p95dB4zKxWS4k+8qAKqD2A9ajMX2ee1W4m3wSALIIjnqM4PvSva3UeozU4IBMptZTcbcCS4fO0n/AGfw708BvO+zW6ySxABmAx16mpjap9kDrGA38Pmfx+u0f41VElzaoIFBDZPzJwRn1NTLR3fUad1ZMndnR2iBZrckbog+ARjI3H61LdIJgVjUiNiGZyAMH0FUmjijutkshbdGGyrcEj271Z3vdozxKCB1Y9gP6U090JoTUI5bdJ/NglTeVG+QZJ7/AIfhVORTKROy7IgyqPMOQO+atWxjiEr/AC3EkiFEDEnyjnrj6U6/hS3jheX/AFwIMcSkEBfUnuT6UpK6GnYbc/aLiO1NxEIbUIXj2gZZM43H19qZGM3KJAfPLceYzfLz6DtURuvtDSHzfLLADy2J3bfQegq0lvcR20LKFSEgsNyYJ7H3IFO6k7oLNaMliAR3jfzruaNsIqNkbR6Ul/M8wEcYFvGqlmVDwvqaNMubuOWOHTTmffhJFHXIweTximxpAgnkuCZZAdpb+EH+tNK6siXvcrLbtJHiIBYFGNzYA/3vWle1EGJLWT7QiY3uFO4e+PfpUUf2guPLLgoD1PT0/GrsUJshP5sk6zo4V4gdqk9eT/QVC97oW249SOB7mRHjQs6E5wegUd81as90ciRxosrbyPMd/kHHp7VWu2jtSYBvJIUlAev5cdfWlnjlLRwSh41QHYmPmOe1NJxJLDSRhNg3S3DbkyDweeM+1UQrwbkdghkAO5Tu+XuParcsUUOm8TEXDPtfaBgD0Ddc+tV7eFbuKCB1MS7ss7D5sAHsOcU3vZiSEdkFv/o0qRumMKoJZz/ez2HtUizSkP58qIdv7xx16dDVS4cQKRDlc8q4PQf57UyJpjEJnty0SP8AMWBC5PqfU9am9nYtLS5auZs2rRxoqqB88z5DOD25pNJiRnS3mvPJgJO5hyGGOAAOSfei4tZrwq5kEdvjKgfMcd2561m38KQtEYy5CDl9+78cdvXFN3Tu0OKTVjQe5iM8cMb7hG/309B3/wDr1BcOXjVpXZmY/Kc8IM9f6c1PILaOQw2sRmM0a7T/ABM/94n0/wAKqzW6JH13SvwpDcLg88d6JXZUbD7nc1xasqrDAvKsQWUL65781Pbx/a5klkDyKDh3fAyO+0fT1rOjM8t1saSTyR8uB3A5+mKv/aWdI4LYiMuNmxWLZJPX2pRabdymrJISCRWjdbc7nIcgM2PLGR83ucVHqMAh0xZXmVpTJtkBB3nuDz2qvcyRR7Qrnzlw3HQeqn1NMjLX04kuWzE7khFblQPrTctOXqUlrchBJhEcZ3KXDCTB5OMYH51LdzRq0ghJ2xFS5brI2f6VLqRG4IjFysBTaoxjn2qMadGujfaprqJ23giAHk9Cx9+woUHdpFc2ibEvNWmv5pnkDuBb+W7f7IGBn0xWbLcTrbxNGPs1vICAVY5bsSfaq91fLidLdcJIfkx0UZ5Pv6Crpsmu9LhMMY8xQxJDZLKPQdeP1pq87pPUv3YW6I1rLWI5TbWYaGO2gyX2jAcL392PY+prMvW8xku7mN4zLLI6grgsAe59RwKpW+ms16kTfOzYChOvP90VRuY5IbxkklciN2QFiecH/GnOcuXVCjFc2h2cusS3muQ3MtrE0qwLBskPlxgZ43e3HToazEgU3bXl55DRytJgDKoxHYAfw54FZmm3ImhkSaV8ySAMg5JAB49zU81wZLsAKNiR7I93AQdRScuazeolDl0RYmuGn0+K1KbRBlmc8bsnj60lxMrSG3hWVztKABsjGMdKhtLf7RN5bzMdzZVB/wAtG/pSSymWPfHD9njiIjRkU8tnkk+uMVDbtdjsr2Jfs8RuIvMZY7eOMb1DfMeec+5q3B+/ga4IjitRL5cduODIfbPoOpPrTF02ZrIef5cRYho94w8gY469l781HcWs/wC5toWikCgu2z+E+jN68U1FrWxDaelyG9R1doW3m6ZtygHKhMZ496tR7owI4l3XrLkyv0jXHYevvTDI0m6OEozhV82YkbivoD2GeKZb282CsLsWcfMVPQE9DUuyd0F9NSaISwJFBG4l8w8qHwuD2OOauTPFbRfY7CRZWLAyybeMj0PpntVVlitoSABM4XLc8Kc9Gq9p96giEs6qoiZTEkcXygE/N9TVR/lbM5d7Bb2f+kQ+e4cO2TxxGuRkn86g8SBn1HyNyOVyqiMcBe2BT1dpJd+Vt4ZsruYn5FqqJVjmc2jMDgRgnln9x6USa5bEq97mjNFOliFlYW0UqqUQHLyDpwB/I1UtFeOad9qrJFtTDckH/GrcURhCzTz7pwvmkdQmei/7xrLj2tdTeY+xch2bHzGhslI0bh83Al8wMwBJ44J9BURSRY4zcNgyLuWJcE8+vpSm5TyI5WtVTb8qsM8t1y2f5U62hmuZZZlHyOpPXGR14PajroCJxcmSa4NpCE2RhVG/KgjuT3qlEkUJaZ5Tu3fJLjgt6/Sm6jIZZ0S0t/IiCKCB0OOpNOVYZSu55JZiQoiC4B9AKV22FtLiQn7XcqsFsp2rl3JJy396mzwpaSDzmWdmPYkc/UVfZZPLkWONUlJ27UGNo9P6VRvvKlnjjhVscM7sOQPQdqco8qu9wTu7ImM0nn/uooY2UZbYMqo6YGf5043EUSBI3YFDu45LHuaY8YaLEUkMca4wpfJb/E+oohjgjYyuXZ8/KhGBj1pNvoLRjrhXvZotqGK2diQDxz0LY7VOkSrdSfZ43uXAK7pFztAH9Kouii2N1KWEkrsnzPwMHoB16etdDaaeRa2knlTGNrYzvIhP7x848th2Xjp1Oatau3cluyMC/tDPcwwXEqKsaGQOpDJjGccd80VP4pFvDfw21naJBcLErTLkkRswztx2x1orKdr6q5cLyjdOxeheOMK0SeW8n3fRB756/WmWJKrJvuMRljyvNQ6NJLAV8lQ8kUpZfM6e3XqKdcGZZDLIwZyxyqcAflWid/eCyu0Tz3glvVa3VwRgKZ8c+5qSR1KlJY/M+bOE5Vvp/jVKb7PcWrmN2WQHhPUepPagzO1tELVdjouGcN1Hv6Uc29w5RiK87rE3ywo24gHbn2pQrzXFuUEe5iVCqOOfXPf3qKWVothkcEsNrxr1Yeua0praH7Kjh1iz8yrnBJ9jUqN7obdtR1nbJvlW4uJVWJThevPoPSi2kVQskcYAUkAN82SPrVMxSzXUa2zM7NgHBzuNaECQ+XKs8jq8JzLtUBUH4960j2SIZQuoDLIJ3XJByEU4yPSp7WXNrcy7YxFjaUP3h9KpyK7yxj7U0cLt/rSDyB649KfAd0TiRSI854HU+wqb63KtoOt5ImiUxxY3HLSN0HooqxNe+SYWgU7ydrPgfL9O1UrKRJbtjcCV4oRjYuRuP17GrKrNNuilMMaoPlDHBX6e/vQm2tAejLEmn21tEZPOfzg7CRxt24/2e5JNMkMzgTzybCo24zgnNU45wrtI8fnyD5QW6A+q+pqYzxSI8Yhdpy+4SbuNo7EetUnFiaYjxzRS7fMAK5JUHBA/wqSP7LZW7zMzNcMuAjDIU+o9eOKZcQZjZriTysttEYHzE+mPT3qRzHb21uWVYyzjaF6sB/Ec9PYVKVncLX0GW6zl1a9MdsqtjJU7hnnJ9cUpKyxE+ez5kJ3E/fP97NLdTTs4mvDJJ5mR5bthnI7n0FQxPtuFaLaxzmQyD5ASMYx6CjZWHvqPeaLYfvL33HkyMOx9BU2mW802QP3ZbpJM2EUdySefSqxRPLG1mJByzbeFHsKsWDtc3cWyF55ACiqG4L9m/Ckt9RPbQQmKMbJzvIYjcXxgDrx7nvRNI8rP5i+UrJkBhkgf0qS5hSGRzch3mY71c4ww5z9eao3ML3JG2bJY5dmOAD/nsKqSktBRsy2rwWtvFIIY5ZZAcK2flPqf6VDGmYHluZWLu+REB8rHuT/Snq1tGUiVzvIwzs2OPYUiXgS22W6B55RhnZeIx6KPX3p3T3BX6EV15tzC8pmRXDAtk4bAGAceg6VSBmkhEcbIlt5n3wAC7Hg9farcqQW0QW7YXMrJuREP3XPXdx29KqzRyyWkjeUxghUsrMwyp46+o/xqeW7NIlq3VLe5gtbaKYTsGUPJxuOO30FVy6sxG0sckKoPAHeo7uebVWga5LiAj92N+Dx3HoKbOfLyZIyoAGDEOB6UpO6uilHXUu3F4cg26KqImza2MKD/ADNU1kMBZlYKufmO3OPf9aFi823EzAKFwoVDlpD2xVm9hEMUPnjajJuVV5LemaPekmxppOxDZwxxxHbEJnlbLbjz5fUke5rOkt5V1IwQbyASo4yxXtwO9WY0xcHIlWKRdrKi7mK+3pVG4bbep5W+OANsVn4Izzk1L+FeprHcsXEr2ds6QeahGGbeNpLg8flWPe3AuNkUaOAB8zO2cE8kCtXUZWaGKAMG2oWZuo69R9awoWUSFgCSpxkj+lOo+V26Mumr6l7T7JHG5pQFI3YI54r1i9trDRtBstSuWVbn7J5EccY2lhzgsvc4PWvI5XkjJK5RWHbtUkl7LLG7XLSSHAC5c/LW9KqqaskY1qLqtNvQu2sq2F9/aEUhFyDujXP3c/zrJv5ftUpYjnJJPvTFY8Mx5x1JzxSPtUZXnPauepU5lY6IwSdyG2YQzM7SbG6cDJNbNpP5NrLIybhMBlD3XqMnt2rM02GK5uWFwrGBPmlZeDtHYe5q1GZZL0pb7dpUZVjtAX/aJqaeiTKnroTrfO9zu24lQ/KoXPJ9qsJhY2jM2XV95XPyq309aoWsywm4uMkkghG6hmFWbNZbfcJmJaUBhCCPmz3PpQvMzlbY2b6Q3drHIseyJ2+U/wAT4HI+g9aoTF4z5ZmjRVziNezY7j9M1BbNcz6l8hG8DC9gvenzIoXHmZupGJZz/dxnpWjlzq5ko8ug6ztSkIE6uWdseSo5ce/sK1nvEa0aCyTy1JWSVs8sAMY+mecVk2cR+3KolKRk481yRjj1q3DDPLaytBHlUBBlYY2qOpz70U20tETNJvVk948TxfZrO3/eunzMpznHeqhU21s0YdPNbqcncPb2oZkhwhLhmOWx0AIqZHnnt5ls4FaPqzqnzKM4BJ9T6UN8z138hbIRnlja3tlxG4wp8zgAHuT+tWUWGOGX7O5Z8GKRlGS3uPQfSs+/jMEASIbwGDPKTksx7H0+lW7JGt7YNcybIW6RJ95yPX2pLe3kTJXV0WrXEsA8iHO84Luc5YdhVTUrgJKoEa72zHtB5B9/1pzCWaeNLZGZwSo2nIyaXU0gtJpJZCklyoBYpyqsRjj+tU3eOmxC3J5J5bm1U3BykeFjgUYGf7x9aS3d288KSsLjBj65Aqnb3qyhY7vzDxhVQckf59avGSVIgywjyyDywwFHYfWiNm7g9NCDUnaARDy/LfOCufvDH8qlhYxkPEgd5UJdnGFj542H196JgZFQBRLcspLbwWKrjqPeqSI0g3RFtyjLbv5D/Ch3T0EtVqXpEVpJH+0oAg3siufXGAf4jWU0plcIochPlJzxgVcksW+zmUvGtonPmA53N6L6n1qu4QO5tAyHIKkjIHHLH61MrvfQqPkX5La3tI4wriV2UNLKOkRP8K+ue57URQLM0It/30rZBXOAvPHzUiW9vCLdZna4fGZEQc+wz3NaF0HKQqqCC1RjHGMgkngnJHWrUU7tmbdjPisjZ3LSu0E8m8p13DOep9s5rXkltPD0aiee9uLmVfMcwT7Yyc4wPXpWNpMiz6hKhkkjDuUEhUEL16itiO6WC3hgg8RW/lR5VC9luGe+CaLq3ukzXRnNXdxHd3yNZq9t5hPErB/Lz94kjrRU14VudUf/AE9J1kVUa5WHylAH+z7UVmrs1voX4ZJ55pVikOWADrgAY9qnikgMDhYDI5Oxfm6Ad6qzvJJIcxIkZAQv098+9WrAMkOYjEkBcK7n1x+eK0jKzsDWl7EdtHAWladiHKEqqc5PvSm6kiCEpH5arjYBw/ufU1PK0V26mJPnXjco5Yj+lVtRR4ZY2jeNXgYFsc5PaiUeVNoSd3ZkSR3V1HLO4XaMbyAAB2pxuRcAxTu4MI+QY+XP+NKZ5p3f7Q4jXJZgo6/U96fFClpH5koUyMN6jf8ANg+qmktdY/Mbfctee8aJJ8qxAcBMZYj1rMnucpKxGIpGB27slm96mgMmyZgwbYSw3DhM+nvUcItY41FxI0zNyAvygH3obbGlbcW0Ko/nwoJMgp5LEkIPX3q8JHkfzVBt1UcRx9Md8/WrAkg+wvBA0TRk7g23EgPpUUCyyxzMFgVX4O/quO49OnWrUeWyTIcr6tGdDdGPzd4aJHkJLJSQKjSN5plkRQSDnGT2JzSxkbdjKXbJ+Zucfh/Wo7y3EEkElzIyxsf3kYGdq+oHes3f7jRWuJIJJ0UAhkjIwsXP41M87GJVBTzMlRGBtYe+aVDcxxo9tvihwdgAGSvrVaO4QwySoQk2MRxH5mOeM+5/xoWnzE+xbtjNDh3VZY+m9/mAJ6/jU7QIrLvIm49cAD0zVaOWc2xLyGOFAAY1+91pTcxiJmjVTHtK7HyWzTVhO5LJ5Ek5lMjOAMnJJwfTPfFVv34dwrArKAAijA/KltRKUQA+SnJAx1PfA71dMUduuFbc7ruZh2Hf6Gko8y10Few5IM2CvdPCiRuVRV5klPofamC4MMgFlNIMkA/LtwfQH07VXkngWZ/mSXY3ILBg3pkCoPtE5YyRszZBVwRhFB9KptLQFFvUvX0gaNUkYlwdmw/wDsKcJHkRXhUIsY2gBBjpj8c9aghjRrRmWbz7lV8yTjCRKPr1NNnkUh2RnSNGztYYyT6Chv7Qkr6DkUpLH9mjDSkYBcBtzew9qrT+aIFigxJNLzIytk+u3Hbmp3kljMUsCtuj+7noMiqrQu1wuXRJydp2v1+ppFR7l5wqqYliaWd16qRuLdc47Cs5oZZHAwJAyklQ+OKlgBzNDtVQuNzZxtPuaqajKYXQFN0SsWDr1U+/tTk9NSoKzsiYRyhi0kkcGAFUE7voq1JGNrok7D+8N/TB71V01pJJnZWDSMpKnqBnqfrirNyY/L3RnIA2h2ySP8KSs1zFNWdmPvLe3tFAMzvdnEmYzgL6jA6Gq0qSeR9omZCjMQq7vTrTJ5UeFlh2xoMFiwyXP1qF5JJJElnG2JgdjMMKQOM4ocot6IqMWiwlysZkMxdYyuEZPvqO23296ypVnubSYiRRFE6s+W554XHc1PeJbGYlXMa7SxyCyk+i98VmrcF0H2iMlGY/MpAHoKlvozWK6oWz8ue+WC7uFhtsZZj2x2qrqO1L3fEVKSAEBTnH196kneO2lCyRqwUYIwSr+4PWqk0avaeYI5RIDwQw247df51L+Hl6mq3uWopTvDNjk9B09qYZEkZxuO/0bp71nLcSrvZ9oEZwNvehZ8r1K5496j2nRl8ly477W4bd6kiklPkxpIByxytRvDcLGjGKTDj5SV+9zjipFSWK/wDKnHlzpjCn5vLPUdO/+NS029QuktC4LcRQqzysI+G8vIDu309KW4uWmU/u0ijUYEajv7+tQ3O4yM0kqvNKdzY5IP8ASrJACIJATcFQELMMIPU1pq9EZ+Yph+yxLlgLtSTsONqD+prQ0vTwjNNqMskMbIXVYwC7+mPSqlq7wSPIiRySHgyOuQvPOKlgkdpvLESiaXJd2bhfpjpx2qko31RnK7WheZ49rvax+WzKQIi2cL06+p5NSyuzmK3vXgSXAYui5Yg8gs1VrF0Yqi7gDyMjqR29+KWCR0DMcYPzs3p6DJ/KruZNDomjQbVhzGjnc7NkE9sUXt1cOixzzuID84QH5ST7fhTRv2CS9h3QI+4RD5SSexPpS+d9oeLyIP8ATWBCkHIUZ44PTHrUtaW28h/iKsP2iSB5ysKOp27jjO319M1cguJm2wxlhCASEh7nHB96z4kiIJnLTTDJKKw6jrV6G4nfMcEflQ54IG0j1GR1oT5XciWoXzu4WSVY5CxBA6KMdCfU0ttbTX08bPcLI0pAJJ2gH0J/CoTbJeCJY1VCgJeRnwNvvTZzKXwgCwxDgxnIz0JB7mh92r/Mnpoa5uYrR2SCz2SxsVOGyBkY69zWNqUyxRbmBIycg8DOexqwtzCJY8xO6R8urN1OOgAqtcxyNAZL1SsIUMin/PSnKTktCYxs9SVLgP5ckiiGHHylVwxGKuLd3LW8M9y+yJWCRKeQ2OrEd8VmSeVczKIyZFUDYiA4z/dHtVxoUKrc3c0bAOyG3TlkUDgnHHXApRb2TKaWgWk7XerSL5xt45RgvjHHfAHQEcVcDoiriLeImOxHGA3+034VntPPdXMaqytcPgMEGNgOOM9MVcltfJeRQFcoWBCncFA4Jz3wauLfQiSKuoRSbIprsFFfiKEHnb3IHpUpmg+wCKKNxcSNuBAwoTptI/XNV7kOs6zW8zLE8eE3Ab2PQgenPeoICWdYEjaSUsHcjqPYn0qXK17DtdamlPcPbQRFVjhE7H98G+cjoeOqimQxTl42kcpF/wAs/MbBcZx8oqK3Uw3Z8i3a4nJ3KFU8fT1qK9vrqR7m5u8sxPz5UEjHQD0obW8hW6Ib5wU5TfBEGYbQcseevNQi4SRWChUCjO8/eJ7hRUlkvn2/+lOscMK9P4nzW7a6bA9rbuLN5IRam6lIOBK5OEjDDkc9e9TZt3G5KJVkiCWsMQhghjdRhjIGZs8ktjkE+lFS6hHY2d0TJFIszQq6xM/+pdsEj1OPf1oq3yvdkKVtkLJGvmSSBRJEq8Hng/SovNjWJRIIgFycMMsxq1aZSYvDhySQC68f4VSmjWVPMcFdrnOTkn8KJXWq3LiyzFdG4liaJXifoPJXO0ehH9adHaymKW5mVzAWK4jIJJ9MdRUTXxtkMdphVIwSvUr6H0NFpGJI4ZHfYTn5Oc49TTTTstwtYjZt1uPLQrGy+WWPAzTJGSDa8W5lAPzEZyaleH7REF812CsXMQGAnvVqKGAQrE+4xDcRITkqO+F7fWjluHMkJbNHcqo8wRkAM27kue3AqBI5kuZJgQQTyUAOAfrSF5kje3syXiX5tyLyw96dNbyqSWcRxlQ5jVgWxQ9RIniaGKXzG8w8Y2jqT2//AF1DKu8B7goi9Nq9WPamxSqpCRAOrNtMpzk+wqXUMSxbzCvmkbQAMAAd6N0GzKqBHk8sBmcKMA8c1pTeQtmBJGzTkYYueMegH9azdkaG3klnjBkyGZckj0zVl57ZpUCvJt3ANJP3HbjsBRF23Y5a2sZ4tLp7CQ+ZIIIDtJz0BPAq0ght5xPbRyGOMY3umecUl3cTSGSIOrwGQMdgIU46YpjLIruqGR0yFGwnYT6UkkvhH6kkAe6AjtsNJKQcgevUGleIWVv5syNINxEfzZB7EcdCKfPMLdIMSRQ7/wB8qD7yEepPqe1U4HuZJQY0icFtx8w8A+pptpeokm/Qjt5fImD3xl2PgpsOCB6Z/rWhJ5UUOHdIzJkbQxZwO2faob2Ib5hP5fnR/Kwi+6Cew/8ArU4W8ccsBkgERlIITeckdck+9JJobsyGSAeez3TZnblcoE49Se1KboyxlTBvPIxnCexPripLg+Y05QBJWbywG+YKp75PvUd15tvbhGMoYnDIR8oFLbYXRDY2ZYJg7LyADtyTj/CrcfkyRsQxaSMA+Y+T16Lj+tQC+CwmF1Qsfl8z7u0H1Pce1TzRxxbzCd8S8LIuRupxSautRPfUbKGuoXTJVIRuZugAHf3NUrlIPLDwRsAxxtYYIOePrxz7UtzBJIiPEswUkjLdfXmoBJ9mjPnK3muDjcOF7ZHvilJvW6LiuxLFE7RGSZ1BY7VQHGcdzVq6DSW8cYVYxGCHVlwce/1qtG/lhEkSF+Awwc7gegPpUlpJZxXBmlmMcwBbLp5i7vTHXp3pxtaw9blNLRnw9sREmNq/NjJ7/Qe9TLJcXlyYLdY1ZIyqqnyqQM569agk3STFyMRkgAKNu7P1/QVNFPDvmUwRo0RGEJJbHsf50kl1Ku1qNRIZV+zWgeS4JB3t90DuMdzmmyBWMBuWLQjKlVPLHv8ASkuYPKWI2LO8jEOx2kbW5+UeuPWmS3sZMhmmeS5I2sdgCgUr20Y0r7EbXCSpMhKRLgKNwyAo759az0h8m+kjswZwSQh24Zh64NT6hFceasbhPNGCNhGMegxRqkHlRQyTsVnXKsqrt28fzpOLlq+hrFpFiCK1vI5/PdpJnjBUMOsnfn+EAY61z7gRuFhfzWBKsevHoB3qw0kn2ZsgbcdSfzquR5hIVmGcBUXqT+FE6idkkXGNtSq1pMoDbSoZSy5I/WlhkNu2GVfM67uoPt9Kv2+nMWRtQl+zQOTl2Ut09B69qEt4RbmQRCXYcBGPzc9DUKDTT2Lc0Vpb9rifdkxrjCgE4T1x6U+3t570MbaNpEgXAcDao55LH1q0hsRE4vYFEqxny0gO0s/q5PYe1BuJbiGGC6meO3iUiGFBwP8A9frT6+87k3fRFuzitYstCWuZo42ad3wqq3RQg746+9V5OQXYHzHPQDr6k1HbSRW6nyiftCvnP8K/X1NXbFpp0SO3SNp2bLPjlevU9utPSXuoh6ajLi7nmSOOcKFVdkYIwAPXjpTRHcR2n7tfLtd2WmYYDE8Z9T9K0HskhlnJdbhkAGcZTPfn2qnqE8121vFNI0hQZEange3tTa5b3JTvsNt7po402gEo3EhPJ9gO1XdPjYMlzuGQ2VR8vgjoSPrTPscduXdPLuLoqCm1spH6hvU1XivJFWNQ+XGd6notK3L8Qvi2NTUVubmUwzeaCQC6nlmP9KzfOWJHAJDN+7x39/wrZs3lMS29lbvPNMG3S4yenIX2HrVB4EUiSZzKygElcYz1A+tVNaXREX0HI8yW8cRiRVQ5G2PDtx3brik3zTuqKGaQ9EjqyqXl7Zl2VxCJAm9iNxB7Ad6msybaKU2sR/drl2LgZHf/ACKXI9N7CciMG3t4V+1I0zKOI1+VRz39c0RXEpctwUIHXARfT/69S7Ulgh3xFCM9Tnef6ADtSCaWQxwxSJH5QKibAwFI/Wm9GQQW0aG5YxuXP3mcD88Cp7mKS6byTKHjIIVQc7c9OaasiybUCJDbY25A5IHcE+venxXEChY0Zix2gKBkD1b+QpxStZibd9DNt5zbWckar5bSKE4X0PPNOS186QLbErBx8545/HvUrCAtM0qsAGOxM52/U1ZtSs0QWNnkaT5RCoyVA7mp5U3ZlOVlcgt4JpmnSyiJWHEjHcASMYyT6e1WZDNb25W4UrM5A2g4bHXGOwqGDB1AmW4NvFjbgDJAB68dTUtxOjSTfY/N8hyMySEM5H+0fXNXG1r9SJXKSRA3Lyykoin/AFYb5unr61JZt9oQpt8lEDOzKcFvYnvQP9JDx2qIAieY7k4wB2pGmiWFVQ+aEx8rnAH/AAHvUxVmU9SSOZWti8Urx3W/BU5wFxyQf6VXuooooYMTIwdiSHOFGOce9PnMU1lMrqY5x86ZPT14rOigdirTDfcKf9V3UDnke9Db6CSTNYTyzD94IIbUOXVynL+w7kegrZZYU0iaOOS8knktPtqKkmI1G8AAKOp9TXMKXufMlupZJNuCyxjlV6degrptMu5NN0ezJ1TT7dLiMlIbm2aRo0LdMjsSPpTUr6smojM8Swpa6iJm3zySwpKqS/MyAjgOe596Km13Tr2Bp7+bUIb9sp56oCpCsPlOO69uKKltLfQundx93UnEVzdO8acow5wdoHpTYVbzSk0gAXIfyhkkf1qzaRPPK6yEopXHPcfTvVaeINdqlqjkICpYnlv8BV8ulyOazsMB3Wh8q1UIGwznufc1LbLG0WWfATjcDwPpVWRka5CXMu6NAWeOM5GfSpVjjt4oSIt0j/MRvGNuePoaFuN2asThgXmEEYZnx+8Ixgd6j+WOSTzJNxQYyxyMHpSmdVIMnJByVHQDPSoLmSS4u99whhgPIXH8P09KG0ldbiSYs1yyv5iSGOJo9hcd+OQKkbFzEqo4eONAHkPGP8aitonvLSaOOJRAPmd2IGBnt6VZjjtYbASqWaQt8zH7q+wxRytvyBtWBDth8uIRPEo+/njPr+FOuWS2gKxzZzjLqOfz9Kr29w9w8gcqsZPBKccDPSmIH1FW4Ve4RRgt+HYChPT3Rta6kd5AsvES42gMWU5DP61JEYYgftO9nIBUtxuHcVFbfPcABWYYKhF/i461ehjMtqkdzKr+UflRBx06565pJX16jb7lOQ70WVpsSHO2EDJx2AxU1hDcvOSBHFIq7gZDjb749aU3KWmDtVgeEwCAT2Of6VA7XNwjNIfMJJLsOPw4/lTaSfmCbaCTyfOkeaM3TIoWMk4QHvwOpqae6iMUUa2vmhosBXP3G7sMU1DKNJWAMvlndKYwO54zmobJoUQJFKiyucHf3X0z0GTRdp6Bp1JdPQjLR25mIGDuPT6etT3ALSFkWMBskAtnaBWZskSZxHL+6U/fU5APpmtOVSrJbwsHEkYZzkE5z+n0pRu1YT3uVng84KN8ezdtznoe2SagmV2JiidGK/eCkkgDuT6UPuLeSDkxgu3GB/8Arq3MbdIEjsmbdMq7x1BPfBHQe1Llvcd7EE1n5ESIkisThiWBOT1qVJpIAiTSiWR1LYHLAAH5T+NSPH5c0a3Lvbq3EhC7mx7DtVCR4LZWEQ/eZb5j1I9MetO3K77AnfRkySSiF3QP5sq5Jf7oB9zTBbpb27i7zIWQbEBwC3bJ68elSmZ7i0iuLqRmlbhCT91R2xUe2EPghZHAGDuwoz2x60Wvqg23IoTKp2RqJJx1+XP4Y9aZcT790s/lrMpXCxrjI+lMiacX0UKlw27C7G2nJ759+lL8tnM4uIo5JXGMk5A57H1qb6Gi3uTWcxkPmI6mTqXnHGfb1Pao9ii4LtKscmAX3Hk89KYis775xsgU4LZyR74qo8sU4WMJK84kBjA6kYO4nH0FNPuOxZnuVQYJ3sTjKZBT2psyQyQ+VZmWREG9nZcD/H8Kq6f+8LmUAyBSQpbGT/WppZXET71EZUYXaOC3bIpXutSnpsKztaJHFb+W5UB3aN927vj2+lLO3mMZerOCxVySFz2p1jaOtlcGSdYXZfmQj5n9APSqzXmVEssYkwNvmSPktj29AKq7Wr0Hu9CtNBGJ4hNGoU4IRX6/U9qtgSQK8Tx+VAeH8vBz6Dd6d6SFGnkaSG2QDkEHhVB7k1XSZrcNHOzyKFxGEbaufepjJLUrViNAXBS5uGiwplBbJLE9AP8AGnwXTLIrRLEsKcEHgn1bnqae9wbphFaxkltowcYyOM57Co1t24WFBNMTgYH8qLtP3Qv3HmKa4ke4uZI4oAxCyTDJJxxx3OKYEjjKSNAHctn958ibcccdfepxbXdzKk05WNzu8vziFAx1JH4U7yo5I9807XEmAEBOFUd8jrjHQVVvIluxQht5LxjEGEUSqXlkLbVIHerCXUrW4gtY3S2yCVwSGbHJJ/pU1xHPLambbFHBGNuCMMfp3NQG4vLn9388oxgr0GPpUaR9Sr82vQsphdPaZ5o4xKcNEh5A9PaokmlMarbIPLXOWCevqaimMRVTvaWX3XCIB/OrdvOZYwjOzBWGyEcbh6DH8zTVmyXpqTy28EW6W4miKooPkQNgtnsCepyMn61WlkllVbu1to7WNTt2r29yT1qyx+zoZ0aOWZF27SBtTIxxnqR61DaabLfXTW0IV9mcuWwqjuWJ9PSqaeyJVt2S2aEmKQT75pDt8pWO7HqD0FOh8mA5PlyPGzMwckqfpjr61XWdYrOWFJIw65U+WMlznrz2+lEFlOkEckkZEb58slgqtjvmltayDdM0p55Jbi1XDI4+ZYxwAoHb6+tJEIvtIkZWKsfuhCQuO3uarRXJZ2eR44zHtQFT17HFXJ7FpY0uX3Rwk7UVmAZzjJOPSmrvVGbVtGR7o7y9eUHyLYEndyTjv+dTCZrZkCgRxqAVYgblz3qpdTg3EUCb2RUEagLipiqCY/aJA2MKqscgY7HFJSfQTB7i4cyRC4xBnrwQ2B2qCK6MClYH2MygHaMlh6Z7VPdTTy4U4MaLiMYAAA78VWKxyNGZpvMkwd21cBVA4+tLXoNeZHZNGsky3LSOWI4U9fqfT2rUgvWW3MVti3Khi0nr7+x7VUDssSSrsiQtwAAGPbNMvXWaCNYYhCq4LsRyT+PWqvyLRk25h17LHut4okAGzGS2ee5+hqdbuVdPuIk8u3tJV+beAWPOePf0NZrSQRbSscj5UcucHP09KZNI0yu6/M5YKsYyfpj6UlKz8xuP3F+RY2t18oELGhEqBsc5689ajtg8hdreFvNRe/3VX1J70woba4RrtBPNje0WeF/3qnmulllCsRHGo3YHf/GjTdi12RGzLDLJuzJOFAdz2J/nis9pJJp0eJnWRSQ75ydverp3ssh2IkTnBZhyPoe1V55Ell/0NRGiDylCjJZu5P41MtV5DROsZji8u1lZg4G/AOCeoHPWur06ymns7WS50uO4nhUJBIl0IvkB/iB6gE8GuZtWNmGE0JDhdzAnOBnpWxalp4reVrHUmj+yPYyGKDcNucq698+orRLlRnUux2pSzpc3NvqlqsfnlIzLCxKxxJz5ajuR1OaKyvEN/MdShiaKdUhgSIG5TYSAOXKds0URktkk/UcYStdOxsM321mY5Vmyck9aruZ7VijhcFc5HPFEBmmVpZ5Yo1HUk8k+gApgDuyZj3ttLIpO3cvelur9QStoVoEd0aSKJgygBpD0wfb1q2kTfY5kjRG3naXbrj2FV4WcIXkkKDzMbM9OPSrG6JIdwR2bBywPQ/WmrPVjd7leGGQ2oyEGRwzPyafFC4RJ7l9wc5zjcSOnSnvF5NkrBgsrDdjrgY61XluHmEcUMMwIG0mTA59qWkdw1ZM0cM6Eu75Mg4J2gj1wKQRiLfvZfIVs4OSW/wABVe5uWju0WVRI/lgCQOMAd+nWrwkhkgeS4iVVwNixjlz6t7U002FmirEzzKzhQF3FvLRT0/3qSaLbdN5pDHI3BWwMY6A+tPctIBBC0inn73AUeuRUL2u2BMyfaCVyFDZ2k+vvUNXKQs14TcedDbbEGVROcYqxDKkLKZWJeReFX9ST2AqOOSS2jRLoyFC3yLjAHuBUtzaH7Al6LqB2ZziHd8y49R2zTSkwk1sStpiyWxmdtkY4VXIy7E/wiqt3JLZLFFHIh8wbyBkAEZGCD35p9tbzXZUuVjl3hWct3PQ49BT7mKB5Wis1e4cHbuYHdMfbHQU2rq6Vib2epFakwwxeYpkeRcIobO0Z6Goru3gt2fzihIP3IzuwTzg//WqSUtDtinjRSrHMWMFfr61YmZApaa3QwheQF5Hp/wDqp2vox3Kp1GdoxbTACJPmjijX5QT9O9NvpX5kZRbllxh+Dn8Khu5ZdzC2QAk8LGuFB7EGpbKya4lRr65IG0lmQbyg+nrS1b5b3HZLXYEgijst7XDyS7gEj2/eGPvE+ntU1nKsSulvuScjhAnQdc5rPs7dppHFvuMMXzNJ02jPBq7cEg+XGhb+++ck/U0l3aE7bXHwrLPL/pMh8hM7z1OD6e9VpPLNzO0IkncjEcbjc2D3Y9uKmWLyHV7uSSS1ZS6iDnc3pmoBeTQusdoDbscFs85yOv69Kq9lqC30FljiSSNrn9zGwyIY23FR9ajW/QHi2jePaVCvyfY5pZCYocLFGQXGZpBnODyPoamvLk3ZiiRUhXouECoM9z6ip9GMgubpowvyRvJgLwmOnoe+fWooxHLHJLdsyykZjj6+2T6e1SJE1q9yPNSdoTtMgOVwepWmgoB+42zSzAjAXPlL6+xod2/eKTVtCe4t2ZI5JFkROys2WYDvjsKqNGyxt5LrEyDLoWwSPRT1P0oSSMRkvK7SMcySHoFHT8aSSJ7xFa2tyMDG8nJbH1o0vccexSSVpGkjAXrwX4EY9a0NLuPsUzOhjmYZWN5F3IcdW5qj5gZsv5KyZzI0nKkjsPf2FNiEkjqsEccrSElEI+6fUjsKmLsXJX0J5mW4ys0zrubPC/M+ew9qSOe3XZEluBJkDzHO4AZ7Co/lB2yyK0i5G4/d46dKbaW8gnDEiNGxhm7D1FF23cLI0kazL7b4yNCnCpGepz1x0zWfsWcsuTCoY7t/8IzV6K3gnvJba0DSRoxYz9ML6kenfio5108AF1nlKkjerbV9uDWjV1rsKMrPQgju/KRrGB40hZsOSoVnH+92FWkhxMVhB8ps7WHHbmm2UuxGSG2tkQoQzSx7jj1BPemw+ZEpxJ5agqQWbBx/9elHZIG+w1obcQqby6YyKnyIi5CexNPjAhka4to441UBkV+Wc5xn3+lVihimIlBVw33HG4n0yKmZIVEfnPMZm5VSAFGeppJ+QDpIZbuaXa22PcWDZPIH9Kp3BaOMBBhPvAg/e/xqyiSCOeS3EqRs2yWR22qM84A9MCrXk2kUYgQFp+He4Y4xjnYo6fjQ4cwKTRRs4ppbR0iwIyQ00rcBR2HP8qs2ZihZoo1R5H5LHqMA8Ukim7cJPKY3XHyqvMhJ6DHeqajyjMUjbaPkYMcAY/rSdo20BvmNG9QXIWGGRD5eA7jhCPY98Gktl8wm3VEYRZIxJw57n3zVKEXN9E08cYS2jHlLtGAT1/E8VJavHILiOMrHEFyZpV+cY5wp7E9Kd9bhayLtzNE9uIII1QkgSE9yOevaqDSs6BHbflsqgGec9Khe4Mj+UgDKi4OPfufertpC9ujNb7ZplX5iFJCDHUHpUuTlsFlFFi0t0gCys0T3AJUxMDhRxyPXvUkskl7PJKbgBT8pbGAo7CqsYl8t2upXACDy0IyWHX8qGka5FvFBB+8XJZlz07Z7cc1XSxm1djppwskcSlQUyrXGS28VP9nDgSglLbO1Nwwz/QUyMW9tDOjBZrgsAkm/Cj1wvemPDKHMksi7o1GCvRc96jdDv2LZnXeqRoE3YG1jkjH+NU2uAJ5SkMeXGwnB2r6ketPtYXeM3sqOIt5UyZ/1hI7ClWS2NmYyQpCjAC9DnoT3/Cq13ZOi2IZ7jNqyRhctgZx8wx6egot1SaFrm8lPnBgvl5yz88n2p8TJ9rLRQ+Yqr8sQzh8d2PYZ5pLi2Zbpv7QxExA3LGuSW/hzQk3qwbSViOSFrtppyI47VfvMeoHQADuaZJcpD5cdqSIwuW6bi2Mdew9qmuG8lo5Gi8xiMLH0C1VE3luVeNPkJO3tz6nqaG0hrXUt2f2iCFpXVQsmGDyHnr271YuJIre9draY3IADLLIuCW7gDsOtUnid4RMQYrcfLmQ53f7o6mmteR2pEFogYDO+Q9XBHT2FClYTjfUtxXUtuzSSXCxooZxGAGHI9D3qppdysc8cojZXHOF+Yk+tLG7zWsUVyxjtN5Y4HzEdwCaVJnkj8i2jRI3kB3HrjoAT6U7tNPsKyL18jrdtLcxlNwDbRLuYHGfm98DpV7ULmF7LSjeavNYTNaj9zGjyZTcdrEjox7/Ss06azz2ttYXEMtyQWbDYWNv9p24rdW3vba1toRbaNfeQmBLPKmSxyTzu/wD11Uupm7KxzV9awi8aSS8luo2Tep8shm/2SCcgUVJrcbfa9rQQw3xUZhs23RY7HIJ5NFZtW6GsdUaSXD3NwpZGbdwIl421YuLZ5Nx3RxyRjKgtkt7DFUJ2G4ZTah6NkgilhRVjcRNuz/EeAPXJq4vXXUTXbQSRTDbxzxFH875lZWyV+o7U9pFSJpZ5CXlKqdvUA9ce9ZtvOVTy1wWOcE9OTxipmuJpJ1jmUyHO8jBH8qm6voOztqaFzLbusKA+W4GxlZ9xc9jjt2qEyXEcnk7DHIQQd642/XNVZRCrIyRYYAjg4AP8zVq2E90ux49zYy7sThR607tu3ULWQ+5hjgsjJJsaZvlUoQMD1xUEUZfAaWVYEwf3mACT6VoWWntcQNhcoFJ8w88Cq93LBJcI0pdigGUk7+3HSqcbLmehKl0Q5XVYhvZdpHCoQWb696ne3cwK8eV5BVcY49az5JTHerO0AjXPKKM/rVxr6RRtuBvVjgJ6L6ChOOqYNPdDAPs8zPPJvULg4PzMT29vrVm3xLGXWMRpnbHu5Zz2H0qnJbykea6na4yM9B6ZNRGW5mjJjXgcfIu7n0zQnZ7A1fqWlnjlsI4TEPtgJVpQ23bz39akhaK3Qwyi4EwYOCjgbsds9RxVSIbUKRRh2f7zMc4IPWrbqZnQFCZTwzNxuPt6YFNNvXqJq2hBd3FtNIkjxOCTwpcscZ7tUjXcTSC0EMSKxbMiksX4yBk+lQtDvYmBGWIkgSkccd6cltFB5BhkBYgn58g5yeR6UXkC5QjhkuAv2hzHblSVJ5Y44xn61Qe1muLyOC1zgjaCTtB9ea0Fk+8JYxJu/iFVdQnmkaERSLJ8uF2nAUe5qZWsVG9yWJUhjlD3kceBho41LbwOxPTFWNOuIWUC4CQ2zHHmKvYd+e5rLLfZCGQx3BJwOOh9cVP5CmNprhgCuGSIn7/vRGT6CaXUfqcqyOXgdktnIJAHQ9OnrimWsyW6EpxA3K+bg8dAT/hSEG6hBRxt2klH+VVx3zTBHHbqshdjMpyBs4470O9+ZDilaxc+z/6NLLPKIkVQqRbTkn+gqgJ5RGyeSjITyAO317Gp7ed76MxhZJ5i/mMck59cCpXluFt2KSLGFbcYtv32HcHv9KNGroNnYT93JC8OVSBMN5SnLMcY61CX+z25SMqrPncp4B/HvUcKecP3cZEzHO/OFHrTb5EhkUSTF3Pyhk5H1+lCbauPRaCCNorJWuw7YcskITAYe7f0qCQxzuz3LiJFxtRc4Gf4fanWwk+2iEiSSQNgfN/F259Ke1q0c7PdMsrsxAUMMbs96la7Ipuz1KlxDIRujRY4l6FeVA9R6mnwzQ29lMx8vJI2k/fOOPwHer93dKZVcnzbheiqAFQf3QOhrNvzbyhXuIkhZRjEY5c+p7cU2kveQ029GJBKkA3+QHUtlZDzuPpipB592N8rhgeGL9FHoKI47KdlSN7iKFRuaaXDDOOgA9TViVYvJ2IkgH8B3Zz68dBQotobaTsRrJ9mU/Z/lEybVVud69M/WktoWkdxcLtgVtzYHPTpntmnQPHb7mhERcnaHfrn0FMk1C4kacTOXZyMjPGRx24xijRJX+4Ltlm4dDaAxzoIXOfJIyyN9feqEztYo2FHm4ypb5v/AK1Au8MoUiWZhtRjyI/p7+9JPLGjPvkWaQjAUchW6Z96HJPW9gStoP06E3KtPPKqIPmZ3blsnnHv/hVuQR2twMKxRzuhlk+9tz1I6c1nQzoY1aZUx90IvBJ/vH2pYLmXEkrYCOPLRn52qOCR+NOLXQUr7lzzbQsyXRlmJDBRHgkvnj8Khs7ZRIBcYCR5/d5w5Ge/51KZLeyUfZmE0gY7rlT8p44AH86qIr3Mu1IzJIx3sR3HuewApS/EF5Fy+fy/IdZDEki8MDl1UHABxVKGBWw16X8jJO3OGc9jz0qecRQmPzJt/U7QflUemafPMlxAjPHPA4XO+R93mEf3Rihq7bY1otBixzMw3I6onyqi8gfh71XCRxJJHdShSh4UDLE49elaDagkkBFtGYgSAXJyz+/tisy3LNfAxwLO7nA3n5VP95qJW05dRpvW5PIyRRALGI3cAnJ3ECraCYW5jgVwjHY0ueHHpiq0bWlq8hdvtMw3DI4QNjGR6irNpd3U9x8oWSTYVGMbQMZJz26Ula+5LvuXU8r55Zg9wQMJ5jYGQKorcyyNLbjchbGQBjI6/XpU6yiMHyzuEhBJxnn2qvaN5sjNbW8k90QSW/unPX6Y45qm27IzRNbSw73CwmdzjbtzkY9Kv3CKbbzrlAiSEuqLxjnHPr/SsqS7e32jzSHP3lQbQvOalknKRMykMh4VnOSP8TSUrKzG4tu4kstw0IUho4yMKZOirkdPelmW08iMtNNNOrkFBHhFH+93NM1AxzKuyR2AUFnfgr7Y6fSolDqNsWTBuyC4x+dL8QRK07MzRRtFbxIhyV4LD0PrUNlJLO53qsobMac4DY4BBqZ/sVtZtKx+1TMSAp+VQegPrVSV7iSNGLYXcAq4xyOMD8KT06jWpYjdbTcbxi8rKAGUZJHqP8aaJolGY1VZic5kG7H096j88l0j8lQIcEl/mHsT+dO+2x2c2+2AZgNrSFcEH1UUOS+QknsXChuLrf5btGwGHl4JzwTgU6aKxt1kjtvMndAS80gAA9lHXOe9R2jSygmIsd/AZ+AvPYnr1zVa6aGLz7e1Ls5OwOOhGeSR2/CtG7K5LV3Yrz3Mkt2vncwKvyqGJH61bt1Z0x5nkW7Z+V8HP0A5qoqpBOpDxyEZDMQTt9wO9MjmZphJCgdgcD/HNZJ66lvsjWNkL26hs7DLs8fGfk3kDOMH8qrxeGtYMp8zSrkxjkAIM1Vjkjiknnm/eTL0ibJzn3rpIPsMsA+1W11dX0un/wBoHy7gxq4BxsQDpgDrVNKWr3IbcCjdWd5F5tobX+z4rZPPk3YDbeikn156UVBr6W0V1Gtqrw20kEcyRZLMykZy5PVs9h0opy5W9QSbV7m5dx3D42IszrkZxlQKyHzP+7aB2GSxJ5/QcYrTbEltukIRCdw25Ksf5Cs1ZJpJGjhZ8bdvAxx705vXQIDLNJLjVoxO4DBSA0h2hcdP0rTijVHdvtBBkyjBBjcv1rLlMlvMq3DkyDGA44U1o3dxO8KhlVYgedifeP170Qsr6DndsiEtpZtIkcDyXL/xucBPoPWmyTJHlV86JyMOJMMDTPtMUCNEkXnTO4YP/F9PanXaNLL9svGE8wxlM9F6Acd6G3ayHbXULW6uVkYRfdYcrngCtH7L/q5dyNK56qOBj1qjF9qaOS4hzHbcqW6A/hU0Tw3MW4ByE5kJG1B6fU04eZMr9C5cwyWklxbSILjcg3Or7gjeuaoyjyhHEqMzE7mJOCM+1SeZLNA8NvLJJuJBiQcnHfPcVVt3kiffcSrHgYyBksPanJ+WgRRYmknjLxW7lUddp38ZTuKqMZ02m2l8uIDcVDfdPTH5VcM9vtO3zBHI3ytJjLeucVHLbyxQ/aoJPLnD4WNl6+4qWr7An3EX9zApkuYgvVRGdxH4VMkQRiJ23yEb1DHIH196qzRLbp5kqsJ/4gE4yegFMjMkiCJgFct94nrRs9gtfqWL+eW4EbSyhUB4P3Qfw9KUyLKCbkoiMAoTuQPT2qtLNbW0sbpvlYj9+CNqjtgCi3lRd4/eB24GRkD8e1C+ILaEVtJPHM0cZZSM7YwO2D19OKdHcoymG2hTa0eAzDJz3I9OaPKeKdmnWRxyWXdtJ+uecUoS5uGaa3gSNA4KopAUe3PNSk1sU7MsWUVxb7Dtg+Q4UzEbVx7d6huWdSZ/MSRpMgKR8owemO1TRosmHEheZjluen41FcbFDFYy4B3PIT8oI7Vaso+RN7spbJLtIohEm9CXdnYAf/qqypKQr9qmMyPnckeAeOnXoKrwTT3Nw7LOpyvVgAMemKk3xPIfs8eSfvFxxn29BUablPsW4mVHL2rNGQoHPyjpzTp5IbRQWT7TuXIJJXae5AqvZyJNcJGYXcE7WweWI9PSpPKjRlmukf7NuOAnVsds1au1dE2VyNrhrpHJco2NyxBeGb0wOgqvOHkh2yDbGuA23kt+PatSGd4llktjFGhRtwJAbHoM1mrujn8yaMklSFRh04xu/ClJL1CLJ3kSTT4lis3jwSpbPLn1J9ahvgyFYYrYLI+1i+07voM0sTfZbiUXPmeYygqqsDuJ6ZPYeuKL12j81hMHDqD87Zb12/hTburgtGN1EG0u45YcrPzllTCKcdAD7daoGM3EKMxX5TtZi2N/pgenvUlyqXNsXyypGAcHjkmqMO4O3O4J8u/tWc5a6bGsNvMtqrRQb0lh2c7oy5G7HbHvVqK4m+zfOI0T7ilh0z3A65qGQwQFDaMZrg8Mzrjb7r60uLiWGPzVjRdpImccgDvVRWugm77laU28Y+fzZcnhUI/P86tJdMII02xxqv3VC4I/x/GqaMIZVWIb8Y+8PmPtirzG4KgSqVjzjy24J9s0o/cDGxu15eDykSWTIVA2FUf73b86bc3SMxafbM44yiBUU+gx1pLsxpayxOHSQnG2M5VvrTLZYo22W8UU7HBLy5AUY5PoKu7va4fIfcSlEQxwxfOpUFVzz6sarvaTyxyyyR4jQfO5OPpx6UXM1wFjYzcMCsYTpt/+vSR2oMQlmlFspVuOSWOPT9Kl6uxS0GxLCdgabzFwB+74UH0561a+0EOEhjVEJAVI+CT7+tU4GVtqRwuzAYGw4UHFW4Xht1UttdnXLAHlcnsaS7Ax8ltOk/mND57xcuAMhT74/nUV2jzztcXMiou7aOdxGeoUdgKuS3MlrGkUbB/OUqRCchx6e9Unt4kOLzl1j+RV6g/7R/pVSitkSmxALdlXyBIwjBLPLgLgngKP8ahia4liK27lVVmAAO3r1+vpSh5W+6d7jAUEcEdh6cUSDyLxo3YE4AJTkZ7/AFqZalXJ1kNxch4oY3aJdxG0CMKO+O9WlaZ1l8rDR9XKDCj6+gqpIIWBNsZNzKB84z5jHqAB0FSl7iGNWvEYxlSsag7Vz2YjuRQhMkvYPKQrK5xuBAi5JX1z2FR/a44GeK1Ro0fjqfy+lU0kd5CZWJd2B3Y6mrbzMHKyIZ5wcbgMgfQUr32FZomTbFI0lwodwpyrnhfTPr9KVltroGSZ1iQfMMk/Lj+BB71FYRxXAxIhkuiSRHnAGOxPrUV7IWZCIERweSI8Zqtlf8Cd2TC4tFt5IooSZnxsMp+VOetWrl0VRuImkfgHdwDnrjtWawD7zOGLNkkIOQO30pYZzHdLIirtxxFjcOn60KVlqFguZEd/KlTbKpyWwAq46dOtC2xmb5JCw4BdupJ7AVEsYYK5wZZH6noD6flSsrSXTAzSSSlfk2gfe7Z9Kl6j2JrkKyShAIokIQjqW75J780k0I/di6YptXhCPmYHoal022KyFGf7Q6NkoDwT7H696l1GGMu8TsiTq58xi+7AxwMjrzxxVKN1zCu1oiG+umdpIBIFiyojAUZwPb19/anWz2iyEbbl4iBnYwDMwqqLZZ1eWzWV/KXdJK5AVQOw96tw+RbJFITtIAO9WBZj6AelKN73YPayEW2tzBKLnchT51jU5d/bNKs22zZIEijDth9vO0DpipmZbizuFmaCCFpEcKOXHPUD1I61TgkkEkj2KCKKI58wjJ9O/Gar4bWJ+K6Kk37yUKHPLBfMPAHPU1vQLd6dbaZFaXlxNOVa5xGq7YYGODtLdc4JI6VmxI1xcrZNNBbxysd0ki7icDILY9eldJYSwNokcTalpM6QA7lu7Z38gE8jI7Z7UoR6inLuYfiMSS6oN900yzxxyxSuuw+Ww4yBwuOmBxRTdauLa41Gdjf/AG+M7N80SBBjGNoBxjHQDpRUSUXvYqOyNaAq1rHEAeCchfmLH2FQF41LeVMLeYcFWOfwrUndY4y4ijijIwu0ncPx71mfYopLoKDtJGfnON3NauLirISaepXchmAKF2P3g53bvoKZcQy3KovlpHJECzFpDkjtxVm73W22O0CCQ4LSK25ifQehqsIi9zG8ykIcqyoed2OPrzU2sVe+oW90DHskhCnbhm/i/E1cgjMs8bCPfgBVjk+XI9c0lpKdPlaaZFDr03YYE+hFRXN1c3159pmBxINgCjg+3sKei33B3ZdeOWS5ZJVMyhsmOJgBx2B/Cqk3mznjYluDlVRskfX3pLh5YbhrUnDgAFFOAD9aqSRzH5rdNqKMZA5aiUruyQRXUmuJrpN6QSLHGw58thkg+pFWIoy9qq3lx5oQhUQHge/qB7VAIp44tsarFgh9rY3MferFxFGjyOxDMeSkfAB9DSUetgbRSkBNwEtpvkHByPu/jV61nkg8+PBacrt8zO/A+vaqJYcbYl7HG3oals5rp5Ve3kKsmPlAwAew96SdmN6o0ZGeK3CRBjKfvNIeR/uj+tQRyQIClwgeX7oIJyCe4xQbx/tC78iRvlfeME/4CmSCKGN5Swd5BhQp+6c1TbJtoRvAse3eVkLc7QeM+9SLaXUyEvgQA7d/VTx7dxUqC1EURVXWKU/Mx7H2pJ4VlgYWe+Rc42b8Ej1HvTUUJyZmupknYGU3ADgKSMu+fQVYlWWOPzbiMg8Iyg4bP9Kgk1G4smMSRi1wcFz1Ue9OQGRnfcRG4++RkN71GiXmUSSTwuwMYWIKudu0kZq5YQf6LKk8gjgbEhQt29KpGSJFAgV3Y8bzjJz7VLcQmzvWZJfLJXCo5BOMd+1UnbV6ieuiB5bVon+RVyxwoXLccBV+opqW+692XaeQSodYUAyQegyaa00lnK5tWjkllBDhQNyDHPtio2hhULNdTLvUgeSGJZhjrmhu4LTQnmv90ka2cC26wKVBycn3J7k1BC0Tyqzs8pDbmizgMO+D2q9bpPdRxxJsjRtzYTgt/s5qtFLH86rZJsVfukkfUk9c0O/xMSfQAqRSb7lWlIHyIjDAx0yaJpp3CCIAEnJVTkn6nvUVnLGitIocP8wCAZwD71o29urYkhnToWd9v3QKSV1ZMG+V3Mu8tikMUq+Y1w7Mj5GAfYGicS2M0Tyw7mHygjD8kcZHSnXljNIPPyscIYZweCfbPU1DcyGG2C26iPIznHzMfb2ofujWpJFC5uzHebyn3njhxnI6CpIgZbbykt2DM2FIxtPsR+dZEAJZ5XbawwBHk5NbdrdXBVRBDhkXaWPCA9QacH5BJW1FYxWyl7ceXLtxuYA4HQ9elZssJUNILlcMON38X4elXZ0WQuZS0jHDYQcknr+FUntHx5l06W0RO3c2WYD2HWnJX2QRa3YW5Zm3QBU2DDybsk++49M0shm3H7RHiHGQWyAP9r3ptqYox5aBQjcb3GSKXy55HMk824hvlExJyPeo1sVfUj+QfNKGJPIbp+npUE6/aLkR2/zp/CgHU+lWSsPliWeV3dzgIOM+1TwywiRWEMUbDB2Bjgeg+vvSstmyr21K8lqLdI3Eu27ByQRnb6DFPRI3K/bpJH5+YL0I+v8ASpUlWS5yEUOxOGxgH8P61LcTx3VxFD5JKI3ATALcevTrVrlexDbK07oUEcc0MUQ+ZYwCOvbPrioLS1ZpcSMkMTqSHkOBj29asoY7K7DNFFPIhOFf5kB9cjrVZri5lmZ3XziOCHGVx9O1Q7Nq+5SvbQsSTx2Sf6HcbZMFCNpbcD/KqyeQFMUju7E7yB0P1NROqDc275YyAR7n0qW3tQf3k0ckcLD5Wx1PYE0nJt6ArI0ZhJPZo1uiqhO1o4x8uP5ms2TJnKOFfDDIjOOAOmfSpri5d43DMEjUbSE4HHAx602OBhCqW0ZYdWlY5BP19ParfvK6JTsWBKluPMt9pkJ4bH3T7U6G3nkgeY5CqDl25APU0ontIHt32RXMy4LKI8IMdvVs+tS3mqH90k5wrAHZHwCB6++KfurdhdlB5I1Ql4mkkODuJ49+O9T/ANoXMkQjhkSCIHczIoGD04PUU97iGQgLbJDAysFfHzP+dZ7tBvUSB8A/Mo4A9MVDfLsxrUluGltWjcnZGx4YcFj6mp0kaX95JKpYsRsJ5H+1ioJYBKA8waOFgdiM2Tiltbh4ljdNluoOxpAMkjvj3pJ9wexOFn84MgUbB95+Nw+hqpuhETLBI7T4KsQOo56enFWby4LxJv3eQ5yjPgswHc1WhtpZZZfsiP5KpveQDjHvTb/lFr1JpIkCvEnJ2qxL/dWq1w4aVIhCI2Ubfl4JanOz7RDGisepcHOabGWiUsEk8/d/rD0HsKHe9rDLr2H2azW4kbCsxRUz83Tvj8qjS3j+z3Ut85iSNfliVcMxPT6Vctjc/at1zbbEVAN8nGwf3vrVS5s3mWWaTUIHkJMjRsSZG/TrVuK3ivvJv0ZDFI9wqxxBhESD5CtwSBjP/wBeppmSBsRxoJD8ucZ2/nRppW2gkCSylWUCRowMn0GeoFaCiJoXb7MioePOZi5V1HK596UYuS3BuxlXNox8iQsIYwMhd3znHt2BzwTUdxOsrKqQNEmcKiEk/Q+tNnMcwkWGJhKwA3hzxg96msZXtRILNd0jKUeR0DBef4c9PrUu3TYNUDQPalg+4SOpUxqeUHoa6m0m1eTStIi0GGCe1WILM6wRuyybjlXB6ADGCfzrm4oWSB45JYPNmYcn5nwPftzWveRW3h/T7FodOt76S6i8ySecM6sckFF2kAYx9eaq1tehEnfTqaHiFhcx6mBFZzyW/kxxPbouBOR+8jUj74A5PoaK5zxNB9g1iFreJrGOW3STyyT+6ZlyUB/yeaKakuug6aaWhtXM8QkiVyzMP4jjCj2qndpLc3jvctsjUBQcZA9qrsSbeYmMKBjGT0qWP/RbZQsrzMfvEHCZPWi7a12LUbbEAKmME7ww4xnrT76fdbR+QDGiMCcdWPfJqSTyTGrqCs44Kbcg+lJKJ1sxLIAsedoLDqfYVKTsO6CzPAa5IkQkkKG5HuafDLIGk8gF1I+63I/GoJJw5cTKJHIyrKoFXLO53J5ax/OF5IPb6UJp2RLdtSskcSsJJ5FLE5K/TtSXN5KqMG3KhIKr0x71PNDiJ1VPMfcGJxgAUkk0bW2bjzJmA+RFX5V9OafK9loO5G0Rumi8r91Gfl8w9CafBsinuI1kOxlOCcc49TVja7LAzkygpkRBSPL+n+NZ1yz290VjRAZRj5uce9DaWoK70JbplukDQgRRIwUrv4J9R7VcRp/LEZjaNSQQoGdxHQ5rMTz54ZBtARR87dAasxv9jdEuJGmLhRGxfJUemKE0/eYmmtEWJVmlmDXGyMythml6Y9qrBrVGk3M0gXgdlz/9eo3mkuHBjO4DqWOf/wBVV7oQoVYq+4tzjoB649alvshpdywJxLCIzG6IrFt245I7gCnxXaCFo44lWZWBDnJIHXilMVzOsARFVAuFDcYH972qszWx3ZZzs+UBO/vzRZr3h2uXLi8hSFjHGpuGIIeRdxbjnA9KoW7yYYNIVzy6ZzuPvV8TJDCHWGPewwrt8zt+HQCqkguLuUfJHGsWA2F5J9T61TvpZiRoxzRGyRHKwxPKAUT5mPqfpWfeoJPNcKRCkhUuec/jSTvBDLsjPmOmfnIIU+4/HtUcZdo1ZWdIM/xnlj3OPTNEnpysSVtSzaGOPKQScup5A5Pt9abJ5ULYWHdLjGZDuIpu9jFNHHD8qHe0qnkVBapI7Ex5U4JZj0xU3eyHy31NO5uJItyoNqAbsI3t1zUbytIUW5CwpsDCVhzjHp3zUEwt7cbIMvLt+d2Hyg+3r+NSSqLxJJLi5VZFUfLjlz7duPSrV9V/wxKQ2SeOO0aO3KsZOXI+8AO1OtpIg6/acgkEKi8DPYn+dVjJFcPGIYzboF2nAJMjevtTreN1m3u+AG+ZB1+tSrtpoq26ZPqEsd0xkijOQwCwgk7R3wf1qGcrF5cyRB1YnYgcnb9addtIsEk9mrwQOdpU8lvx9KpwXLxkRxI0m1t8Qfkbu+RTk9dRLa6FM0jGWIwmFFAJfbgue2T2q1DJNJDsuFZ0Rf3SAcc9z61VSNo0imlleedlIkDKcIf4R7mnRz3dw/3mwcjLHG31xQ209Q0a0J7pnuSiqdkyJjCjaSB3NVma7wBJGwEnG9h94d8ZpjXTRzXQU+aQyhZWJLADsPSrl5OttKn2e5aV3TL/AC8Jnkque3vSeu41dEEchQjAErj5jgcLVu6vpZxiRkKbMj/Gls4LhU8+TbFF0BkGd30Heq9w9urx/ZVDOTyzgYz6gdhVJOPWwr3YzyA+JPkiXb1k+np60QGztZWypfC8NICM++KiLG4u2ZzJMM4Yjkkj0qw9rcXe791hF43OMEY7ewqVf7I2+7KoVrx3mkJVQMqAevoB7VPcyk2qpKIkwTtwAxOBjBqdoojcp/aV0PLRMfuAGyB0AqSKe3gYtbRhQVJUFAxH+NVGPdicr7GckLyrG6bkjYHliBjHpT7cujCK1kZvmzleB+JqCL54gkJ3SSHLbgfkH16VeiCxWpTd5m8BsAfL9T9KlWb0Hd2FSzXyrtmUTXXykPuComevHc01ZHR5jNCJk27dzudoP4dcelR3gjvLo+QwSMgDkbVJx1FMkVRI0Yc787UiUE5Pr7fWm/IS8y9azRrHiVhCmCwITOSBxxWdbfaNswlufIjwWwT9/wCgohdIXDOVkm5C7uQMj0phSSVt5wsZP329RxwOuKm97XHaz0L0TLHaSywQKFH3jIdxwRVXC+XG06KAMjAB3MSOp7Ul5KI5UFtsdnX51xtVT7A9frV2WQz24EIyq8ySspUNx09+lV8V12EUJJGMsbIjSLHgqh5yKvxRW8GWjkSWZvnLAfKjeg9fSqxufssDLC8qvNlZOBgr7Hr+VMsvJjxI8G9I2wQ7nP4qKUWluDHzIskgOXYKBuXO76gVXuIZnvXgTmPAdFbgAVrGdDYZtZEM+4l1U42gnisq4ZVk8xZWCofmDfebPBolFaAmSxC0GCz7juALKNqj1wOpq/fSNdQkxMFjjUJ5aNgFfcVRiaYOzP5cUJUxKJEyQvoB6+9NjntbZmXDScfLk9T6H2p81t9EG4++kuZTFbxBXVeQkQ4J9TinPYtZyzf2oJQUAYxow5JHGTUSTySpHbW8KFVJYuOOvUbu46cVWmjEM0kT53rw+TwuOoqXZa7j1ejHW0c14WjifbGCN29sKB6k011ZYSVKsT8g2n52JPQCrUVtJcQB22wW2domc4HHbHc81LETaQr5BiDkb/NI+Y9Rgen86FBbsTl2KkkE1qU89GQkfKhO3K9KsSzz3KwwNm2gQZUMMAD1HqT61HezyRybmhaMOgGJBnI+poaC5MiC6fyuF2+a3zkHkYHYYot0Vx9NSOaeKOJ4bWKQ8g/PjJ9KkmtJbWNBfO0aOzfJGQzA47rn6VH5jtI/2dBIXBAY5LfX6+9WJLOKBW3Mk84fDKG3YGMjB700uZXFe2hWhjl2YhVfMxuMmeEHfk1c03WbrTozDa6nPCrvldrAxkdzg8g1Gmr3EM0EwkjzDlkj8kFQx6jB4P1rRuPF18ZSytYrF28u0jJJx06UJx6Ckm+hT8SJHHd2pkee4D20dwS8hcyMwySD6UVWutXudZut06q82wRoYlCDA6AgUUkubWI0mkaEfnSy+U0bTjbhcDLZ+tWLaGe2crIIU9Vb5qjRp7mdfNlER2nLA7RgfzpbeeeMrlQ0Qbhn4J989qas7Njd9i2kRVWaF1WR/l3y8CoJop7hP36kwIQiANwSfSrV1ciVVY3EbAfwuQAAO1ZMsiPLm5MgGfug5H1+laSsiY3ZK8dwJmURr5kZHzAA7QO3FSLPbjy1i3CVeXlfgMe+BVSKQsPJik4Yn5gcVfjMMFtAJYlYqWPIyzntnPas0/kW/MmOqxszRxZKemOT7k0ty10I4hLMY4nBcA42/wD66pTyoUf5YFYLjKjGP/r1DCIXRH3sVXHyueWbvgenvTc29L3JUUie1a5SNjDiSP8AikYkf5+lNu5YRcElhNIw5bGFDew9KclyzI6AOI88HsPYU/y2lhmDRwW5LbskfOR6D0HeharQT31Id8rHLqrnttHGafc2tuImeWTyW/uM2WP0HbFPtXjihIOSrHAVOrHtT57a3mT7SrKSBjyx1BPdqEroblZlLT1MiFUlxtOCSmAB6mtUWcauyGZXPRmHOP8AAVjPFdxXUOFG6VfXjaKuRRh4WkQ7UH3wrDcSD6elEXboEk+5Xu45recqCkhGVGx88difekjt5xPHJDBI8mfvbcLux056UXdx5MguLVSsRbYylckr/eJ9ammtLl7AGa4LLKSUgR8knHU+neiybC7SsTWZLOymNDIp3Oc5YAHnJ7VVu2aG5MsMwAYnORk47Z9armSW1T7MwYebgjPU+gOO1RkywOjuN+44aMVMpXWo1oy4LiGygWQmK7kkRh5HOIz2Y+3tTEtXW1t8xujPjY0hxuPfAqKO4mWQJaqqiQgYUDLfX2p0n2ie6SO2b7RIo5I+7HnqBmnpYVmaP2F44Y5Q0bKBtdG4zg9PxqsiTXU2YkzMPmwnRQOTx6Co1uJYfNjllIfgkgZ3emKhlbYDJGQ+7Adc5/OiUl0CKLllNPebIbW0LOSzvJGNzOeucdABSi8JmXaEVlJ3BhwP8arQXE8gUm5kjiXj5TtAzwQMe1WoFlumcWkWLVD06k+57mqUrrQVktWQW80cyGGJSdsh2sDgkH1qS6tmsL0wXEyK4yGwQwx9RUMAcXT/AGeL5gx8zcMAHPepnlhhMKRW0lzK4zIZkKrn+6o7j3oW2oXtsQyymFAsk0hiJDLbK3Bz69qnvbmL+zS0cY84nG9OxAyAB9e9UGs1lmlYNHblMt5YfOPp9KrTzmMhLcADGS+7Jb/ClzON2PlTLJ+1SR7rid9spD4LYyw6YJqS1nly43LEiqflTBJx2qja/aZyI53CRRjIMh4Ud8VKfKhVVtysspySSOh9hUp9UUyW2tZ2u2G3YkkwC8Z5Izirk8Mmmagy3UW+UdRIeoNQRXM1vE0cgDDIbaR97I6/4UklzCjmR5HYFQuzdnvnBNWuW2m5GrLUG64DRiGSaX/lmQ+Ag/wqGSG2Vy/nKz7sMegbjoMdqjllm8mR1kEIbgRDsp6DNNsoUU/vVG4JvUE45PY0pPyuCXUlF5JCxMUUcERwqrHkEDvg+9T6fJ5rG4kYqAP3a5zj/PPWq127TgKi+ZOwJJA+5k1ClxHarmSHdOrf8tFwpGOmPWlzWeuxXLdaFho2uLuU2yZhRifm+6B65qGSWLLuX7gKAMZzxkUwXk8/nF5C2QH24wDj2HakuI5bmaA+QYw/Kg98entScuqQeTLl1tlE0tnFEsMPJRmBDdi3vVGIbUeR8qOAEXPzd8/SpI4YI4wJd7yg5wR8iDuPc1cgurh7ojT1j3Abgyr8qKOuc9qqybuxLRaGXcO0t1uZiWwGGOg+g7VYZ40K4keWVvvHGM59+9LqE8v2p5nnDyyqxkIAAJz0wO1RLMJoljhTJQ/6xhgHJ5+lTypaDvfUlnfbCVh8pVDZBKDefqf6U6ytLh3Y7VUEYbd1A/xNJb/LeImnotxcnILP90HHUZ/rViwF5cLNGiGJYl+d+gVh/ExPrzTWr1Jd0ivaywWl3G0qpKUY7luFJVj6YFE008/ngtubH3Rwqj0x0FRMgLTTSM0jE4UbT8/qw9OKWef7QiRo+CmAsSjAPvx1+tGtrDGLKkMYVhvuOiOzZEYHYCo4YZcre3W9LZ5CN3d8YJx+dSRWzOZPORmmVTsVehx1OahimM11LIymRVG1PMbCp2pWfUL66FvKTGT7FuggJyfMYbiOozjrTUmhWDBGZCvzu/UH2/nUUtwVjkjeSKTfjcUG7/vk+tRxXdspmhEBWORQzSyHLbgeq47eoqrq+4WEjupkPmCYvLIOd3JHtzTjGJn824ZVY4IRRyR6+1V1ulhmYRFZY2GzLDn1B9qtqk0jo0sLoWUsp24yP61nuUR3Eo+xSJHHIRkbBu4Rv8abbNboiuzGS4UggMMoP97vVyXYLE53bpioEhXBGDk7fwqPTGto52LKgB3ANOu9RkdwO+e/ar5dVclSI0kVo2d1y6klgzDbgnjaPWq5kaOFfLyQrEsx5xmrCrII8TK/ltyAByTQ8bXayxW0cy2o+bLDvj+L/Gps2O6sE0yx5EbCeVwCZXOQo9BTEae7n2hQ03OcDnj/AOtSWEcqWfnTAJEP4j8xJ9BTHuI1j22yTxydHOetDV9WGnQmKJGR5twIy0ZO+L5iuRwCewNNjuBGkQt2kEgUqSo5IIqKSyltkkjunjiY4LRFxwegBq5yISu+C2icKhQdWAPHPemot7iuXdAtbSXW7O01bOG6RrgBzgkKzdsnAq7DbrrYube40iz0jUoSFhdU2IX7QupPU9m/OsGG3gN9HA0yQhjh55QSsJ9SB26c1rX+lpBqEsepeI7H7YjDeJIpWY8cc457c072Idu4/wAUW0VlqtvBb2y27x2kJdD8pB2/MT75oqjdr5k4NxqkN3bxgKJYwSzeqqG5yPfiiizfkNe6rF6aRk2mIoinlSRyKjY3MQyzh4W+QMeQ1PtliFqzSmSRgQAijioX86WUoju2w5X2NNrqy/IfeLDBFtiAZnGMnrj+lR2cqeWYp1i2NxuYHK/406SR4WcygSSlcbifu/SqIRpG3IC2ckg/w/jUN21X3FaW1NeK3sjC8SsXlJxGn8WfWpXURRPm36AZ3NwR7HrVSJPI8sxIGm4JLDhfb3Jonu5YrgR3a+Y4wQD/AA+wrTmS3M+W73GPNB5cjNCFwMCLvn1qygSa1cwQhnYZckYMf4+lU7uING8zLtcYwmck1KjJcIAsj7RwFVdv/wCuo1vqPToPttSNs6JxuQk5ZcnOOmD2qw1z9qh2ypI8vUMoyQPf2qOaOBUaa53sMfID1J9SahEknlJDbyFXP8IXBx6k09Y6Ng0nqCpLA6yAb3YblX+tRvLLPEY0VlVSc4OAW9TUkccEKK1xOWmYnCrzsHuanSZniaIWwKFSFPr7mlyg2VBDFDcKrs0i7N22JupPvUkcqFWNtEDLjOW7Adeajhtg0gxIIW4wC2Mfj2qW8hklkdURbaJAA207gf8AHNNJ9A0e4k93HLEyF2UH5TsGByOmKz7RpbaTbvY4+UOpztH/AOqpo47aC6CMTMVJ4bj8TStOYrtoo2AjcAskYwDj+dK3d6j0WiL6xyyN9xYFbh5ZGClh9O3HpUE9g8URmkcNbscoFOWwP6VSnfpOxMsp+8O64qe2u93M7ErGhVFU45PTPtT5k3Zi5WitKZvMY2sbJFt2jA4yffvU727zrGscWxkjG5S4JPqfpVZ3NyCLbzDglpFBwAO7D/Co4LjaDtYFT8uR39/rSbSfkUrmi8DNuEEZlmVdzOhDKqfQdKihI3s5+RsfcA6+1RJGY1SaSVo1Y4IAw2Pp6Vbjv40lYxoGX+9MMMQev0o066EkdxuVY4HjMGPmIc9j7UQTQ20jxFGkl2naQxAT3x6025d7kGVcsqcb2Gc/jVaaRCpW2VxvXDnuaTbT0GldGnbXo2Wq3G5cAlgnG7n7xPrSXEkzr5Uchltyd6kD5vcZ649qz3jRI4/IlZyF/iXG2p4xdStGloGdixAPTcT1GaqMm9CWktSA/vJsiPPGAF+UD0p8lkojDSuoLYOD0/8A1VeN86xW8cnkW8AyPLjiDHBPJYnqcjrVVEtnk3SnbGpxlm/1hJ4wPSnyJO/Uak2ivKrw6kkd1JDJEuCpBwrfQ/jUkdmkrMYZd4Y4ZlGFU9lyepp+tQQQmNo8MsWCZg2d+fT0HanXRAUhRGkeFwI3yB7/AF9aJRSbuCfYhuV8lAERUfb85ZwWyD+lV4YHlm/d4llOCIx8zHPoKa6tOyowAiCk78YJ/wAaWCWW3hLWrMhIILp1IPbNS2m72GkaVtZ3DmJ3khLAZVHcA/jVdkjkklLtuVDjCtkk+maFllazcMiKrEfMxwRRPBHAxSI+fwpJGcA9cH3qnZpWQk9dQjnuGQwW48qHOcdACO5NOllAQI8zyxA7jn1PpmoZp32urRmLf0VVxmtSOO78y3N3EjgII0klX5Iwemcd/rSirg3YoCOW5kf7Ept4GPMjnCgHrknt7VCoIikdLuMOGCJ1LsOnA7Cp9XMzssOTtz8u1sqO2SPrUSW/2KQ4dDKVysg+YA9voc0Na6AmWoIisfl3UwjRj8wbrn3ouJLdwUwEhGEUx8B8Dr71Ukjm3LG04kaQksckkH3z3qxc24sLdVkRRdHlTvDD6YH58009BPuystpIzvPLG3kgqNi8ZznHXp9ai/0kPI0CMsSPtIHIXJwB79KbI7CaTzWYynb+7PfI6Yq4trIbIwjbHHuMr7nAJAHQD8eKlJbWG3Zaif6PAgKjc78qHHX6Ae9TSWt5I5MmPLC71GQq4/8ArVDL5dpEVs2DgsGWZlwy47D0qOR5pUga7kf7L8wVyMlj3A9s1XkxK+4N5iBna4Xy+FOG3CopLuJUaGygaFFIZXZsuV6EenWmssLDCHaSAAoOfxNM1BG+R3XbGPkxnBIPf8am7WxVkWBfTCXZEpZVzhG/hPfHtVRFUIJLljnHCL0+hpbyYPthtIgihAG5ySSepNOjtGhuIWkhMyxsC6bsKR3XP0payDRETQXE7ExfvYo1++gIC024MRliWdmAjUjEfPP19K03YvMM7orbeUSCM7iM9iR1HvVOG3gjkZr6VzCSSYoh1IPTPbPrT5OwXGQShlaO3t1bIwc9frmrKXkok2GVZZ0xiXPCgD7opiXqokwg/cxSdVU4JHZc9xVeJHK/aBHtjLYHoeM/lST6INN2Wp5VvniiglIRMlnkOFU45/z70kNxFbMGt4lknOAGlGQrdyB+VZwkZgkYdjGrFgF9T3/GtIWSJF5t3cCOUkbIivJXruOPw+tNNyfuhayHTyzXo3mIrDbKI5GQ5J/2s+9V1uZ5ImtxzD6k4Vcd+OprRaG1kh8+KKUQbzGZpTlScZwFFUJJXKnyUEYA+baaJaO9xJpq1hxe1tRNHbzNcE8FipUN3OB7USXMslowUqtruBZFUAse3vVZcvLGAC4xlR79/wAKdb26O7G6uBbxrkjjcc9gAKLt7D0I5ZS0i5QPI2MDHT/GnXNvJBFm4G0qc7W4PHrVk3dvFEjWUMq3RTY7PhiDnqvHHbFLdJqETotykiA/PmVD83bJB+tJRW+4X6Fi2trzU5YLKzuY3MrHeMYWMYySzY6Y5/Cr2NDQlX1i8vJNojFw1kXXaOgXLZ21Q02LUbaS0WyBju4rgKiqQTIxHHHQgjPtjNbuopDYhZ7zw1YXMZOwzWl4xhR/7rBSdv0q2tV0M29Tn9Xiez1KVbowXBlRXhlgGFdSPlYD9CD3oq/rDOuppLc+XHcNbxSJ5WBHChX5VUegGKKIx7tDvoLHJPKGFu5XHJGepqeyaaISQ+WxduQe/wBaopK1042REFvuhOB+NTSl0O6aXeRxlD09s1CvuaPsXcWt5vaWQRzBcLHjIY/WqV0t5C26Tb5ZwCVA5/Kq9wZp5ItiFEjGOEwBV+CNIcm7BlP90MBiqvzdCfhG2tuzp5gYp3Gep+gpbm4tzIBDFK79XkkPJPsO1a1jeS7fNSJFnX7rHGAOlULpoDdeZKy+YeSqHqfatOVKOjJUry1RTuZVmdfIBZRjnbg596W0YRtsjBZ1YgsPX0ouZVt4IzHDNHKDvwz4BFJpV2n2hy0HyudqEtwD6motrZsd9LlqW2maFvMaNAcck/N9AO9LYLNGCjkrAAwLIAST6UmoXO6YhJQxwVJP9KpulxMVSFWAHXac5NOVr+7qCu1qMnkVz+6jMeO/UtjqatRXxuEWMzlVHK4459M05ZWtIWhmhgMp6hzuIA+lZIeJbhfJVlVskHjhv6Co1XUrc0Z5I3JxLMz4wNwB59qWFEjSQ3ty6E8qkYzuPue1RTiJEwJA8gXdv7sfTFVVHDGRSpwGbJ++PQD1pttO4rdCdpgVh2qkcinJYj7w9/enma3Fz50bSM5+XcuFJPfr0qskkUkG9oizEYQE/rTWJnAEabZdoHyDGcdzUpvYbLF21tG2y3ty+CCXdj07jH9aZEyq8jylbePG7hcsfYVcs7ZrWSUXc0f3BnPzD6D1pt7b27RPcTSv8y/Kuc8+/pV8suorrYzJXErO6jaGOFjXrUcsS2VytxAQ+eJYWGdv+0D61bZbVbVZY43VhhcM3J46irtkkV5IkNpD+8Iw7sf8eKUVd2ugb0M2WTzkd3y7ZAAXPzL7VPaxo7TNcJLJtHCKAMH3zWdn7JezRwsCsJ2oO4+lSafPIqFVb942cqeSc/1qdE7PcLF557hYhCWYW6HcBjgZ7ketPtoBPEogVleMlnkc4THbPvmqksYtZQtzhnKhim4kLnpuxVuzvGWQTPJG6RgDy9uAQPanGzeoPbQkeOG2Uk/vWY4DD7o/DvVMSyyybfNIIzhV5BPpj3qwNR86eVRCnlSEDLjOKS7u7dY2EsAeYjhw2wg9iAKbcX1sgV+pTJhtZW88+c8q52p92Nqkjt3N1Hu2TIMfu2bAxjODRHHa+SP9J2ysp3Iw9e2aZHAUt2HlySSMdu3OBke360co7lSRHuN/msVTdwR/6CKkSNpYOdoCt5YAbJz64qS2ee6c29zMsdvvLZkyVRu7YHfikaaOK5cQbygAPmlcFj7DsKnS12NvoW7i1lCpCEeEBCHWVv4h3A7U52jtQhtImcqAWllHQ98D0p8dyjW7XFy4mnm4dmOSv+1n19qqGZBMVtSzorBsMMfiattJaf8ABItfcneFpY2luC6zluFAx8uOD/8AWpJYrx2lA/dwK4Oc/KWx+pxViS4WWOSWW4e6uWG75Rwvt/n0qlPNG6qXMpdjlTuG3bjp9aTSQJskuPIth/ozPLKMbpH4wPQDrUkbyzWMpuGItgwVjv8AmJHQAfSmS2Msg3TSLEkagqJjh3J9qiLRDeDHI4ZRvdjjB74A/Knqndho9gllWdx5LeRFGuCHblien1qO32B90Ydjg5yMke/0qubndLOUWP58csvQYwMVoXV9EnkmxdZJFUHeUxt45Uj0qbp6sNtiOZJnXKCSVmGZJCpC59M0ltFZC3druWQyjoEXP5n8qkudTmvLZBLcykYC+TnAXHGQB/Kq8che38ycJtX7p24bPvRpf3Q6WY+S78t42FtFBGW3Jgkk47ljyauh7e/3IIfLzkpIWxg9cVnhbbyAQHklGC2/5Qo9FHeo5mHnB5CwB+6CcFcfzpuTW7CyehLKlsAd8rscZAHIH1989qS2CuiSFkCp1aQkqv0FOWJbqYLZo8ju2cY+UeuT9aVEtElJv98zAkCKL5VHuT/hSt1He61JLS+T5lVIAGGw/LhnB7gCodQvHvZfKuSmC6qoI2qg4AJ9OKSed0hX7IoiJOflHzDj164qL7EJdLmu7idY4w4RY+rytn09BQnJ6IVktSvMuyWSG2kWQAkbl5Dc/wAqWRHS3dbpnLKpIjVTkfWpo797eGeC1ZYo5hh+MFlz0JNQ3CnY4VXZdvzOHzg/X09qlW6FX7lqPUmaKNxBHEIwfKEXBHHOfU1WWRTKWlRnJHCf41ZjaGyVZFBlkC8ZGFQ/1qCG4YyqwjJkDB/M+nqKp9E2JWQ/7OGPmXasmVyMY59KbJ5t27GS6/fEAKjAAbQO/pgdquAJcy+beylnLF2hQ4JHXJPQE1QlinuoZZLe3CWyMNzk8jJ9eppyVugk7mhbW9qliGEoAK5ZNnz7sdc/3faqnlsoDPuYFQY1Jz9PwpiKEjEqSkz7sFCOw6fWpI4wm9riUs5JdUAzhcdyOn0pb9B7ak/2pY50dYhhx0P8XGOlMvNrmFr10jbbtKR8tx/eHao5blZ2zHaxwIi9VJG0nuT1zUGQzK4V/MGCHYA5bPf0ovcEuoty6rNDsnd4huCrgBh9RUUV0I2cyoD5i5CgY24PX61eeCSK5iuJo4RKVLKrn8j9TVO5gIlTzl2z5IMRGCR6+wpSTWo1a4gM3mkxu23jDelOlvLhi5d5WPR/MYkk+v0piCcyNCikBP4BwBVxrf7Lb5nkR45D91cMePftSSbG9Nxui3DWGpW2oRxmSOFwJwWx8rArge+CauaZqVnpN7PBbeY2lupimhnGGuU7BscBh2IrKhtjqN/DaWy7WlbADPgAd2PsACa2xpdil5BAYNXubiaPetwNi/uwDhxGevsM5Ipq/QzlZbkfie5sL+5im01rgxrbxwqkw+cBBj5u35UVXv8ASrvTr7ynmt5VZRKksTZDIfut7Z9O1FJwk38I00luaSi9kgRUtysGCQVGPrUtrtZoY7YqW+8crnBrMWWQHaJHALHIzVofJcR7fl+btxV3tqW1c07u3leATGdc4+Yen4VQRVMKys6ySg/cx1+talsS0D7iW4PXmsiPhmPfB5rSaW5nHsWLqOaKITvIoL4IUc8fSqTlWkDYCuWzt6AD1p8n3/0qrOB56cDpWUi46mg8sVzGz3Tu84HCEYUD696zYndp3ycIqkqF7fhWs6g6NGxALBwASOcVRtFUzyEgZ+ntTktmJbEcIMtzGJpPKhI5b/63rVmSWaFTBHIPIY7gAen/ANeqd6fmt/xrUiRRpjsFAY9TjmpjHoNsJEP2eJETyo34Z5By2e/0qK8gWNNrK5h3bgwXAcDjPsKqQOzuxdmYjGCTmtayJZ9rEkbCMH/drRWZD0Zn2175LloY4oyAVEhXcx+melSxrc3CnzkASPrv4ABpukAG5UkDP/1qi1J2e4IdmYFzkE5qVtdl21Lmn2VruLTzqqsCY2PT8BVe8crEwVNrf6v5Oh+oqOHmwkzzhuPbiq+nEsjbiTlQDnuM0+bRJdSLaly3eV40UlSoAUlzhfbn2p18oixNvW4/hBXIG72Hce9Y4Y/aXXJ28jHbFWLFm+1jk8L6+1TzW0L5epNP5d6RJbQGJgP353fL9faofPl5SHAUDbhR1ou+GjUcKwUsB0P1rR1dQi2gQBRntxSavdhsZMsMIjle5mJuFwViQZ3g9ct2xVxZndFgWGCHGcKq8nPqfWqtuB/bIGBjd/SqwYkykkkgnnPvS5rLQdi3OixyoVXOByByTUslozRiadTHG/zAZ5P+FXLIDyGbA3eU/PesyIklcnuKqUVbUVyRJJGhAWDZAnQ479+aYsK/aV3XAZn5ULzj2JqSJ2+2Ebmxk8ZqrcAfZJ+P41pNJagS3MsSyeXCoQc5J5J/Go5pDHIklwziKQY+X73Ht2qTSwGiuGYAsOhPUVlXPMiA9PMFTzaXKL5nUOxtldARwhO4471YMAtVtp5J0e4kzm2Qk7U7bj6mp9BVf7IvX2jfnG7HOKrw8Qcf31/kapK1m+pDZYlIeASPH5NsXAcAgHPsPSqjxTylPsisSc4G3GR/WtC3Aef5wG/d9+aZdyP9vzvbK8DnpxTa01BMfI0ENrbiSSFCF48hCX6Y2sTVYLDBKrb/AJiMYPzFB9KhjAZ/mAPzd6kvAFuNqgAbug+lKT0YItxKJw0plaaRTuIf09zU80dhGgzLI7b9wix8nI7kc9apKSttGFJAYnIHeo7bnUIs856072FuyPcTIxI8kDqFGTj2zTp5JGmZLZiY8AttHX65qCYY1HA6bTWvYfJorbPl3SfNjjPXrSj710U9NSrGojUXYZXlUgyF8BUP8OB3pkzy3MW6WVCGO51GBz15p1+AJAQACQc+/wAtZ2jfPLbB/mBI6896pvVRI8zRgMsirI1uvlj5QzfKFP1o8uHy0Eo3szZBxkCtnxmSj7FJVBJwo4A4HaudmJFkME+tOXuuyBPmLN7PcThrhmhiUjHlx4Tpx92q1sJU+dgEDjBZh97PYe9RNy1sTyT1PrzW4CTJfITlAjYXsKVuZ3C9kipbXFrEsu9SqAZVe+exz3qiLf7dHLPHPEHSRNsJOGlJJ+6vfHeq84wqEdd/9KktyY43aMlGyOV4PQ1HNzaMponNmIb4R6ggMi5LorAY9iemabcvMbVAsTeV/DjHQn07mqkBLSDcSfn71at/+PiRv4lIIPcHI6U422QCR3UiwNZ3vULui45x12k1UFzJOzx2xKRL97PQnrjNSaqS1y5Y5O89fqaqxH/RIB2Z3Yj1OTyaJNgibzTwhcDnO/1q3Z4uG8vYJGZvkkDbcN6n2FZeTjr3xWy/yW42fLiNTxx3qIytqVJCiQWc0sKSxys3y+dIMhfXb7n1qraLOfOkkLiE53BXGSKntwGmXcAfrVSQ4LkcHd1/Gqv1JTLV1DNO8QEcKARgiOFskj3A7+tSTRS2liIrx2jDgOkSc7v9on26UyxYx2kkkZKyf3l4PT1pt2xOWJJYoSTnk809veEOfUI4gkKIr53M7Nkk8dM+1VEhlnvovNYwh1O1pP4x7U20AN/BkA/MP51J4iZjq9/lidj4Xn7o56elCfMrsNthPPjgLKu5sHGema0yypal47XyxIu1w54DD+If4Vk6R817Du5yMnNWp5ZGln3Ox+YHk0QejuEkWtHv7ay1OFyR5UqtFcOV5VWBBK+h5rae3WaeLUpBFK9tsdLoXiLayug2q5B+deByuO1chFxC3+81SSxp9mlO1eEGOOnIoTuJxvqaOpOZb+FLJybK3iSFJZF2eYcHLEHoCSce1FYBZnni3sW57nNFNVLdB7aH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A vesicle on an erythematous base is present. Varicella lesions are often described as resembling a \"dew drop on a rose petal\".",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1816=[""].join("\n");
var outline_f1_49_1816=null;
var title_f1_49_1817="Treatment of polycystic ovary syndrome in adults";
var content_f1_49_1817=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of polycystic ovary syndrome in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1817/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1817/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1817/contributors\">",
"     David A Ehrmann, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1817/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1817/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1817/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1817/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/49/1817/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The polycystic ovary syndrome (PCOS) is an important cause of both menstrual irregularity and androgen excess in women. When fully expressed, the manifestations include irregular menstrual cycles, hirsutism, and obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of PCOS will be reviewed here. The epidemiology and pathogenesis, diagnostic criteria for, and clinical manifestations of PCOS are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40568?source=see_link\">",
"     \"Epidemiology and pathogenesis of the polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=see_link\">",
"     \"Diagnosis of polycystic ovary syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several treatments for each of the symptoms of PCOS; the choice among them depends upon the woman's goals. In those women who are obese, some of the manifestations of PCOS can be ameliorated by weight loss. Drugs that decrease insulin levels can be effective in both obese and normal-weight women (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Insulin-lowering agents'",
"    </a>",
"    below). The issue of fertility should always be discussed with the woman first because the desire for pregnancy in the near-term can be a major determinant in the choice of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Androgen excess",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5944730\">",
"    <span class=\"h3\">",
"     Hirsutism and acne",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our approach to the management of hirsutism is consistent with the 2008 Endocrine Society Clinical Practice Guidelines, which suggest an estrogen-progestin contraceptive as first-line pharmacologic therapy for most women [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/2\">",
"     2",
"    </a>",
"    ]. An antiandrogen is then added after six months if the cosmetic response is suboptimal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/17/27928?source=see_link\">",
"     \"Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women with hirsutism and contraindications to oral contraceptives, we sometimes use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    alone, but an alternative form of contraception is essential because, if pregnancy occurs, an antiandrogen such as spironolactone could prevent development of normal external genitalia in a male fetus. If spironolactone alone is used, endometrial protection is also needed.",
"   </p>",
"   <p>",
"    We typically start with an oral contraceptive preparation containing 30 to 35 mcg of ethinyl estradiol combined with a progestin with minimal androgenicity (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    , norgestimate, desogestrel, or drospirenone). After six months, if the patient is not satisfied with the clinical response, we typically add",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    50 to 100 mg twice daily; this dose can then be reduced over time as needed.",
"   </p>",
"   <p>",
"    Other antiandrogens that are effective include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39301?source=see_link\">",
"     finasteride",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14374?source=see_link\">",
"     cyproterone acetate",
"    </a>",
"    (available in most countries, but not the United States). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    .) GnRH agonists are also sometimes used to suppress ovarian androgen production; &ldquo;add-back&rdquo; estrogen-progestin therapy is necessary to avoid bone loss and estrogen deficiency symptoms. Although this approach is effective, it is limited by its complexity and cost. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of hirsutism\", section on 'GnRH agonist'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although some clinicians use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    to treat hirsutism, the Endocrine Society Clinical Practice Guidelines suggests against its routine use as it is associated with minimal or no benefit and is less effective than treatment with OCPs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antiandrogens [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link&amp;anchor=H13#H13\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\", section on 'Hirsutism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral contraceptives and antiandrogen therapy may also reduce acne, but an occasional woman needs antibiotic or other therapy (as determined by a dermatologist). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39370?source=see_link\">",
"     \"Treatment of acne vulgaris\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hirsutism can also be treated by removal of hair by mechanical means such as shaving, waxing, depilatories, electrolysis or laser treatment. In addition, Vaniqa (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/49/37652?source=see_link\">",
"     eflornithine",
"    </a>",
"    hydrochloride cream 13.9 percent) is a topical drug that inhibits hair growth. It is not a depilatory and must be used indefinitely to prevent regrowth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37014?source=see_link\">",
"     \"Removal of unwanted hair\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link&amp;anchor=H929892094#H929892094\">",
"     \"Treatment of hirsutism\", section on 'Nonpharmacologic methods'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5944795\">",
"    <span class=\"h3\">",
"     Androgenetic alopeica",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of scalp hair loss (androgenetic alopecia) in women with polycystic ovary syndrome is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23336?source=see_link\">",
"     \"Treatment of androgenetic alopecia in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Endometrial protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronic anovulation seen in PCOS is associated with an increased risk of endometrial hyperplasia, dysfunctional uterine bleeding, and possibly endometrial cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=see_link&amp;anchor=H6#H6\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Chronic anovulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral contraceptives are most commonly used for endometrial protection in these patients, as they also provide contraception and cosmetic benefit. Oral contraceptives provide daily exposure to progestin, which antagonizes the endometrial proliferative effect of estrogen.",
"   </p>",
"   <p>",
"    Absence of pregnancy should be documented before oral contraceptive therapy is begun. If the woman has had no menstrual period for six or more weeks, withdrawal bleeding should be induced by administration of 5 to 10 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    daily for 10 days prior to initiation of oral contraceptive treatment (to minimize breakthrough bleeding when starting the pill).",
"   </p>",
"   <p>",
"    Therapy then is begun with an oral contraceptive containing 30 to 35 mcg ethinyl estradiol and a progestin like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone",
"    </a>",
"    (0.5 mg), or a third generation progestin such as norgestimate or desogestrel. Drospirenone is a newer progestin with antiandrogenic properties, but it is not known whether it has any advantages when compared with other progestins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risks and side effects of oral contraceptives (including breakthrough bleeding) are similar to those for women without PCOS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"     \"Risks and side effects associated with estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women with PCOS who choose not to or cannot take oral contraceptives, an alternative treatment for endometrial protection is intermittent progestin therapy. In this setting, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    (10 mg) for 7 to 10 days every one to two months. Patients should be made aware that progestin therapy alone will not reduce the symptoms of acne or hirsutism, nor will it provide contraception.",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    is a potential alternative to restore menstrual cyclicity, its ability to provide endometrial protection has not been established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ovulation induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to complete a basic evaluation of the couple before initiating therapy in an infertile woman, including a semen analysis of the male. Weight loss should always be attempted prior to initiating ovulation induction because ovulation can be restored with a modest amount of weight loss. If unsuccessful, a multistep approach to ovulation induction is then undertaken (",
"    <a class=\"graphic graphic_table graphicRef56718 \" href=\"UTD.htm?4/36/4684\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Weight loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many overweight and obese women with PCOS, weight loss alone is often associated with a reduction in serum testosterone concentration, resumption of ovulation, and pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. As an example, in one series of 18 obese women with PCOS treated with a hypocaloric diet, mean weight fell from 77 to 57 kg and mean plasma testosterone concentration fell from 0.75 to 0.39",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/4\">",
"     4",
"    </a>",
"    ]. Moreover, many women resumed ovulation after the weight loss.",
"   </p>",
"   <p>",
"    Another study placed 20 women with PCOS and mean BMI of 32",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    amenorrhea for greater than three months, and increased plasma concentrations of androstenedione, testosterone, or dehydroepiandrosterone sulfate, on a hypocaloric diet (1000 to 1500",
"    <span class=\"nowrap\">",
"     kcal/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/4\">",
"     4",
"    </a>",
"    ]. After weight loss ranging from 4.8 to 15.2 kg (mean 9.7 kg), significant reductions in the concentration of LH (45 percent decrease), fasting insulin (40 percent decrease), and testosterone (35 percent decrease) were observed; most of the women ovulated, and many of the infertile women became pregnant. Similar results were reported in a small randomized study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clomiphene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 80 percent of women with PCOS ovulate in response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate and approximately 50 percent conceive. Clomiphene regimens and success rates are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link\">",
"     \"Ovulation induction with clomiphene citrate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Metformin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    , a drug whose major effect is to increase insulin action and lower serum insulin concentrations, may promote ovulation either alone or in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    , although results have been inconsistent. However, in the largest trial to date, live birth rates were higher with clomiphene than metformin therapy, and the addition of metformin to clomiphene did not improve outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/6\">",
"     6",
"    </a>",
"    ]. A consensus group has recommended against the routine use of metformin except in women with glucose intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    therapy for PCOS and strategies for prevention of type 2 diabetes are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H226083\">",
"    <span class=\"h3\">",
"     Aromatase inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aromatase inhibitors may also be effective for ovulation induction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/6/4201?source=see_link\">",
"     \"Ovulation induction with aromatase inhibitors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Gonadotropin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another method to induce ovulation is administration of exogenous gonadotropins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/8\">",
"     8",
"    </a>",
"    ]. A study of 225 women with PCOS treated over a 10-year period at one center found rates of ovulation and pregnancy of 72 percent and 45 percent, respectively, after the administration of low-dose gonadotropins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/9\">",
"     9",
"    </a>",
"    ]. Exogenous gonadotropin therapy is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .) Women with PCOS and anovulatory infertility treated with gonadotropins are at high risk for OHSS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=see_link\">",
"     \"Classification and treatment of ovarian hyperstimulation syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=see_link\">",
"     \"Pathogenesis of ovarian hyperstimulation syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=see_link\">",
"     \"Prevention of ovarian hyperstimulation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Laparoscopic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, wedge resection of the ovaries was a standard treatment for infertility in women with PCOS. However, this approach has been abandoned, both because of the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    and because of the high incidence of pelvic adhesions seen with wedge resection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/10\">",
"     10",
"    </a>",
"    ]. A substitute for wedge resection, laparoscopic ovarian laser electrocautery, may be effective in some women with PCOS. However, given the other pharmacologic options for ovulation induction, surgery is not often indicated. The use of laparoscopic surgery for ovulation induction in PCOS is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24583?source=see_link\">",
"     \"Laparoscopic surgery for ovulation induction in polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16744605\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thiazolidinedione therapy has been investigated for induction of ovulation, but we do not suggest their use. In a study of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"     rosiglitazone",
"    </a>",
"    (4 mg twice daily for two months) with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    in 25 women with PCOS who had not responded to clomiphene alone, ovulatory rates were higher in the combined versus monotherapy groups (77 and 33 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/11\">",
"     11",
"    </a>",
"    ]. In some [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/12,13\">",
"     12,13",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/14\">",
"     14",
"    </a>",
"    ] studies in women with PCOS, ovulatory rates were higher with rosiglitazone when compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    . Combination",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/39/27255?source=see_link\">",
"     rosiglitazone-metformin",
"    </a>",
"    therapy did not result in additional benefit in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/12\">",
"     12",
"    </a>",
"    ]. Other effects of thiazolidinediones are discussed below (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Insulin-lowering agents'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    As noted, we do not suggest the routine use of these drugs, as concern has been raised about their cardiovascular safety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=see_link\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Troglitazone also improved ovulation in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], but was removed from the market due to hepatotoxicity.",
"   </p>",
"   <p>",
"    Although women with PCOS are not likely GnRH deficient, pulsatile GnRH is moderately effective for ovulation induction. It is currently available in Europe but not in the United States. In one study of 41 patients undergoing 114 ovulation induction cycles, 56 percent of women ovulated, and 40 percent of ovulatory patients achieved pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/17\">",
"     17",
"    </a>",
"    ]. Ovulatory cycles were associated with lower body mass index and fasting insulin, and higher baseline serum FSH concentrations. Thus, pulsatile GnRH may be a reasonable option, particularly for lean women with PCOS.",
"   </p>",
"   <p>",
"    Both pulsatile GnRH and exogenous gonadotropin regimens are complex and expensive and are best carried out by experienced clinicians; most clinicians recommend an assessment of fallopian tube patency before initiating these relatively aggressive therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Obesity and insulin resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to obesity management is the same as that for patients without PCOS, starting with lifestyle changes (diet and exercise). Modest weight loss in women with PCOS may result in restoration of normal ovulatory cycles (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link\">",
"     \"Overview of therapy for obesity in adults\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'Weight reduction'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Any treatment that reduces insulin levels in both obese and lean women with PCOS may have beneficial effects. These include a fall in ovarian androgen secretion and an improvement in cyclic pituitary-ovarian function, which may reduce hair growth and restore menstrual regularity and presumably fertility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Weight reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of the therapies that may improve insulin resistance, the most extensively studied is weight reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/3,18,19\">",
"     3,18,19",
"    </a>",
"    ]. One study, as an example, evaluated 26 obese women with PCOS, 13 of whom lost more than 5 percent of their initial weight [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/18\">",
"     18",
"    </a>",
"    ]. Among these 13 women, four had more normal menstrual cycles, four conceived, and the majority had a decrease in hirsutism; there was little change in these parameters in women who did not lose weight. In another group of 15 women with PCOS, a program of diet and increased exercise resulted in only modest weight reduction, but insulin sensitivity increased and, in 56 percent, ovulatory cycles returned [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Low-carbohydrate diets have become very popular for women with PCOS, based upon the notion that less carbohydrate leads to less hyperinsulinemia, and therefore less insulin resistance. However, a 12-week study of a high",
"    <span class=\"nowrap\">",
"     protein/low",
"    </span>",
"    carbohydrate diet (30 percent protein, 40 percent carbohydrate, 30 percent fat) and a low",
"    <span class=\"nowrap\">",
"     protein/high",
"    </span>",
"    carbohydrate diet (15 percent protein, 55 percent carbohydrate, 30 percent fat) were equally effective for weight loss, improvements in menstrual cyclicity, insulin resistance, dyslipidemia, and abdominal fat in one study of 28 overweight women with PCOS [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/20\">",
"     20",
"    </a>",
"    ]. It is not known if an extremely low carbohydrate diet would be any more effective for these endpoints. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H531240920\">",
"    <span class=\"h4\">",
"     Bariatric surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bariatric surgery is another strategy for weight loss in women with PCOS. In one study of 17 obese women with PCOS with a mean BMI of 50.7",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    bariatric surgery was associated with a mean weight loss after 12 months of 41 &plusmn; 9 kg, restoration of ovulatory cycles, and improvements in insulin resistance, hyperandrogenemia, and hirsutism scores [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=see_link\">",
"     \"Surgical management of severe obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Insulin-lowering agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs, including biguanides (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    ), thiazolidinediones (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"     pioglitazone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"     rosiglitazone",
"    </a>",
"    ), and D-chiro-inositol (not clinically available), can reduce insulin levels in women with PCOS. These drugs may also reduce ovarian androgen production (and serum free testosterone concentrations) and restore normal menstrual cyclicity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=see_link\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there had been widespread enthusiasm and use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    for a number of indications in polycystic ovary syndrome, clinical data no longer support this approach. A detailed discussion of metformin use in PCOS is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Strategies recommended by the American Diabetes Association for prevention of type 2 diabetes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thiazolidinediones have been less well studied than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    . Although they appear to improve insulin sensitivity, they are associated with weight gain. The metabolic effects of thiazolidinediones in women with PCOS have been studied in a number of trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two studies of troglitazone (400",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for three months) reported an improvement in insulin action and a 20 to 30 percent decrease in serum free testosterone concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. However, troglitazone was removed from the market because of its associated hepatotoxicity.",
"     </li>",
"     <li>",
"      A trial in 40 women with PCOS randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"       pioglitazone",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      or placebo for three months reported a significant improvement in insulin sensitivity, a decrease in the free androgen index (due to an increase in SHBG), and an increase in ovulatory rates in the pioglitazone group when compared with placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a six-month trial of 52 obese women with PCOS randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"       pioglitazone",
"      </a>",
"      (30 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      (850 mg three times daily), insulin sensitivity and hyperandrogenemia improved to a similar degree, in spite of significant weight gain in the pioglitazone group [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similar results have been reported with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"       rosiglitazone",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of limited clinical data, the potential weight gain, and a possible association with cardiovascular adverse events, we do not recommend the use of thiazolidinediones in women with PCOS who are not diabetic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=see_link\">",
"     \"Thiazolidinediones in the treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    D-chiro-inositol also increases insulin sensitivity in women with PCOS, perhaps by reversing a deficiency of d-chiro-inositol-containing phosphoglycan, a putative intracellular mediator of the action of insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/24\">",
"     24",
"    </a>",
"    ]. However, this agent is not available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     OCs and insulin sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;In healthy women, oral contraceptive use decreases insulin sensitivity, but in general, this decrease is not clinically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/29\">",
"     29",
"    </a>",
"    ]. It has been assumed that oral contraceptive use would also worsen insulin sensitivity in women with PCOS, although data are conflicting, with studies showing an improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/30\">",
"     30",
"    </a>",
"    ], worsening [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/31\">",
"     31",
"    </a>",
"    ], or no change [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/32\">",
"     32",
"    </a>",
"    ] in insulin sensitivity.",
"   </p>",
"   <p>",
"    When compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , oral contraceptives may be less beneficial for insulin sensitivity, but better for androgen suppression and menstrual cycle control. This topic is reviewed separately.",
"   </p>",
"   <p>",
"    There are also theoretical concerns that women with PCOS may be at particular risk for cardiovascular complications with oral contraceptives, given their other underlying cardiovascular risk factors. However, there are no oral contraceptive risk data specific to women with PCOS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link&amp;anchor=H8#H8\">",
"     \"Risks and side effects associated with estrogen-progestin contraceptives\", section on 'Coronary heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effects of combination oral contraceptive-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    therapy are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link&amp;anchor=H24#H24\">",
"     \"Metformin for treatment of the polycystic ovary syndrome\", section on 'Metformin plus oral contraceptives'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5944834\">",
"    <span class=\"h2\">",
"     Dyslipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to treatment of dyslipidemia in women with PCOS is the same as for other patients with dyslipidemia. Exercise and weight loss are the first line approach, followed by pharmacotherapy, if needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5944842\">",
"    <span class=\"h2\">",
"     Statins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statins are effective for dyslipidemia in women with polycystic ovary syndrome (PCOS), but do not appear to have other clinically important metabolic or endocrine effects. In a meta-analysis of four trials in 244 women randomly assigned to a statin (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    ) or placebo for 6 to 12 months, statin therapy decreased serum LDL and triglycerides, but had no effect on HDL, fasting insulin, or C-reactive protein. A small decrease in serum testosterone was observed, but there were no improvements in menstrual cycle regularity, ovulation, acne, hirsutism, or body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H226109\">",
"    <span class=\"h2\">",
"     Obstructive sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep apnea, a common disorder in women with PCOS, is an important determinant of insulin resistance, glucose intolerance, and type 2 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    .) In one report of women with PCOS and obstructive sleep apnea, treatment with continuous positive airway pressure (CPAP) improved insulin sensitivity and reduced diastolic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16744851\">",
"    <span class=\"h2\">",
"     Nonalcoholic steatohepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of nonalcoholic steatohepatitis (NASH) appears to be increased in women with PCOS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\"",
"    </a>",
"    .) Both weight loss and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    use appear to improve metabolic and hepatic function in these women [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/29/28115?source=see_link\">",
"       \"Patient information: Polycystic ovary syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30437?source=see_link\">",
"       \"Patient information: Polycystic ovary syndrome (PCOS) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regardless of the diagnostic criteria used, the management of PCOS includes treatment of individual components of the syndrome (hirsutism, oligomenorrhea, infertility, obesity, and glucose intolerance), depending upon the patient's goals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hirsutism",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Our approach to the management of hirsutism is consistent with the Endocrine Society Clinical Practice Guidelines [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1817/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For hirsutism or other androgenic symptoms, we suggest an oral contraceptive as the treatment of choice (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Androgen excess'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We typically start with a preparation containing 30 to 35 mcg of ethinyl estradiol combined with a progestin with minimal androgenicity (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"       norethindrone",
"      </a>",
"      , norgestimate, desogestrel, and drospirenone). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"       \"Overview of the use of estrogen-progestin contraceptives\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If the patient is not satisfied with the clinical response to the oral contraceptive after six months of therapy, we suggest adding",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"       spironolactone",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Androgen excess'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other options for treating hirsutism are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=see_link\">",
"     \"Treatment of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Endometrium",
"    </span>",
"   </p>",
"   <p>",
"    Oral contraceptives provide endometrial protection (preventing dysfunctional uterine bleeding and possibly endometrial cancer) as well as contraception and androgen suppression. Intermittent progestin therapy is effective for endometrial protection, but it provides no contraception or androgen suppression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations of polycystic ovary syndrome in adults\", section on 'Menstrual dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with PCOS who present with dysfunctional uterine bleeding due to chronic anovulation (and anatomic causes have been ruled out), we recommend oral contraceptives (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For prevention of endometrial hyperplasia and possibly cancer, we suggest oral contraceptive therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Endometrial protection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with PCOS who choose not to or cannot take oral contraceptives, we suggest intermittent progestin therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Endometrial protection'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      In this setting, we typically use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      (10 mg) for 7 to 10 days every one to two months.",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       Metformin",
"      </a>",
"      can also be used, but as noted above, it has not been proven to be endometrial protective. However, if the patient is having regular ovulatory cycles in response to metformin, she presumably has endometrial protection. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Endometrial protection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ovulation induction",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with PCOS who desire pregnancy, we first recommend weight loss if the woman is overweight or obese (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Ovulation induction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If they are unable to lose weight or modest weight loss does not restore ovulatory cycles, we suggest initiating ovulation induction with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       clomiphene",
"      </a>",
"      citrate (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). If this is unsuccessful, we continue with other ovulation induction strategies outlined elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=see_link\">",
"       \"Metformin for treatment of the polycystic ovary syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"       \"Overview of ovulation induction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to obesity management is the same as that for patients without PCOS, starting with lifestyle changes (diet and exercise). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link\">",
"     \"Overview of therapy for obesity in adults\"",
"    </a>",
"    .) Modest weight loss in women with PCOS may result in restoration of normal ovulatory cycles. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Ovulation induction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Weight reduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Glucose intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with PCOS who are found to have type 2 diabetes mellitus or impaired glucose tolerance, the management is the same as other non-PCOS patients with these disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=see_link\">",
"     \"Overview of medical care in adults with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/1\">",
"      Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/2\">",
"      Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/3\">",
"      Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/4\">",
"      Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 1982; 38:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/5\">",
"      Guzick DS, Wing R, Smith D, et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994; 61:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/6\">",
"      Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/7\">",
"      Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/8\">",
"      Kelly AC, Jewelewicz R. Alternate regimens for ovulation induction in polycystic ovarian disease. Fertil Steril 1990; 54:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/9\">",
"      White DM, Polson DW, Kiddy D, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996; 81:3821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/10\">",
"      Portuondo JA, Melchor JC, Neyro JL, Alegre A. Periovarian adhesions following ovarian wedge resection or laparoscopic biopsy. Endoscopy 1984; 16:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/11\">",
"      Ghazeeri G, Kutteh WH, Bryer-Ash M, et al. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 2003; 79:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/12\">",
"      Legro RS, Zaino RJ, Demers LM, et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 2007; 196:402.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/13\">",
"      Yilmaz M, Karako&ccedil; A, T&ouml;r&uuml;ner FB, et al. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Gynecol Endocrinol 2005; 21:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/14\">",
"      Baillargeon JP, Jakubowicz DJ, Iuorno MJ, et al. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 2004; 82:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/15\">",
"      Hasegawa I, Murakawa H, Suzuki M, et al. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 1999; 71:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/16\">",
"      Azziz R, Ehrmann D, Legro RS, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2001; 86:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/17\">",
"      Gill S, Taylor AE, Martin KA, et al. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86:2428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/18\">",
"      Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/19\">",
"      Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/20\">",
"      Moran LJ, Noakes M, Clifton PM, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/21\">",
"      Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005; 90:6364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/22\">",
"      Dunaif A, Scott D, Finegood D, et al. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81:3299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/23\">",
"      Ehrmann DA, Schneider DJ, Sobel BE, et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82:2108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/24\">",
"      Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 1999; 340:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/25\">",
"      Sepilian V, Nagamani M. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 2005; 90:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/26\">",
"      Brettenthaler N, De Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89:3835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/27\">",
"      Ortega-Gonz&aacute;lez C, Luna S, Hern&aacute;ndez L, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/28\">",
"      Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. Hum Reprod 2006; 21:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/29\">",
"      Godsland IF, Walton C, Felton C, et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992; 74:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/30\">",
"      Pasquali R, Gambineri A, Anconetani B, et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 1999; 50:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/31\">",
"      Korytkowski MT, Mokan M, Horwitz MJ, Berga SL. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80:3327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/32\">",
"      Cibula D, Sindelka G, Hill M, et al. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum Reprod 2002; 17:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/33\">",
"      Raval AD, Hunter T, Stuckey B, Hart RJ. Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev 2011; :CD008565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/34\">",
"      Tasali E, Chapotot F, Leproult R, et al. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/35\">",
"      Gangale MF, Miele L, Lanzone A, et al. Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 2011; 75:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1817/abstract/36\">",
"      Brown AJ, Tendler DA, McMurray RG, Setji TL. Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings. Endocr Pract 2005; 11:319.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7421 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-118.195.65.248-47B75F185E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1817=[""].join("\n");
var outline_f1_49_1817=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Androgen excess",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5944730\">",
"      - Hirsutism and acne",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5944795\">",
"      - Androgenetic alopeica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Endometrial protection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Weight loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clomiphene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Metformin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H226083\">",
"      - Aromatase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Gonadotropin therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16744605\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Obesity and insulin resistance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Weight reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H531240920\">",
"      Bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Insulin-lowering agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - OCs and insulin sensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5944834\">",
"      Dyslipidemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5944842\">",
"      Statins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H226109\">",
"      Obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16744851\">",
"      Nonalcoholic steatohepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hirsutism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Endometrium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Glucose intolerance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7421\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7421|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/36/4684\" title=\"table 1\">",
"      Multistep approach treatment infertility PCOS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=related_link\">",
"      Classification and treatment of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/6/16490?source=related_link\">",
"      Clinical manifestations of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=related_link\">",
"      Diagnosis of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=related_link\">",
"      Dietary therapy for obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40568?source=related_link\">",
"      Epidemiology and pathogenesis of the polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24583?source=related_link\">",
"      Laparoscopic surgery for ovulation induction in polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/27/16826?source=related_link\">",
"      Metformin for treatment of the polycystic ovary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=related_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=related_link\">",
"      Overview of therapy for obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/6/4201?source=related_link\">",
"      Ovulation induction with aromatase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=related_link\">",
"      Ovulation induction with clomiphene citrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=related_link\">",
"      Pathogenesis of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30437?source=related_link\">",
"      Patient information: Polycystic ovary syndrome (PCOS) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/29/28115?source=related_link\">",
"      Patient information: Polycystic ovary syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=related_link\">",
"      Prevention of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/9/37014?source=related_link\">",
"      Removal of unwanted hair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=related_link\">",
"      Surgical management of severe obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21290?source=related_link\">",
"      Thiazolidinediones in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39370?source=related_link\">",
"      Treatment of acne vulgaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23336?source=related_link\">",
"      Treatment of androgenetic alopecia in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/37/35416?source=related_link\">",
"      Treatment of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/17/27928?source=related_link\">",
"      Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_49_1818="Radiation-induced thyroid cancer";
var content_f1_49_1818=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiation-induced thyroid cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Arthur B Schneider, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1818/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/49/1818/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/49/1818/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation exposure of the thyroid during childhood is the most clearly defined environmental factor associated with benign and malignant thyroid tumors. The risk of thyroid cancer following irradiation is related to radiation dose and age (greater for children exposed early in life), and the risk persists throughout life. Radiation exposure during childhood also increases the risk of benign thyroid nodules and hypothyroidism.",
"   </p>",
"   <p>",
"    The purpose of this topic is to review the evaluation of a patient with a history of childhood radiation exposure and how such a history affects treatment of patients with thyroid tumors. Radiation injury to other organs is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=see_link\">",
"     \"Biology and clinical features of radiation injury in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/17/38170?source=see_link\">",
"     \"Treatment of radiation injury in the adult\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17689?source=see_link\">",
"     \"Clinical features of radiation exposure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25193?source=see_link\">",
"     \"Management of radiation exposure in children following a nuclear disaster\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RADIATION EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation exposure may be external (eg, proximity to a source of radiation) or internal (eg, ingestion of foods or liquids contaminated with radioactivity or by inhalation of radioactive gases or particles). The predominant types of external radiation are diagnostic x-rays, therapeutic radiation for the treatment of cancer, and historical use of external radiation to treat a wide variety of nonmalignant conditions. Internal radiation exposure occurs after exposure to nuclear fallout (from testing and accidents at operating nuclear power plants or above ground nuclear explosive testing) or after ingestion of radioiodine therapy for the treatment of hyperthyroidism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Magnitude of risk",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H238696761\">",
"    <span class=\"h3\">",
"     Thyroid cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of thyroid nodules and cancer has been investigated in many radiation-exposed groups, including children irradiated for benign diseases (enlarged thymus glands or tonsils, hemangiomas of the face and neck, tinea capitis of the scalp) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/1\">",
"     1",
"    </a>",
"    ], survivors of atomic bombing in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/2\">",
"     2",
"    </a>",
"    ], Marshall Islanders exposed to nuclear test fall-out [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/3\">",
"     3",
"    </a>",
"    ], and children living in the area of Chernobyl, Three Mile Island, and Fukushima, sites of a nuclear accidents [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The thyroid exposures in these groups vary, but for most purposes they are considered \"low dose.\"",
"   </p>",
"   <p>",
"    The increasing success of treating children for a variety of malignancies, often using radiation, has resulted in studies of their risk for developing thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These are generally considered \"high dose\" thyroid exposures.",
"   </p>",
"   <p>",
"    Available data make the relationship between thyroid radiation and thyroid tumorigenesis incontrovertible. A pooled analysis of seven studies of radiation exposure, which included a variety of patients (atomic bomb survivors, children treated for tinea capitis or enlarged tonsils, infants irradiated for an enlarged thymus gland, children treated for cancer) showed the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyroid nodules of all types and sizes, including small ones only detected by screening methods, were increased by radiation exposure.",
"     </li>",
"     <li>",
"      The thyroid is among the most radiation-sensitive tissues in the body, with excess cancers occurring at doses as low as 100 mGy (milligray, 10 mGy = 1 rad).",
"     </li>",
"     <li>",
"      There was a linear dose-response curve, with no evidence of a threshold at low doses (100 mGy) (",
"      <a class=\"graphic graphic_figure graphicRef81877 \" href=\"UTD.htm?22/5/22623\">",
"       figure 1",
"      </a>",
"      ). The pooled excess absolute risk was estimated to be 4.4 per 10,000",
"      <span class=\"nowrap\">",
"       person-years/Gy",
"      </span>",
"      (95% CI 1.9-10.1).",
"     </li>",
"     <li>",
"      The risk of thyroid cancer was higher in patients exposed to radiation before age 15 years. Risk decreased with increasing age at exposure, with little apparent risk with exposure after age 20 years.",
"     </li>",
"     <li>",
"      The effects of radiation persisted for several decades and then eventually waned. It was still elevated at 40 years, and data from studies of atomic bomb survivors show persistent effects at &gt;50 years [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subsequent studies in a variety of radiation-exposed children, including those receiving high dose exposure, have generally supported and expanded these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/2,9-12\">",
"     2,9-12",
"    </a>",
"    ]. In a pooled analysis of four observational studies of childhood cancer survivors (16,757 patients with 187 developing primary thyroid cancer), the risk of thyroid cancer after radiotherapy increased with radiation dose (RRs of 6.8 for 2 to 4 Gy and 14.9 for 5 to 9 Gy), plateaued between a dose of 10 and 30 Gy (RRs of 14.8 at 10 to 19 Gy and 15.2 at 20 to 29 Gy), and then declined with the highest doses (RRs 9.3 at 30 to 39 Gy and 5.1 at &gt;40 Gy) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/12\">",
"     12",
"    </a>",
"    ]. The pooled excess absolute risk at 10 Gy was 12.4 per 10,000 patient-years. The risk increased significantly with decreasing age at exposure (RR 17.5 and 3.9 for age at exposure &lt;5 years and &gt;15 years, respectively). The risk remained elevated more than 25 years after exposure.",
"   </p>",
"   <p>",
"    Exposure of children to low doses of I-131 (estimated mean thyroid dose of 174 mGy) over a prolonged period of time (13 years as a result of releases from the Hanford nuclear facility) was not associated with an increased risk of thyroid disease in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/13\">",
"     13",
"    </a>",
"    ]. On the other hand, children exposed to radiation, predominantly I-131, after the Chernobyl accident have developed thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. Additionally, among 1494 subjects aged 16 to 20 years who were exposed to I-131 fallout from the Chernobyl accident in utero, there was an increase in thyroid cancer; this is consistent with other data, but the risk estimate was based on only seven cases and was not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/17\">",
"     17",
"    </a>",
"    ]. It is not clear how far the Chernobyl experience can be extrapolated because other factors, such as iodine deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/14\">",
"     14",
"    </a>",
"    ] and exposure to short-lived iodine isotopes, may come into play.",
"   </p>",
"   <p>",
"    Ionizing radiation from medical imaging now accounts for nearly half of the radiation exposure experienced by the population in the United States. Concern has been raised about a potential increase in risk of thyroid cancer in children receiving frequent diagnostic x-rays, particularly CT scan. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link&amp;anchor=H244757#H244757\">",
"     \"Radiation-related risks of imaging studies\", section on 'Pediatrics'",
"    </a>",
"    .) The results of ongoing, large epidemiologic studies are needed to determine if there is a risk of thyroid cancer from diagnostic x-rays [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiation-exposed adults may also develop thyroid cancer. However, the risk is much lower than the risk in radiation-exposed children. As mentioned above, the pooled analysis did not detect a risk following adult exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/8\">",
"     8",
"    </a>",
"    ]. In a study of patients treated with hematopoietic cell transplantation (including total body irradiation), compared with nonirradiated patients, the risk of developing a second cancer was higher among patients irradiated at &lt;30 years of age, whereas there was no difference between nonirradiated and irradiated patients when treatments were given at &gt;30 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/21\">",
"     21",
"    </a>",
"    ]. The majority of second cancers, including thyroid, occurred among children &lt;17 years at the time of hematopoietic cell transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=see_link&amp;anchor=H31#H31\">",
"     \"Second malignancies after treatment of classical Hodgkin lymphoma\", section on 'Thyroid cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28280?source=see_link&amp;anchor=H15631842#H15631842\">",
"     \"Malignancy after hematopoietic cell transplantation\", section on 'Solid tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However there is some evidence for a risk, albeit a small one. In adult survivors exposed to atomic bomb fallout, the risk appeared to depend on the endpoint used for the estimate. For thyroid cancers &ge;10 mm, no statistically significant risk was evident [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/2\">",
"     2",
"    </a>",
"    ], but when the endpoint included small thyroid cancers, found in surgical or autopsy specimens, a dose-response relationship was found [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Further evidence of a risk from adult exposure comes from a study of 107 thyroid cancer cases and 423 controls among Chernobyl liquidators. The median thyroid dose was estimated to be 69 mGy and the observed, statistically significant excess relative risk (RR) at 100 mGy was 1.38 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults, a small increase in the absolute risk of secondary malignancies has been reported after radioiodine therapy for thyroid cancer. This topic is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34010?source=see_link&amp;anchor=H26#H26\">",
"     \"Radioiodine treatment of differentiated thyroid cancer\", section on 'Secondary malignancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H238696768\">",
"    <span class=\"h3\">",
"     Hypothyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood cancer survivors who receive higher dose head and neck radiation are also at risk for hypothyroidism. This topic is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=see_link&amp;anchor=H11#H11\">",
"     \"Disorders that cause hypothyroidism\", section on 'External neck irradiation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39223?source=see_link&amp;anchor=H103572081#H103572081\">",
"     \"Growth failure after childhood cancer: Role of hypothyroidism\", section on 'Thyroid disease in cancer survivors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatic mutations play a central role in the genesis of radiation-induced cancers (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/60/1990?source=see_link\">",
"     \"Overview of thyroid nodule formation\"",
"    </a>",
"    ). Even though radiation can cause the entire range of possible mutations, those resulting in breakage and rejoining of the DNA chain are most important [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These assumptions about radiation carcinogenesis are supported by work on the papillary thyroid cancers found in children in the aftermath of the nuclear power plant accident at Chernobyl in 1986 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In some papillary thyroid cancers, a translocation of the RET (rearranged during transfection) gene occurs, resulting in its constitutive expression and activation; this gene is not expressed in normal thyroid cells. The RET translocation has been found in a higher proportion of Chernobyl-related cancers than those not associated with radiation. Similarly, the frequency of RET translocations is increased in thyroid cancer cases associated with external radiation treatment for benign and malignant conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The specificity of RET translocations is illustrated by the observation that point mutations in the BRAF gene, the other common genetic activation in papillary thyroid cancer, are rarely found in radiation-related cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/20/43337?source=see_link&amp;anchor=H8#H8\">",
"     \"Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer\", section on 'Papillary thyroid cancer'",
"    </a>",
"    .) Thus far, it is not clear whether radiation-related papillary thyroid cancers containing translocations behave differently from cancers without them.",
"   </p>",
"   <p>",
"    Proliferative activity of normal human thyroid cells decreases with increasing age [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/32\">",
"     32",
"    </a>",
"    ]. This could explain, in part, the higher risk of radiation-related thyroid cancer in children rather than adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828503\">",
"    <span class=\"h1\">",
"     CLINICAL CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical characteristics of radiation-related benign and malignant thyroid nodules are not different from those of thyroid nodules in other patients. Most patients with radiation-related thyroid cancer present with a thyroid nodule, detected either by physical examination or imaging. Papillary thyroid cancer is the most common radiation-related histologic type [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/8,12\">",
"     8,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23191?source=see_link&amp;anchor=H8#H8\">",
"     \"Thyroid nodules and cancer in children\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a retrospective analysis of 4296 patients who received external radiation treatment before age 16 years for a variety of benign conditions, 1059 patients underwent thyroid surgery due to the presence of a suspicious thyroid lesion (detected either by physical examination or imaging) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/33\">",
"     33",
"    </a>",
"    ]. There were 612 malignant nodules in 358 patients, and 2037 benign nodules in 930 patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A solitary nodule had the same risk of malignancy as one of multiple nodules (18.8 versus 17.3 percent).",
"     </li>",
"     <li>",
"      Patients with multiple nodules were more likely to have cancer than those with a solitary nodule (30.7 versus 18.7 percent).",
"     </li>",
"     <li>",
"      FNA of the two largest nodules in each patient missed micropapillary cancers in 17 percent of patients.",
"     </li>",
"     <li>",
"      More than half of the patients had multifocal cancers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12519856\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because children with a history of external radiation exposure to the neck region or environmental radiation exposure are at risk for developing thyroid nodules and thyroid cancer, they require regular thyroid examinations. The evaluation typically includes a history, physical examination, and assessment of thyroid function tests [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/34\">",
"     34",
"    </a>",
"    ]. Thyroid ultrasound is frequently used, based on estimation of risk factors (especially the radiation dose) to screen for nonpalpable nodules in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical records of patients with a history of childhood cancer treated with external radiation therapy to the neck region should be reviewed to determine the dose and site of radiation, as well as the age of radiation exposure. Cranial, nasopharyngeal, oropharyngeal, neck, cervical spine, upper chest, mantle, mediastinal, and total body irradiation can potentially increase the risk of thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, all patients with thyroid disease who grew up in the era when radiation was used to treat a wide variety of nonmalignant conditions, chiefly during the 1940s and 1950s, should be asked about radiation exposure. For those who were exposed, the actual records usually are not available. Nevertheless, a few guidelines are helpful in obtaining and evaluating the history, remembering that the goal is to determine the thyroid radiation dose.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Confirmatory history is that the mother was asked to leave the room when the treatment was administered. Contradictory history is memory of a purple light (UV treatment) and the presence of the mother or other personnel in the room during treatment.",
"     </li>",
"     <li>",
"      Dermatologists used radiation treatments. For chronic cystic acne, of which the residua might still be clinically noticeable, penetrating x-rays were used. This should be distinguished from UV treatment and nonpenetrating x-ray treatment (Grenz rays).",
"     </li>",
"     <li>",
"      Many doctors' offices were equipped with fluoroscope machines that were used during routine examinations.",
"     </li>",
"     <li>",
"      Radiation-tipped rods were placed through the nose into the posterior pharynx to shrink the tonsils and adenoids of children. During this treatment only a very small amount of radiation reached the thyroid gland and the risk is proportionately smaller or absent [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/36,37\">",
"       36,37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who have been exposed to nuclear fall-out (from testing, accidents, or in Japanese survivors of atomic bombing) are typically aware of the exposure and are followed as a cohort for radiation-related adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All patients with a history of radiation exposure to the thyroid should have a yearly thyroid examination. The thyroid-related physical examination is no different for radiation-exposed and non-exposed patients. The neck should be palpated to assess the size of the thyroid gland, for the presence of firm or dominant nodules, and for cervical adenopathy. In general, physical examination has a low accuracy for predicting thyroid cancer. However, a fixed hard mass, obstructive symptoms, cervical lymphadenopathy or vocal cord paralysis all suggest the possibility of cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'History and physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828245\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid function should be assessed in all patients with a history of high dose thyroid irradiation. External irradiation of the neck (in doses of 25 Gy or more) also causes hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/38\">",
"     38",
"    </a>",
"    ]. The effect is dose-dependent, the onset is gradual, and many patients have subclinical hypothyroidism for several years before developing overt disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=see_link&amp;anchor=H11#H11\">",
"     \"Disorders that cause hypothyroidism\", section on 'External neck irradiation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39223?source=see_link&amp;anchor=H103572081#H103572081\">",
"     \"Growth failure after childhood cancer: Role of hypothyroidism\", section on 'Thyroid disease in cancer survivors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with a history of cranial or nasopharyngeal irradiation, who are at risk for central hypothyroidism, we measure TSH and free T4. For patients with radiation confined to the neck area alone, who are at risk for primary hypothyroidism, measurement of TSH is sufficient. If the serum TSH concentration is elevated, the TSH measurement should be repeated along with a serum free T4 to make the diagnosis of hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnosis of and screening for hypothyroidism\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing is initiated within the first year and is carried out annually. We also measure serum thyroglobulin at least once. Following radiation treatment of benign conditions, serum thyroglobulin is related to the risk of developing thyroid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. In a study of 172 children with cancer, including 47 who were treated with radiation, thyroglobulin measurements were useful in identifying thyroid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid ultrasound should be performed in all patients with a suspected palpable thyroid nodule or nodular goiter on physical examination or with nodules incidentally noted on other imaging studies (carotid ultrasound, CT, MRI, or FDG-PET scan). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Thyroid ultrasonography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, an important question is whether thyroid ultrasonography should be performed as a screening test in radiation-exposed patients whose physical examination is normal. Many patients with a history of radiation exposure during childhood have nonpalpable thyroid nodules. This was illustrated by a report in which 54 patients with low dose childhood exposure underwent thyroid ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/39\">",
"     39",
"    </a>",
"    ]. Although most of the patients had no palpable nodules, 47 had 157 nodules on ultrasonography. The nodules ranged in size from a few millimeters to 3.0 cm (",
"    <a class=\"graphic graphic_figure graphicRef63470 \" href=\"UTD.htm?26/55/27517\">",
"     figure 2",
"    </a>",
"    ). Eleven nodules were 1.5 cm or larger, only five of which could be palpated.",
"   </p>",
"   <p>",
"    Although there are several ultrasonographic findings that are suspicious for thyroid cancer, the predictive value of these characteristics varies widely, and we do not rely on thyroid ultrasound alone to diagnose thyroid cancer or to select patients for surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/62/21482?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of the clinical utility of ultrasonography in thyroid disease\", section on 'Criteria for identifying cancer'",
"    </a>",
"    .) Thyroid ultrasound findings are used to select nodules for fine needle aspiration biopsy. Because thyroid ultrasound is more sensitive than physical examination in detecting thyroid nodules, screening irradiated patients with thyroid ultrasound will result in many more FNA biopsies (and potentially surgical procedures) for benign nodular disease. In one decision model, screening with ultrasound in 10,000 patients with low dose environmental exposure would detect an additional 27 thyroid cancers compared with those screened with palpation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/42\">",
"     42",
"    </a>",
"    ]. However, an additional 51 patients would have thyroid surgery for nonmalignant nodules (compared with 17 patients screened with palpation).",
"   </p>",
"   <p>",
"    The absence of thyroid nodules on a single thyroid ultrasound examination does not predict the absence of nodular growth and thyroid cancer development in the future. In a prospective study of ultrasound examination in 2637 atomic-bomb survivors during an average follow-up of 13.3 years, six thyroid cancer cases were found among 68 subjects who had a solid thyroid nodule (7.3 percent) on baseline screening, one case among 121 subjects who had a thyroid cyst (0.8 percent), and seven cases among 2434 (0.3 percent) patients who did not have any nodules on baseline examination [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/43\">",
"     43",
"    </a>",
"    ]. Thus, to be most effective as a screening tool, thyroid ultrasound would have to be repeated at regular intervals.",
"   </p>",
"   <p>",
"    The arguments for screening thyroid ultrasound are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ultrasonography is the most sensitive method of imaging the thyroid, does not involve further radiation exposure, and is performed without stopping thyroid hormone therapy",
"     </li>",
"     <li>",
"      Nodules sized 1.0 to 1.5 cm, and even larger ones, are not always palpable, but are easily detected by ultrasonography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The opposing arguments are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinically important nodules will be detected by physical examination",
"     </li>",
"     <li>",
"      Detection of small nodules may result in anxiety and inappropriate evaluation and treatment, and the complications of unneeded therapy may be greater than the potential risk from the nodules",
"     </li>",
"     <li>",
"      The cost of screening a large number of patients is too high",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no trials that evaluate screening ultrasonography in radiation exposed children. Studies are needed to determine if long-term outcomes are better in patients diagnosed with thyroid cancer via screening ultrasound versus palpation. In the absence of such studies, the author believes that ultrasonography in patients with a history of radiation should be guided by an assessment of each patient's risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/35\">",
"     35",
"    </a>",
"    ]. In an attempt to identify patients at highest risk for the development of thyroid cancer, one group combined data from three childhood cancer survivor databases to develop risk prediction models that project the absolute thyroid cancer risk among five-year survivors of childhood cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/44\">",
"     44",
"    </a>",
"    ]. The model that included gender, birth after 1970, age &lt;15 years when diagnosed with a childhood cancer, prior diagnosis of a thyroid nodule, history of radiation therapy including the neck, and history of treatment with an alkylating agent had the best overall discriminatory performance. This model performed as well as one that included a reconstructed radiation absorbed dose to the thyroid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/44\">",
"     44",
"    </a>",
"    ]. Further validation is required before this risk prediction tool can be used to guide clinical monitoring for thyroid cancer.",
"   </p>",
"   <p>",
"    The author considers the following risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/12,41,45\">",
"     12,41,45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age &mdash; Given the steep decline in risk with increasing age of exposure, being exposed before age 18 is a reasonable threshold to include in the risk assessment.",
"     </li>",
"     <li>",
"      Dose &mdash; All patients who had radiation treatments for childhood malignancies that included the neck area should be considered at high risk.",
"      <br/>",
"      <br/>",
"      Low dose exposure, estimated to be greater than 100 mGy to the thyroid at a young age, is also considered high risk. With rare exceptions, this excludes patients with exposure limited to diagnostic radiology. Above 100 mGy, the pooled analysis shows that the relative risk is proportional to dose and inversely proportional to age at exposure.",
"     </li>",
"     <li>",
"      Female gender &mdash; While the radiation-associated relative risk is not demonstrably different for males and females, the absolute risk is higher for females because of their higher baseline risk.",
"     </li>",
"     <li>",
"      A high serum thyroglobulin concentration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, for childhood cancer survivors, largely based on their high dose, one reasonable ultrasound-based follow-up regimen is as follows: Ultrasound at baseline, at five years, and then annually if nodule(s) are found, or approximately every two years if no nodules are found [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/46\">",
"     46",
"    </a>",
"    ]. In contrast, the Children's Oncology Group long-term follow-up guidelines recommend thyroid ultrasound whenever a palpable nodule is present [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/34\">",
"     34",
"    </a>",
"    ]. While the guidelines do not endorse screening ultrasound, the rationale supporting this recommendation is not provided.",
"   </p>",
"   <p>",
"    Unfortunately, for patients with low dose exposure at a young age (for nonmalignant conditions), accurate dosimetry is usually not available. When dosing information is not available, the author usually suggests ultrasound screening, but only after a discussion of its potential risks (biopsy and potential surgery for benign nodules) and benefits (early diagnosis and treatment of thyroid cancer) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/42\">",
"     42",
"    </a>",
"    ]. For low dose childhood exposure, we typically repeat every three to five years unless prior findings (eg, small",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    FNA-benign nodules) indicate a shorter interval. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Monitoring'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Benign nodules'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828529\">",
"    <span class=\"h2\">",
"     Fine needle aspiration biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fine-needle-aspiration (FNA) biopsy is the most informative method for characterizing thyroid nodules. The sensitivity of FNA appears to be similar for nodules in the general population and in patients exposed to radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/47\">",
"     47",
"    </a>",
"    ]. In patients with thyroid nodules, however, a history of radiation exposure increases the likelihood that the nodule is a thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/43,48\">",
"     43,48",
"    </a>",
"    ]. According to the American Thyroid Association guidelines, in irradiated patients, all accessible nodules, usually those larger than 0.5 cm, should be biopsied whether they are palpable or detected by ultrasonography alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/49\">",
"     49",
"    </a>",
"    ]. The author agrees with this, especially if the nodule is in a high risk patient or has appeared in the interval since a prior ultrasound. Some thyroid specialists feel that the threshold should be 1.0 cm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12520001\">",
"    <span class=\"h2\">",
"     Other radiation-related tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation exposure is also associated with increases in tumors of the parathyroid glands (causing hyperparathyroidism), salivary glands, and neural tissue. Therefore, the evaluation of a radiation-exposed patient should also include measurement of serum calcium as part of a patient's regular general medical check-ups, and probably not less than every three years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12520090\">",
"    <span class=\"h3\">",
"     Parathyroid adenomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between head and neck radiation and hyperparathyroidism has been confirmed by studies establishing a dose-response relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30361?source=see_link&amp;anchor=H6#H6\">",
"     \"Pathogenesis and etiology of primary hyperparathyroidism\", section on 'Radiation exposure'",
"    </a>",
"    .) Occasionally, a nonfunctioning parathyroid adenoma is discovered during thyroid surgery. Whether these adenomas are related to radiation or have any clinical importance is not known.",
"   </p>",
"   <p>",
"    One study compared the clinical presentation and course of hyperparathyroidism in 458 patients, of whom 49 had been exposed to radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/52\">",
"     52",
"    </a>",
"    ]. The exposed patients had higher serum parathyroid hormone concentrations, but the serum calcium concentrations in the two groups were the same. There were no clinically important differences with respect to presentation, pathology, or recurrences during six years of follow-up.",
"   </p>",
"   <p>",
"    One difference was that the exposed patients with hyperparathyroidism had more concurrent thyroid tumors. This is not surprising, given the results of ultrasonography in exposed patients noted above, but it does make treatment more difficult.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior to parathyroidectomy, patients should have a thyroid ultrasound, and all suspicious nodules should be biopsied prior to surgery. Treatment of the thyroid nodule should be individualized according to the results of the biopsy. Some patients may require concomitant parathyroidectomy and thyroidectomy. Even if the hyperparathyroidism can be managed without surgery, all suspicious thyroid nodules should be biopsied. Treatment of the thyroid nodules should be individualized according to the results of the biopsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H24#H24\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For hyperparathyroid patients with evidence of single gland disease and no concomitant thyroid nodules, a history of radiation exposure does not preclude a minimally invasive surgical approach. This suggestion is based upon a retrospective study of the surgical findings of 412 hyperparathyroid patients, 53 with prior radiation exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=see_link&amp;anchor=H10#H10\">",
"       \"Management of primary hyperparathyroidism\", section on 'Surgical procedure'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12520097\">",
"    <span class=\"h3\">",
"     Salivary gland tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between benign and malignant salivary gland tumors and radiation exposure has been established by studies of dose-response relationships [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Because almost all of these tumors occur at or close to the surface of the body, the history and physical examination are usually sufficient to identify these tumors. Approximately twice as many tumors are benign as are malignant, a ratio similar to that with thyroid nodules. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12520104\">",
"    <span class=\"h3\">",
"     Schwannomas and other neural tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neural tumors most often found in patients with a history of head and neck radiation are schwannomas and meningiomas [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/56\">",
"     56",
"    </a>",
"    ]. These tumors are usually discovered as a result of a careful history and physical examination; routine imaging for screening purposes is not indicated. Among these tumors, schwannomas originating on the acoustic nerve (acoustic neuromas) are the most common, and should be looked for in any patient with a history of radiation exposure who complains of headache, vertigo, or unilateral hearing loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12520341\">",
"    <span class=\"h2\">",
"     Autoimmune thyroid disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been thought that radiation may increase the possibility of developing markers of autoimmune thyroid disease, although the evidence for this and developing hypothyroidism are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/10,13,57-60\">",
"     10,13,57-60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Twelve to 15 years after the Chernobyl accident, thyroid peroxidase (TPO) antibodies were elevated with a dose-response relationship in a cohort of radiation-exposed individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/59\">",
"       59",
"      </a>",
"      ]. In the same cohort, a small increase in subclinical hypothyroidism related to the level of radiation exposure was found [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/61\">",
"       61",
"      </a>",
"      ]. However, the risk of subclinical hypothyroidism was",
"      <strong>",
"       less",
"      </strong>",
"      when TPO antibodies were present. In another study in the Chernobyl region comparing people in high and low exposure levels, the prevalence of TPO antibodies increased and then abated without evidence of appreciable levels of hypothyroidism [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 71 men occupationally exposed in a nuclear power plant in Germany, there were higher serum TSH levels than in non-workers, but no increase in TPO antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the long-term follow-up of atomic bomb survivors, no dose-response relationship was found for autoimmune thyroid disease, the strongest evidence so far that no association exists [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/10\">",
"       10",
"      </a>",
"      ]. Similarly, the long-term follow-up of people exposed by the releases from the Hanford nuclear facility found no increase in autoimmune thyroid disease and hypothyroidism [",
"      <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the preponderance of evidence so far does not support routine screening for autoimmune thyroid disease and hypothyroidism in individuals with a history of low dose radiation exposure. In contrast, childhood cancer survivors who receive higher dose head and neck radiation (typically &gt;25 Gy) are at risk for hypothyroidism and require annual assessment of thyroid function tests. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Monitoring'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=see_link&amp;anchor=H11#H11\">",
"     \"Disorders that cause hypothyroidism\", section on 'External neck irradiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828683\">",
"    <span class=\"h2\">",
"     Thyroid cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of radiation-induced thyroid cancer can be predicted with fair reliability by a series of risk factors. These risk factors, which were identified in several large longitudinal studies using multivariate analysis, include age; size, invasiveness, and histological grade of the cancer; and presence of metastases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/16/14599?source=see_link\">",
"     \"Clinicopathologic staging of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a study of 296 patients with radiation-related thyroid cancers, although multicentricity was frequent, the risk factors for recurrence were similar to those for thyroid-cancer patients in general [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/63\">",
"     63",
"    </a>",
"    ]. Similarly, in a case-control study of thyroid cancer (91 radiation-related cases versus 273 cases with no radiation exposure) recurrences and thyroid cancer-related death were similar [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/64\">",
"     64",
"    </a>",
"    ]. Therefore, patients with radiation-related thyroid cancer should be treated in the same way as non-exposed patients with thyroid cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link\">",
"     \"Overview of the management of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This conclusion has been validated by the findings in patients exposed to radiation as a result of the Chernobyl accident. Even though their thyroid cancers tended to have aggressive histologic features, controlled studies have shown that recurrence rates were not higher in radiation exposed patients versus patients with sporadic thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. After an average clinical follow-up of 10 years, the disease-specific mortality rate in these thyroid cancer cases is &lt;1 percent, and short-term recurrence rates range from 7 to 28 percent (mean 17 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828690\">",
"    <span class=\"h2\">",
"     Benign nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with surgically confirmed benign nodules (ie, nodule with suspicious cytology on FNA which when resected had benign pathology), a history of radiation exposure supports postoperative thyroid hormone treatment, even if only one lobe was removed, because it appears to reduce recurrences. In a nonrandomized study of 632 adults who were treated prior to age 16 with conventional radiation for nonmalignant conditions and who subsequently had benign thyroid nodules removed surgically, patients who were treated with thyroid hormone had a lower incidence of recurrent nodules than those who were not (14 versus 34 percent, RR 0.69, 95% CI 0.47-1.01) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/68\">",
"     68",
"    </a>",
"    ]. Histologic analysis of 91 tissue samples from patients with recurrent nodules showed that 18 percent were malignancies and that thyroid hormone treatment had no effect on the rate of malignancy. Thus, thyroid hormone reduced the risk of new nodules, but it did not reduce the risk of thyroid cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22535?source=see_link\">",
"     \"Thyroid hormone suppressive therapy for thyroid nodules and benign goiter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency and method of follow-up of irradiated patients depends upon their estimated risk and the clinical findings at the initial evaluation. If the initial examination is normal and the level of risk is low, then annual palpation is reasonable. When the exposure occurred years earlier and the risk is high, usually based on an estimate of a large dose exposure at a young age, we perform ultrasound every two to five years in addition to annual palpation.",
"   </p>",
"   <p>",
"    The follow-up of patients with biopsy-proven benign nodules should include at least annual palpation and repeat ultrasonography, initially at 6 to 12 months, then at increasing intervals over time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Benign nodules'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The increased risk of thyroid cancer resulting from radiation exposure during childhood persists for at least four decades [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/8\">",
"     8",
"    </a>",
"    ]. Thereafter, it begins to decline, but has not reached baseline for as long as observations have been made. Periodic repetition of thyroid ultrasonography in high risk patients may also disclose previously missed neoplasms. In 140 subjects in a Chernobyl-related study with confirmed nodules, about 10 to 25 percent of the nodules were present on follow-up that were not diagnosed on earlier imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific long-term follow-up guidelines after treatment of childhood cancer (those who have received head or neck radiation) have been published by the",
"    <a class=\"external\" href=\"file://www.survivorshipguidelines.org/\">",
"     Children's Oncology Group",
"    </a>",
"    . Because high dose exposure may lead to hypothyroidism, a yearly history, physical exam, free T4 and TSH are recommended. For these patients, the author suggests a thyroid ultrasound early in follow-up to serve as a baseline comparator followed in about five years (based on the shortest reported latency observed in the Chernobyl area).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4845394\">",
"    <span class=\"h1\">",
"     PREVENTION OF RADIATION-RELATED THYROID DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4845402\">",
"    <span class=\"h2\">",
"     Medical radiation exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;While radiation exposure of the thyroid during the treatment of benign medical conditions has decreased, exposure from diagnostic procedures (eg, computerized tomography, CT) is increasing rapidly, particularly among children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/19\">",
"     19",
"    </a>",
"    ]. In many cases, the exposure is greater than necessary. Efforts to minimize exposure include the &ldquo;image gently&rdquo; campaign initiated by radiologists. In addition, clinicians providing direct patient care should evaluate the risks and benefits of any procedure, explain them to the patient or parent, and consider strategies to reduce radiation risks to the thyroid gland. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link&amp;anchor=H244757#H244757\">",
"     \"Radiation-related risks of imaging studies\", section on 'Pediatrics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Potassium iodide for thyroid protection in a nuclear accident",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the event of a nuclear accident,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/27/30134?source=see_link\">",
"     potassium iodide",
"    </a>",
"    tablets, taken once daily, can decrease thyroid uptake of radioactive iodine. Potassium iodide can almost completely protect the thyroid if administered within 12 hours before radioactive iodine exposure; after an exposure, the degree of protection declines (80, 40, and 7 percent after 2, 8, and 24 hours, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25193?source=see_link\">",
"     \"Management of radiation exposure in children following a nuclear disaster\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/27/30134?source=see_link\">",
"     Potassium iodide",
"    </a>",
"    (KI) is well tolerated, as shown by the experience of administering it to a large population in Poland after the Chernobyl accident [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/71\">",
"     71",
"    </a>",
"    ]. In older people, especially those with goiters, one might expect rare cases of iodine-induced hyper- or hypothyroidism. It has been estimated that for the fetus, the newborn, children, and adolescents, the benefit of preventing radiation-induced thyroid cancer in the event of an accidental exposure outweighs the potential risk of hypothyroidism. In older adults, arbitrarily taken as above 40 years, the potential benefits of potassium iodide prophylaxis probably do not outweigh the risks, except for exposure levels that threaten to produce hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/72\">",
"     72",
"    </a>",
"    ]. Thus, in the event of an accident, iodine prophylaxis should be given, with the possible exception of older adults. Treatment should begin as soon as possible after exposure, and continued for the duration of the exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/49/1818/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    KI tablets and a solution designed for children are available commercially without a prescription. Alternatively, for children, KI tablets may be dissolved according to directions found at the",
"    <a class=\"external\" href=\"file://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm072254.htm\">",
"     US Food and Drug Administration website",
"    </a>",
"    and the",
"    <a class=\"external\" href=\"file://www.thyroid.org/questions-and-answers-about-potassium-iodide-ki-american-thyroid-association/\">",
"     American Thyroid Association website",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H879756\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiation exposure of the thyroid during childhood is the most clearly defined environmental factor associated with benign and malignant thyroid tumors. The predominant types of radiation are therapeutic external radiation for the treatment of cancer, historical use of external radiation to treat a wide variety of nonmalignant conditions, and exposure to nuclear fallout (from testing, accidents, or in Japanese survivors of atomic bombing). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Radiation exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical characteristics of radiation-related benign and malignant thyroid nodules are not different from those of thyroid nodules in non-exposed patients. Most patients with radiation-related thyroid cancer present with a thyroid nodule, detected either by physical examination or imaging. (See",
"      <a class=\"local\" href=\"#H1828503\">",
"       'Clinical characteristics'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23191?source=see_link&amp;anchor=H8#H8\">",
"       \"Thyroid nodules and cancer in children\", section on 'Clinical presentation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The medical records of patients with a history of childhood cancer treated with external radiation therapy to the neck region should be reviewed to determine the dose and site of radiation, as well as the age of radiation exposure. Cranial, nasopharyngeal, oropharyngeal, neck, cervical spine, upper chest, mantle, mediastinal, and total body irradiation can potentially increase the risk of thyroid cancer. All patients with thyroid disease who grew up in the era when radiation was used to treat nonmalignant conditions, chiefly during the 1940s and 1950s, should be asked about radiation exposure. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thyroid function should be assessed in all patients with history of high dose thyroid irradiation. In patients with a history of cranial or nasopharyngeal irradiation, who are at risk for both thyroid nodules and central hypothyroidism, we measure TSH and free T4. For patients with radiation confined to the neck area alone, measurement of TSH is sufficient. We also measure serum thyroglobulin at least once. (See",
"      <a class=\"local\" href=\"#H1828245\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thyroid ultrasonography is indicated in those patients who develop a palpable nodule. Multiple nodules are more common in exposed patients, a finding that could be missed without ultrasonography. Fine needle aspiration (FNA) biopsy is the most informative method for characterizing thyroid nodules. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ultrasound'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1828529\">",
"       'Fine needle aspiration biopsy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of screening thyroid ultrasound to detect nodules in radiation-exposed patients should be guided by individual risk factors, including dose of radiation to the thyroid, when it is available, and young age of exposure. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of recurrences and thyroid cancer-related death are similar in radiation-exposed and non-exposed patients. Therefore, patients with radiation-related thyroid cancer should be treated in the same way as non-exposed patients with thyroid cancer. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link\">",
"       \"Overview of the management of differentiated thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The frequency and method of follow-up of irradiated patients without thyroid nodules or thyroid cancer depends upon their estimated risk and the clinical findings at the initial evaluation. If the initial exam is normal, annual palpation and repeat thyroid ultrasonography every two to five years, or more frequently in selected cases, is a reasonable approach. The increased risk of thyroid cancer resulting from radiation exposure during childhood persists for at least four decades. Thereafter, it begins to decline, but has not reached baseline for as long as observations have been made. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      External radiation to the head and neck area is also associated with increases in tumors of the parathyroid glands, salivary glands, and neural tissue. (See",
"      <a class=\"local\" href=\"#H12520001\">",
"       'Other radiation-related tumors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/1\">",
"      Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006; 36 Suppl 2:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/2\">",
"      Furukawa K, Preston D, Funamoto S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer 2013; 132:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/3\">",
"      Land CE, Bouville A, Apostoaei I, Simon SL. Projected lifetime cancer risks from exposure to regional radioactive fallout in the Marshall Islands. Health Phys 2010; 99:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/4\">",
"      Cardis E, Howe G, Ron E, et al. Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006; 26:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/5\">",
"      Yasumura S, Hosoya M, Yamashita S, et al. Study protocol for the Fukushima Health Management Survey. J Epidemiol 2012; 22:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/6\">",
"      Davies SM. Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies. Pediatr Blood Cancer 2007; 48:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/7\">",
"      Taylor AJ, Croft AP, Palace AM, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 2009; 125:2400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/8\">",
"      Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/9\">",
"      Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000; 85:3227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/10\">",
"      Imaizumi M, Usa T, Tominaga T, et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 2006; 295:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/11\">",
"      Sadetzki S, Chetrit A, Lubina A, et al. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91:4798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/12\">",
"      Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012; 178:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/13\">",
"      Davis S, Kopecky KJ, Hamilton TE, et al. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA 2004; 292:2600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/14\">",
"      Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005; 97:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/15\">",
"      Tronko MD, Howe GR, Bogdanova TI, et al. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst 2006; 98:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/16\">",
"      Zablotska LB, Ron E, Rozhko AV, et al. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2011; 104:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/17\">",
"      Hatch M, Brenner A, Bogdanova T, et al. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab 2009; 94:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/18\">",
"      Brenner AV, Tronko MD, Hatch M, et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011; 119:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/19\">",
"      Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010; 31:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/20\">",
"      Schonfeld SJ, Lee C, Berrington de Gonz&aacute;lez A. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) 2011; 23:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/21\">",
"      Rizzo JD, Curtis RE, Soci&eacute; G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/22\">",
"      Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009; 20:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/23\">",
"      Hayashi Y, Lagarde F, Tsuda N, et al. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer 2010; 116:1646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/24\">",
"      Kesminiene A, Evrard AS, Ivanov VK, et al. Risk of thyroid cancer among chernobyl liquidators. Radiat Res 2012; 178:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/25\">",
"      Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000; 290:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/26\">",
"      Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995; 11:2459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/27\">",
"      Nikiforov YE, Rowland JM, Bove KE, et al. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997; 57:1690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/28\">",
"      Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997; 15:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/29\">",
"      Collins BJ, Chiappetta G, Schneider AB, et al. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 2002; 87:3941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/30\">",
"      Nikiforova MN, Ciampi R, Salvatore G, et al. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Lett 2004; 209:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/31\">",
"      Ciampi R, Knauf JA, Kerler R, et al. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 2005; 115:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/32\">",
"      Saad AG, Kumar S, Ron E, et al. Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab 2006; 91:2672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/33\">",
"      Mihailescu DV, Schneider AB. Size, number, and distribution of thyroid nodules and the risk of malignancy in radiation-exposed patients who underwent surgery. J Clin Endocrinol Metab 2008; 93:2188.",
"     </a>",
"    </li>",
"    <li>",
"     CureSearch Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, October 2008. file://www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdf (Accessed on November 12, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/35\">",
"      Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab 2005; 1:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/36\">",
"      Yeh H, Matanoski GM, Sandler DP, et al. Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County, Maryland. Am J Epidemiol 2001; 153:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/37\">",
"      Ronckers CM, Van Leeuwen FE, Hayes RB, et al. Cancer incidence after nasopharyngeal radium irradiation. Epidemiology 2002; 13:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/38\">",
"      Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995; 31:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/39\">",
"      Schneider AB, Bekerman C, Leland J, et al. Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 1997; 82:4020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/40\">",
"      Schneider AB, Bekerman C, Favus M, et al. Continuing occurrence of thyroid nodules after head and neck irradiation. Relation to plasma thyroglobulin concentration. Ann Intern Med 1981; 94:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/41\">",
"      Lando A, Holm K, Nysom K, et al. Serum thyroglobulin as a marker of thyroid neoplasms after childhood cancer. Acta Paediatr 2003; 92:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/42\">",
"      Eden K, Mahon S, Helfand M. Screening high-risk populations for thyroid cancer. Med Pediatr Oncol 2001; 36:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/43\">",
"      Imaizumi M, Usa T, Tominaga T, et al. Long-term prognosis of thyroid nodule cases compared with nodule-free controls in atomic bomb survivors. J Clin Endocrinol Metab 2005; 90:5009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/44\">",
"      Kovalchik SA, Ronckers CM, Veiga LH, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol 2013; 31:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/45\">",
"      Momani MS, Shore-Freedman E, Collins BJ, et al. Familial concordance of thyroid and other head and neck tumors in an irradiated cohort: analysis of contributing factors. J Clin Endocrinol Metab 2004; 89:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/46\">",
"      Piccardo A, Foppiani L, Puntoni M, et al. Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor. Q J Nucl Med Mol Imaging 2012; 56:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/47\">",
"      Hatipoglu BA, Gierlowski T, Shore-Freedman E, et al. Fine-needle aspiration of thyroid nodules in radiation-exposed patients. Thyroid 2000; 10:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/48\">",
"      Nagataki S, Hirayu H, Izumi M, et al. High prevalence of thyroid nodule in area of radioactive fallout. Lancet 1989; 2:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/49\">",
"      American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/50\">",
"      Schneider AB, Gierlowski TC, Shore-Freedman E, et al. Dose-response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab 1995; 80:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/51\">",
"      Tisell LE, Carlsson S, Fj&auml;lling M, et al. Hyperparathyroidism subsequent to neck irradiation. Risk factors. Cancer 1985; 56:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/52\">",
"      Tezelman S, Rodriguez JM, Shen W, et al. Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy. J Am Coll Surg 1995; 180:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/53\">",
"      Rahbari R, Sansano IG, Elaraj DM, et al. Prior head and neck radiation exposure is not a contraindication to minimally invasive parathyroidectomy. J Am Coll Surg 2010; 210:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/54\">",
"      Land CE, Saku T, Hayashi Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 1996; 146:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/55\">",
"      Schneider AB, Lubin J, Ron E, et al. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res 1998; 149:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/56\">",
"      Sznajder L, Abrahams C, Parry DM, et al. Multiple schwannomas and meningiomas associated with irradiation in childhood. Arch Intern Med 1996; 156:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/57\">",
"      Eheman CR, Garbe P, Tuttle RM. Autoimmune thyroid disease associated with environmental thyroidal irradiation. Thyroid 2003; 13:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/58\">",
"      V&ouml;lzke H, Werner A, Wallaschofski H, et al. Occupational exposure to ionizing radiation is associated with autoimmune thyroid disease. J Clin Endocrinol Metab 2005; 90:4587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/59\">",
"      Tronko MD, Brenner AV, Olijnyk VA, et al. Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab 2006; 91:4344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/60\">",
"      Kindler S, Roser M, Below H, et al. Thyroid disorders in employees of a nuclear power plant. Thyroid 2006; 16:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/61\">",
"      Ostroumova E, Brenner A, Oliynyk V, et al. Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident (1998-2000). Environ Health Perspect 2009; 117:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/62\">",
"      Agate L, Mariotti S, Elisei R, et al. Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. J Clin Endocrinol Metab 2008; 93:2729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/63\">",
"      Schneider AB, Recant W, Pinsky SM, et al. Radiation-induced thyroid carcinoma. Clinical course and results of therapy in 296 patients. Ann Intern Med 1986; 105:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/64\">",
"      Rubino C, Cailleux AF, Abbas M, et al. Characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort. Thyroid 2002; 12:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/65\">",
"      Nikiforov YE. Radiation-induced thyroid cancer: what we have learned from chernobyl. Endocr Pathol 2006; 17:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/66\">",
"      Rumyantsev PO, Saenko VA, Ilyin AA, et al. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer. J Clin Endocrinol Metab 2011; 96:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/67\">",
"      Tuttle RM, Vaisman F, Tronko MD. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future? Clin Oncol (R Coll Radiol) 2011; 23:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/68\">",
"      Subbiah S, Collins BJ, Schneider AB. Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid 2007; 17:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/69\">",
"      O'Kane P, Shelkovoy E, McConnell RJ, et al. Frequency of undetected thyroid nodules in a large I-131-exposed population repeatedly screened by ultrasonography: results from the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases following the Chornobyl accident. Thyroid 2010; 20:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/70\">",
"      Zanzonico PB, Becker DV. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys 2000; 78:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/49/1818/abstract/71\">",
"      Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94:524.",
"     </a>",
"    </li>",
"    <li>",
"     Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Distribution and administration of potassium iodide in the event of a nuclear incident. National Research Council of the national Academies. National Academies of Science, 2004.",
"    </li>",
"    <li>",
"     The Medical Letter 2002; 44:95.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7059 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-E0FBF310BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1818=[""].join("\n");
var outline_f1_49_1818=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H879756\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RADIATION EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Magnitude of risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H238696761\">",
"      - Thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H238696768\">",
"      - Hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1828503\">",
"      CLINICAL CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12519856\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828245\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828529\">",
"      Fine needle aspiration biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12520001\">",
"      Other radiation-related tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12520090\">",
"      - Parathyroid adenomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12520097\">",
"      - Salivary gland tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12520104\">",
"      - Schwannomas and other neural tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12520341\">",
"      Autoimmune thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828683\">",
"      Thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828690\">",
"      Benign nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4845394\">",
"      PREVENTION OF RADIATION-RELATED THYROID DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4845402\">",
"      Medical radiation exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Potassium iodide for thyroid protection in a nuclear accident",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H879756\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7059\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7059|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/5/22623\" title=\"figure 1\">",
"      Radiation thyroid ca dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/55/27517\" title=\"figure 2\">",
"      Thyroid nodules after radiation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=related_link\">",
"      Biology and clinical features of radiation injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/17/17689?source=related_link\">",
"      Clinical features of radiation exposure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/16/14599?source=related_link\">",
"      Clinicopathologic staging of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=related_link\">",
"      Disorders that cause hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39223?source=related_link\">",
"      Growth failure after childhood cancer: Role of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28280?source=related_link\">",
"      Malignancy after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/47/8954?source=related_link\">",
"      Management of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/38/25193?source=related_link\">",
"      Management of radiation exposure in children following a nuclear disaster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/20/43337?source=related_link\">",
"      Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/62/21482?source=related_link\">",
"      Overview of the clinical utility of ultrasonography in thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/60/1990?source=related_link\">",
"      Overview of thyroid nodule formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30361?source=related_link\">",
"      Pathogenesis and etiology of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34010?source=related_link\">",
"      Radioiodine treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=related_link\">",
"      Second malignancies after treatment of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22535?source=related_link\">",
"      Thyroid hormone suppressive therapy for thyroid nodules and benign goiter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23191?source=related_link\">",
"      Thyroid nodules and cancer in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/17/38170?source=related_link\">",
"      Treatment of radiation injury in the adult",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_49_1819="TIMI flow grades";
var content_f1_49_1819=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Thrombolysis in myocardial infarction (TIMI) flow grading system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Grade 0 - Complete occlusion of the infarct-related artery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grade 1 - Some penetration of contrast material beyond the point of",
"obstruction but without perfusion of the distal coronary bed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grade 2 - Perfusion of the entire infarct vessel into the distal bed",
"but with delayed flow compared with a normal artery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grade 3 - Full perfusion of the infarct vessel with normal flow",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Chesebro JH, Knatterud G, Roberts R, et al. Circulation 1987; 76:142.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1819=[""].join("\n");
var outline_f1_49_1819=null;
var title_f1_49_1820="Dsyphagia questions patients";
var content_f1_49_1820=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Questions to ask patients with dysphagia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Do you have problems initiating a swallow or do you feel food getting stuck a few seconds after swallowing? (Helps distinguish oropharyngeal from esophageal dysphagia.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do you cough or choke or is food coming back through your nose after swallowing? (Coughing, choking, or nasal regurgitation suggests aspiration and oropharyngeal dysphagia.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do you have problem swallowing solids, liquids, or both? (Liquids not solids suggests a motility disorder; solids progressing to liquids suggests a benign or malignant obstruction.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        How long have you had problems swallowing and have your symptoms progressed, remained stable, or are they intermittent? (Rapidly progressive dysphagia is concerning for malignancy.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Could you point to where you feel food is getting stuck? (Ability to localize source of dysphagia is unreliable; best with oropharyngeal dysphagia.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do you have other symptoms such as loss of appetite, weight loss, nausea, vomiting, regurgitation of food particles, heartburn, vomiting fresh or old blood, pain during swallowing, or chest pain?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do you have medical problems such as diabetes mellitus, scleroderma, Sj&ouml;gren syndrome, overlap syndrome, AIDS, neuromuscular disorders (stroke, Parkinson, myasthenia gravis, muscular dystrophy, multiple sclerosis), cancer, Chagas' disease or others?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you had surgery on your larynx, esophagus, stomach, or spine?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you received radiation therapy in the past?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What medications are you using now (ask specifically about potassium chloride, alendronate, ferrous sulfate, quinidine, ascorbic acid, tetracycline, aspirin and NSAIDs)? (Pill esophagitis can cause dysphagia.)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AIDs: acquired immune deficiency syndrome; NSAIDs: nonsteroidal antiinflammatory drugs.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1820=[""].join("\n");
var outline_f1_49_1820=null;
var title_f1_49_1821="CF infection control A";
var content_f1_49_1821=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of infection control recommendations for healthcare settings for patients with cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Setting",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommendation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Category*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"9\">",
"        General principles",
"       </td>",
"       <td>",
"        Assume all patients with CF could have transmissible",
"pathogens and apply Standard precautions",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Implement transmission-based precautions according to",
"CDC/HICPAC published recommendations",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Healthcare workers should use approved methods of hand",
"hygiene",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gloves should be worn when caring for patients who require Contact or Droplet precautions",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Published recommendations for sterilization and",
"disinfection of patient care equipment should be followed",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gowns should be worn as defined by Standard or pathogen",
"specific precautions",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wall humidifiers and \"in-line\" and hand-held nebulizers",
"should be cleaned and dried according to manufacturer's",
"recommendations; disposable and single-use items should be discarded",
"after use",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In ambulatory care settings, examination room surfaces should",
"be cleaned after the room is vacated; regular cleaning of",
"other surfaces should be on a regular basis and as soiling occurs",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PFT",
"equipment should use disposable in-line bacterial filters in between each patient; disposable mouthpieces are",
"preferred; sterilization of the internal machinery of PFT machines is",
"not needed between patients",
"       </td>",
"       <td>",
"        II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Microbiology and surveillance",
"       </td>",
"       <td>",
"        Molecular typing using approved genotyping methods",
"should be performed as epidemiologically indicated",
"       </td>",
"       <td>",
"        IA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory tract cultures should be performed at least",
"quarterly and processed for culture and susceptibility according",
"to CF-specific guidelines",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All Burkholderia cepacia complex isolates should be",
"confirmed and speciated at the Cystic Fibrosis Foundation Burkholderia",
"cepacia Research Laboratory and Repository (University of Michigan)",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Surveillance strategies should be developed in",
"collaboration with the institutional infection control team",
"       </td>",
"       <td>",
"        IB",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CF: cystic fibrosis; HICPAC: Hospital Infection Control Practices Advisory Committee; MRSA: methicillin-resistant staphylococcus aureus; PFT: pulmonary function testing; VRE: vancomycin-resistant enterococcus.",
"     <br>",
"      * Categories are based on the CDC/HICPAC system. Category IA: strongly recommended for implementation and strongly supported by well designed experimental, clinical, or epidemiologic studies. Category IB: strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies and a strong theoretic rationale. Category II: suggested for implementation and supported by suggestive clinical or epidemiologic studies or a theoretic rationale.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gibson, RL, Burns, JL, Ramsey, BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918. Copyright &copy; 2003 American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1821=[""].join("\n");
var outline_f1_49_1821=null;
var title_f1_49_1822="Survival in flail MV leaflet";
var content_f1_49_1822=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Long-term survival in flail mitral leaflet",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 196px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 229 patients with isolated mitral regurgitation due to a flail mitral leaflet, long-term survival was related to NYHA class (left panel) and left ventricular ejection fraction (LVEF) (right panel). Mortality was higher in patients with poor left ventricular function as indicated by more significant clinical heart failure (class III or IV) and lower EF (&lt;60 percent).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Ling LH, Enriquez-Sarano M, Steward JB, et al. N Engl J Med 1996; 335:1417.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1822=[""].join("\n");
var outline_f1_49_1822=null;
var title_f1_49_1823="Parous and nonparous cervix";
var content_f1_49_1823=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parous and nonparous cervix",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 494px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (top) Normal nulligravid cervix: The external os is a small, smooth circular opening. (bottom) Normal parous cervix: The external os is a large, transverse, stellate slit.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Pritchard, JA, MacDonald, PC. Williams obstetrics. 16th ed, Appleton-Century-Crofts, Prentice Hall, New York 1981. p. 23.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_49_1823=[""].join("\n");
var outline_f1_49_1823=null;
